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Abstract
Investigations in Molecular Recognition Element Selection and Single-Wall
Carbon Nanotube Properties
Ryan Martin Williams
The in vitro selection of Molecular Recognition Elements (MREs) is a powerful tool for
identifying molecules useful in numerous applications. This is achieved using the iterative
Systematic Evolution of Ligands by EXponential Enrichment (SELEX) process. This technique
utilizes a large library of 109-1015 different molecules which is enriched for those that bind to a
target of interest. It also can be designed to enrich for molecules which do not bind to other,
closely-related negative targets. We have developed a novel variation of this process called
Decoy-SELEX. This enriches molecules that bind to the target of interest, but focuses on what
the MRE should not bind to by using highly stringent negative selections with multiple targets.
We have used this novel technique to identify separate MREs for three targets. First, a singlechain Fragment variable (scFv) antibody fragment MRE was identified that binds to prostate
cancer cells but not benign prostatic cells. This molecule will be useful in the specific detection
and targeted therapy of prostate cancer. Then, a single-stranded DNA (ssDNA) MRE was
identified that binds to the herbicide atrazine but not other closely-related molecules. This
molecule will be useful in the rapid, field-use detection of environmental contamination by
atrazine. Finally, a ssDNA MRE binding to the pesticide malathion but not its metabolites was
obtained. This molecule will also be useful as an environmental sensor for malathion
contamination.
Single-wall carbon nanotubes (SWCNT) are a relatively new class of materials with
novel mechanical, electrical, and optical properties. These properties are dependent upon the
chirality and length of individual tubes, and can be altered with modifications, including
chemical conjugates, DNA-wrapping, or protein adsorption. Therefore, SWCNT have many
potential uses, including incorporation into electrical or optical molecular sensors. In order to
determine the future potential of DNA-wrapped SWCNT in sensing applications, chirality
identification, and purification, we tested their effect on the polymerase chain reaction (PCR).
We determined the reaction-limiting concentration for different DNA sequences and SWCNT
chiralities in addition to determining that DNA can be PCR-amplified directly from a SWCNT
scaffold. This study identified parameters important in future studies for SWCNT application.
Additionally, we determined the effect of DNA-wrapped SWCNT on a green algae model
organism compared to sodium cholate-wrapped SWCNT. We determined that there was no
effect of either type of SWCNT on algal growth at the concentrations assayed. This is important
as the manufacture and application of SWCNT increases, making the likelihood of
environmental exposure more prominent.
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CHAPTER 1
Introduction to In Vitro Selection of Molecular Recognition
Elements

1

1.1 Introduction
The Selective Evolution of Ligands by EXponential Enrichment (SELEX) is a method of
obtaining molecular recognition elements (MREs) that bind to a target of interest (Figure 1.1).
This in vitro process is a powerful tool for selecting molecules useful in the specific detection or
treatment of targets of interest. Selectivity for a certain molecule or disease state can be ensured
in designing the experiment with expected use of the final product being considered.

Figure 1.1. Visual depiction of Molecular Recognition Element (MRE) binding. A MRE is
any molecule with strong and specific binding to a target of interest.
The SELEX, or in vitro selection, method obtains one or a few molecules that bind to the
target with high affinity and specificity. These MREs are selected from a large library of 1071015 random molecules. SELEX was originally described independently by the laboratories of
Gold and Szostak in 1990 (Ellington and Szostak 1990; Tuerk and Gold 1990). These
experiments selected RNA MREs that bind to proteins. Both ribonucleic acid (RNA) and
deoxyribonucleic acid (DNA) MREs have been selected that recognize a range of targets, from
single ions and small molecules to nanoparticles and proteins (Paborsky et al. 1993; Breaker and
Joyce 1994; Huizenga and Szostak 1995; Gugliotti et al. 2004). These molecules are typically
referred to in the literature as aptamers. The same SELEX method has been used to develop
antibody fragment and peptide MREs that bind to small molecules, proteins, nucleic acids, and
nanoparticles (Boder et al. 2000; Schaffitzel et al. 2001; El-Mousawi et al. 2003; Kase et al.
2

2004). The wide variety of MRE libraries and potential targets speaks to the numerous
applications of SELEX.
The SELEX process uses a large library of random molecules that are incubated with the
target of interest (Figure 1.2). Those molecules that bind to this target are kept and amplified,
while those that don't are discarded. The amplified binding molecules are then incubated with
negative targets, something the final MRE is designed to not bind to. Those molecules that do
bind these targets are discarded and those that don't are amplified and re-subjected to the target
of interest. This process of targeting and negative targeting is performed (rounds of selection)
until one or a few high-affinity molecules remain in the library. The selected MREs are then

Figure 1.2. Scheme depicting the iterative SELEX process. A large pool of random
molecules is incubated with the target of interest. Non-bound molecules are washed away while
bound are amplified and subjected to negative targets. Non-bound molecules are amplified and
re-subjected to the target under more stringent conditions.
assayed for their binding affinity and selectivity before they are used for various applications.
Regarding amino acid libraries, amplification typically occurs by use of a cellular host. For
DNA and RNA libraries, amplification occurs via the polymerase chain reaction (PCR).
3

Molecular recognition elements have been selected that bind to molecules displayed on
the surface of cells. Originally performed by the Gold laboratory, DNA MREs that bind to the
surface of red blood cells were selected (Morris et al. 1998). This work showed the ability to
select MREs that bind to molecules displayed on cell surface membranes in their natural state.
Since that time, SELEX has been used to select MREs that bind to cell surface molecules that are
differentially expressed on the surface of cells. DNA ligands have been selected that bind to the
vasculature of rat brain glioblastoma and not normal rat brain vasculature (Blank et al. 2001).
Other nucleic acid MREs have been selected that bind to molecules on the surface of cancer cells
but not other types of cells (Shangguan et al. 2008; Sefah et al. 2009; Zhao et al. 2009). This
type of MRE selection provides the dual benefits of binding to anchored molecules and taking
advantage of differences in surface expression of cells for the therapy and diagnosis of disease.
Compared to DNA and RNA MREs, amino acid-based MREs potentially provide the
stability and specificity of antibodies in vivo (Table 1.1) (Nelson 2010; Li et al. 2011).
Additionally, the non-reversible nature of their target interaction and high binding affinity is an
advantage in tumor cell targeting. While having the positive attributes of antibodies in vivo,
these MREs are selected in vitro. Therefore, more control over their binding target is possible
for the experimenter. This includes the ability to preferentially select molecules which bind to a
target but not a closely-related target. In the case of differential cell SELEX, differential surface
molecule expression is taken advantage of for MRE binding (Cerchia et al. 2009). The result of
amino acid MRE selection using differential cell SELEX is a molecule that has the advantages of
antibodies with tunability in the experimental design.
Nucleic acid MREs have been investigated for their potential as in vivo diagnostic and
therapeutic tools (Cerchia et al. 2002; Ireson and Kelland 2006; Lee et al. 2006; Guo et al. 2008;
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Kim et al. 2009). It is possible that they will be degraded in the body by nucleases, however
there are modification strategies to overcome this (Kanwar et al. 2011). In fact, Macugen
(pegaptanib) is an anti-vascular endothelial growth factor (VEGF) nucleic acid MRE currently
used in the clinic for macular degeneration (Moshfeghi and Puliafito 2005). This drug, however,
is only used in the relatively closed environment of the eye, while Avastin (bevacizumab) is an
anti-VEGF antibody used in anti-cancer therapy (Jain et al. 2006). Thus, there are modifications
for using nucleic acid MREs in vivo, but amino acid MREs may be more useful.
Despite limited use in vivo, nucleic acid MREs have great potential for molecular
detection in a variety of other settings. This is due to their typically strong affinity and
selectivity, as well as their ability to be re-used. They can be denatured to release the target of
interest after a binding event, and regenerated for further detection of the analyte (Ocana et al.
2012). Additionally, it is possible that nucleic acid MREs change their conformation upon
binding their target, which can be capitalized on for detection transduction (Liu et al. 2010).
Therefore, DNA and RNA MREs have a great deal of potential that is not found with antibodies
or amino acid MREs.
There are advantages and disadvantages for DNA MREs compared to RNA MREs.
Reports have shown that RNA MREs have a higher affinity for their target in general than DNA
MREs (Potty et al. 2011). This is likely due to the inclusion of a 2' hydroxyl in the ribose
backbone of RNA. However, nucleases that target RNA are much more abundant than those that
target DNA, and thus identifying and applying RNA MREs is much more difficult.
Additionally, PCR amplification of RNA is more difficult, as it must first be reverse-transcribed
to DNA beforehand. Thus, DNA MREs typically are more stable and suitable for most
applications, though RNA MREs do have value.

5

Discussed here is an overview on the creation of both amino acid and nucleic acid
libraries for SELEX experiments. Then, selections for different types of each and finally, their
applications, are investigated. Selection of antibody fragments for cell surface molecules and of
nucleic acids for small molecules is focused upon.
Table 1.1. Summary of the advantages of the four most typical types of MRE libraries.
Type of Library Library
Advantages
Subtype
Amino Acid

-In vivo stability
-Diversity of 20 amino acids,
Peptide

-Well-studied
-Widely available libraries

Antibody
Fragment

-Antibody structure and diversity selectable in vitro
-Final product can be made into a full antibody
-Pharmacological profile similar to antibodies which are
clinically available
-Large and diverse libraries easily obtained through
combinatorial chemistry

Nucleic Acid

-Easily distributable (only need to know sequence to make
your own)
-Re-usable (can be removed from a target and regenerated for
future use)
-Easily modifiable
DNA

-Easier to work with and less degradable than RNA
-Very useful in molecular detection

RNA

-Typically higher affinity than DNA
-Useful for sensing

6

1.2 Methodology Overview
1.2.1 Amino Acid Library Creation
Amino acid libraries used in SELEX are typically displayed on the surface of living
microorganisms. Generally, coding regions are inserted into phage, bacteria, or yeast that
encode for surface expression of the randomized library. After expression of the library, it is
incubated with the target cells of interest. Those that do not bind are discarded while those that
do bind are kept and amplified. This amplification is performed by the natural replication of the
microorganism. This enriched library is then incubated with the negative target cells. Those
molecules that bind these cells are discarded while those that do not are amplified. Between
every few rounds, the diversity of the enriched library is assayed by DNA sequencing of the
amino acid library-encoding plasmid. The process continues until just one or a few specific and
strongly-binding amino acid MREs are present. These are then assayed for their binding,
specificity, and stability.
1.2.1.1 Phage Display
Bacteriophage have been used to display amino acid libraries. Libraries of short, random
peptides that are displayed on the surface of phage have been used for SELEX experiments and
are commercially available (e.g. Phage Display Peptide Library from New England Biolabs;
Beverly, MA). These typically consist of 7-15 random peptides displayed by fusion to a surface
protein. An example of this is the pIII protein of M13 phage, which is necessary for phage
infection of Escherichia coli (Giebel et al. 1995). Random nucleic acid codons are synthesized
and inserted into the plasmid for protein fusion. These libraries often consist of approximately
109 different peptides.
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Additionally, a single chain Fragment variable (scFv) antibody fragment library has been
constructed that is displayed on M13 phage (Pansri et al. 2009). An antibody fragment (Fab)
library has also been constructed that is fused to the surface protein D of bacteriophage lambda
(Huse et al. 1989). In this case, non-immune human antibody fragments are amplified from
donors and constructed into a vector which displays the fusion protein on the virus surface. It
has been noted that phage lambda is more capable of displaying large antibody fragments than
M13 (Vaccaro et al. 2006).
Phage displayed amino acid libraries offer the advantages of rapid screening and
amplification for the SELEX process. Selected phage are incubated with E. coli and plaques are
produced. The replicated phage are then subjected to the next round of selection. The method
used for SELEX is often panning (see below). While rapid, this method is not as efficient at
isolating specific molecules as fluorescent activated cell sorting (FACS) (see below). A careful
outline for the use of phage display has been published (Kay et al. 2001). Rapid and efficient
amplification coupled with detailed protocols allow phage displayed amino acid libraries to be
useful tools in cell SELEX.
1.2.1.2 Bacterial Display
Another platform for amino acid library display is through the use of bacterial hosts. A
peptide display library of 12 random amino acids has been displayed as fusions to the E. coli
flagellin gene (Lu et al. 1995). This library contains approximately 5 X 1010 different peptides
and is available commercially (Invitrogen; Grand Island, NY). A library of the same size
consisting of 15 random peptides has been displayed as a fusion to the E. coli outer membrane
protein A (ompA) (Bessette et al. 2004). These libraries offer the rapid and efficient screening
necessary to create a MRE.
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Antibody fragment display has also been performed in bacterial systems. A sub-library
of scFv molecules in E. coli was created by PCR randomization of immune antibody fragments
(Daugherty et al. 1998). Additionally, scFv molecules have been expressed as fusions to the
surface protein A of gram-positive Staphylococcus carnosus (Gunneriusson et al. 1996). These
constructs, however, have not been extensively explored for display of entire libraries or their
use in SELEX experiments.
Bacterial display of amino acid libraries provides the benefit of rapid screening and
amplification. Furthermore, they can be used in both panning and FACS-based separation
(Kronqvist et al. 2008). While not as widely used as phage libraries, these libraries do not
require multiple hosts, therefore increasing speed of the selection. In addition, detailed protocols
for their use are available (Lu et al. 2003). These benefits render bacterial display of amino acid
libraries a potential avenue for new developments in developing MREs.
1.2.1.3 Yeast display
Yeast display of amino acid libraries is a widely-used platform for generating MREs. A
library consisting of approximately 107 random twelve amino acid peptides has been constructed
(Krauland et al. 2007). It was formed as a C-terminal fusion to the Aga2p protein that is
expressed on the surface of Saccharomyces cerevisiae. This library has proven to be of use in
the selection of MREs.
The use of S. cerevisiae to display antibody fragments has also been extensively
explored. This microorganism has been used to display a scFv library of approximately 109
different antibody fragments (Boder and Wittrup 1997). This library is freely available from the
Pacific Northwest National Laboratory (PNNL; Richland, WA). A Fab sub-library has also been
constructed that displays on the surface of yeast (van den Beucken et al. 2003).
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Yeast display of amino acid libraries offers the advantages of use in FACS, as most
include sequences for fluorescent protein tagging. Importantly, eukaryotic yeast have the ability
to perform post-translational modifications not available in bacteria or phage. This allows for
expressing the full diversity of antibody fragment libraries (Feldhaus and Siegel 2004). The
described yeast systems also offer easy secretion and purification of selected MREs. Protocols
for using these libraries are also easily available (Wang and Shusta 2005; Chao et al. 2006).
These attributes allow the use of yeast in protein expression platforms to be an important tool in
obtaining MREs by cell SELEX.
1.2.2 Nucleic Acid Library Creation
The design of a single stranded nucleic acid library for in vitro selection largely focuses
on determining constant regions for PCR amplification. These are often designed by individual
laboratories, however both DNA and RNA libraries are available for commercial purchase (e.g.
TriLink BioTechnologies; San Diego, CA). A DNA library itself consists of two regions with
known bases flanking a region with randomized bases. A RNA library also contains a promoter
region to allow for reverse transcription of the library before PCR amplification. The greatest
consideration in designing a DNA library is abrogating primer dimer formation and primer
secondary structure effects. It is important to determine whether designed primer sequences will
bind to each other or themselves (hetero- and homo-dimers), or if their reverse complement
sequences will bind to one another, as all four sequences will be in the amplification reaction.
Additionally, highly favorable secondary structures of primer sequences may inhibit PCR, and
thus needs to be avoided for all four primer sequences. These can easily be interrogated using
online PCR primer design software (e.g. Integrated DNA Technologies; Coralville, IA). The
size of the randomized region must next be determined. This region must be designed to confer
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the pool sufficient diversity, which can be represented by 4n, with n being the number of random
bases in the pool. For example, a pool with 34 random bases will have 434, or approximately
2.95 X 1020, different possible sequences. Thus, longer random regions contain exponentially
greater possible sequence space. In spite of this, longer random regions are more difficult to
analyze for consensus binding sequences and are more likely to form secondary structures which
inhibit PCR amplification. Therefore, random regions are typically between 20 and 80 bases,
making overall libraries shorter than 150 bases (Hall et al. 2009). Longer regions are sometimes
necessary, for example in obtaining catalytic MREs (Sabeti et al. 1997).
After design of the library for either DNA or RNA selections, it may be chemically
synthesized using phosphoramidite chemistry (Hall et al. 2009). The library must then be
purified from remnants of the synthesis reaction, and PCR amplification conditions optimized.
During this optimization step, the library may not amplify properly, and it will be necessary to
re-design it to suit the researcher's needs. Up to 1015 different sequences in the library are then
incubated with the target of interest to begin the in vitro selection.
1.2.3 Amino Acid Separation Methods
A necessity of the SELEX process is separating molecules that bind to the target from
those that don't. In cell SELEX, this is typically done by panning, magnetic sorting, or FACS.
Often, a combination of these methods is used in order to most efficiently select MREs with high
affinity (Table 1.2).
Panning, as used in cell SELEX, is a method of incubating the library with the target cells
directly in the tissue culture well or flask. The unbound microorganism-displayed molecules are
simply aspirated or decanted. The flask is washed typically three times taking care not to detach
the target cells. The bound molecules are then amplified by replication of their host. This
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process is most thoroughly described for phage-displayed libraries (Watters et al. 1997; McGuire
et al. 2009) but has also been explored for yeast libraries (Wang and Shusta 2005). For phage,
the bound molecules must be eluted and plated on bacteria for replication. In bacterial or yeast
libraries, however, the appropriate microbiological media can be added to the cell culture flask or
the human cells can be scraped from the flask. The enriched library-containing bacteria or yeast
will amplify in this media, while any remaining human cells will not survive under these
Table 1.2. Typical methods of separation in SELEX.
Method
Commonly Used With
Advantages
Amino acid libraries, some
High throughput,
Panning
filter-immobilized targets
quick
with nucleic acid libraries
Magnetic
Separation/
MACS*

Typical for magnetic beadimmobilized targets with
nucleic acid libraries, MACS
can be used for amino acid
library separation

High throughput

FACS*

Typical for amino acid
libraries

Non-magnetic
target
immobilization

Nucleic acid libraries; e.g.
filter columns

Very powerful
separation ability
with efficient
tunability
Rapid, cheap, high
throughput

Disadvantages
Less powerful
separation, some
undesired molecules
remain after washes
Limited space if
using large cells
(clogging), higher
failure chance
compared to
panning with no
advantages
Lower throughput,
slower processing,
expensive
equipment
Less powerful
separation, may
require many rounds

Very powerful
Expensive and
separation ability
expertly-used
with efficient
equipment
tunability
*MACS is Magnetic-Activated Cell Sorting. FACS is Fluorescence-Activated Cell Sorting.
Capillary
Electrophoresis

Nucleic acid libraries

conditions. Regarding negative selections, the unbound library molecules are removed by
careful pipetting. The collected host organisms are then placed under optimal growth conditions.
This method of separation is robust for large libraries. However, flocculation of the host
12

organisms or inefficient removal of non-binding molecules is possible. This creates an enriched
library that contains some molecules that do not bind to the target. Therefore, panning is an
efficient method of initial screening for the first few rounds of SELEX.
Magnetic sorting is another mechanism for separating binding for non-binding molecules.
Often, magnetic-activated cell sorting (MACS) is used as a pre-enrichment procedure for similar
reasons to those for panning. In the case of non-cellular targets such as proteins, the target is
typically attached to magnetic beads and the library is passed through the column (Rice et al.
2006). A variation of this used a B cell antigen to bind chronic lymphocytic leukemia cells to
magnetic beads for use with a phage library (Takahashi et al. 2003). The library molecules
bound to the target are then eluted and replicated under appropriate conditions (or unbound
molecules for negative selections). While useful for robust screening, this method may be
difficult for use in cell SELEX due limited space within the column when considering human
cells and library host cells are present. Therefore this method requires more preparation and
greater potential for failure while performing the same pre-enrichment task as panning. It is for
these reasons that the use of MACS for cell SELEX in obtaining amino acid MREs is rare in the
literature.
Fluorescence-activated cell sorting (FACS) is often used to select MREs that bind to
molecules on the surface of cancer cells. This method uses dual fluorescent labeling of the
library and the target cells, which are removed from the culture flask. After incubation together,
this mixture is subjected to FACS, wherein the software is instructed to collect events
corresponding to double fluorescence. For negative targeting, collecting single fluorescent
events corresponding to the library alone will render molecules that do not bind to the target. A
basic protocol for yeast-displayed scFv library SELEX using FACS has been described
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(Feldhaus et al. 2003). Additionally, a bacterial-displayed peptide library has been used for cell
SELEX through the FACS method (Dane et al. 2006). The greatest advantage of FACS is the
tunability of separation parameters and extremely efficient enrichment of binding molecules. It
does, however, take considerably longer to screen very large numbers of cells. This is
exacerbated when using two largely different cell sizes, as is the case with human and bacterial
or yeast cells. Also, expensive equipment and expertise in operation is necessary. Therefore,
FACS is more efficiently used after the library has been enriched and it is not necessary to use a
large number of host cells to ensure full diversity is represented.
1.2.4 Nucleic Acid Separation Methods
Just as in selection of amino acid MREs, it is necessary to remove molecules that are not
bound to the target of interest. Typically, this involves immobilization of the target of interest
onto a substrate. There are separation techniques, such as capillary electrophoresis, that do not
require this however (Mosing et al. 2005).
Immobilization of the target of interest is the most common form of nucleic acid MRE
selection. This can be done with magnetic beads for manipulation in solution by a magnet,
allowing library molecules not bound to the immobilized target to be simply washed away
(Stoltenburg et al. 2005). This method has been successful for both protein and small molecule
targets (Wang et al. 2009; Kim et al. 2010). Additionally, both protein and small molecule
targets have been immobilized onto non-magnetic beads for column chromatography-based
selection of MREs (Jackson et al. 2009). Protein targets can also be adsorbed onto nitrocellulose
filter paper, however this is more difficult for small molecule targets (Ulrich et al. 1998; Sayer et
al. 2002). A variation of this technique is to immobilize the target onto a microfluidic chamber
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for rapid MRE identification (Lou et al. 2009; Ahn et al. 2011). Immobilization of the target
typically occurs by conjugation through combinatorial chemistry approaches or adsorption.
Other immobilization techniques have been developed, however they all ensure facile separation
of bound from unbound molecules.
1.3 Amino Acid Molecular Recognition Elements for Cell Surface Targets
1.3.1 Peptide MREs
Molecular recognition elements selected from peptide libraries have been extensively
explored. Especially from phage display libraries, the cell SELEX procedure has been used to
select MREs that bind specifically to tumor cells. Peptides are short sequences generally less
than 25 amino acids. Libraries with a very large diversity can be formed drawing from the
inherent diversity of the 20 amino acids. A theoretical maximum for a 25 amino acid library is
~1032 (2025) or 1.28 X 109 for a seven amino acid library. However, typical construction
techniques and reasonable working volumes typically limit library size to around 1010 molecules.
Additionally, there is some bias in insertion of particular amino acids (Krumpe et al. 2006). A
breakthrough in peptide library construction was the introduction of codon phosphoramidites
(Glen Research; Sterling, VA), which ensures no premature stop codon or insertional biases are
present. Compared to antibody fragment libraries, there may be less inherent structure within the
MRE, but randomness is ensured.
Peptide MREs in cell SELEX have largely been selected through phage display methods.
An example of this is the selection of peptide MREs that bound to the B-cell lymphoma line A20
(McGuire et al. 2006). This experiment did not use differential cell SELEX, but they were able
to differentiate lymphoma cells from other normal white blood cells. In another study, primary
chronic lymphocytic leukemia (CLL) cells were the targets of phage selection using a modified
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MACS protocol (Takahashi et al. 2003). This study also did not use negative cell lines, however
a panel of peptide MREs were selected that bound to different types of blood cells. A study
performed that selected peptide MREs for non-small cell lung cancer (NSCLC) cell lines also did
not use a negative target cell (Chang et al. 2009). One of the selected peptides, however, was
successfully used for in vivo chemotherapeutic delivery studies. It is therefore possible to select
useful peptides without a differential component of the selection.
The likelihood of selecting one or a few specific MREs that are fit for their expected use
is increased if negative targets are used. One study selected for peptides that bound to the breast
cancer cell line BT-474 but not the benign cell line MCF 10A (Shukla and Krag 2010). This
study even did a negative selection against the tissue culture flask itself. This, however, seems to
be inherent if negative selections are performed in the same type of flask as positive selections.
The selected peptides did not bind to any of four benign cell lines that were used for binding
studies. They bound to some, but not all, tumor cell lines studied and internalized into some.
Another study with breast cancer cells selected for peptides that bound to HER positive SKBR-3
cancer cells but not HER negative MCF-10A benign cells (Abbineni et al. 2010). The selected
peptides showed homology to other ligands for HER2, however the actual cell surface target
molecule was not determined. Other studies targeting a follicular thyroid carcinoma cell line
(Zitzmann et al. 2007) and separate colorectal tumor cell lines (Rasmussen et al. 2002; Kelly and
Jones 2003) have been performed. Separate studies using the metastatic prostate cancer cell
lines LNCaP (androgen sensitive) and PC-3 (androgen insensitive) selected peptides that showed
no real homology between the reported sequence sets (Romanov et al. 2001; Jayanna et al.
2010). As these peptide sequence families did not converge, it can be concluded that they were
not binding to the same cell surface molecule. Therefore it is likely these could be used together
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to differentiate the two forms of prostate cancer and potentially define cell surface molecules
present in one but not the other.
There also have been variations of the phage display peptide MRE selection process. A
bacterial peptide display library has been used to select molecules that bound to breast
adenocarcinoma cells ZR-75-1 but not benign cells (Dane et al. 2006). A variation on phagedisplayed peptide panning has been performed in a microfluidic system for semi-automated
selection of MREs (Wang et al. 2011). The above examples of using peptide libraries for
selecting MREs express their potential in quick and efficient screening of random molecules to
obtain diagnostically or therapeutically useful tools.
1.3.2 Antibody Fragment MREs
Antibody fragment MREs have also been selected that specifically bind to tumor cells.
Antibody fragment libraries can be in the form of scFv, Fab, or others. These libraries typically
have diversity on the order of 109-1010 molecules. This well exceeds the natural potential
diversity of the human immune system, which has a maximum of approximately 107 different
antibodies (based on heavy and light chain combinations of genetic diversity). Therefore,
antibody-like MREs can be selected from libraries with much greater diversity than in vivo
antibody production. It is likely that strong and specifically binding antibody fragments will be
selected for cancer cells using differential cell SELEX.
Multiple studies have selected MREs that bind to tumor cells but not normal cells or
other types of tumor cells. Two separate studies selected scFv MREs that bind to androgen
insensitive prostate cancer cell lines. One targeted PC-3 cells and did negative selections with
normal prostate cell lines (Liu et al. 2004). The other targeted the C4-2B cell line, which is
derived from LNCaP cells that were used as a negative target (Conrad et al. 2009). The selected
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antibody fragments were used for separate purposes, but the differences in selection design make
it unlikely the MREs bind to the same surface molecule. Other studies have selected scFv MREs
specific for melanoma cells (Kupsch et al. 1999), hepatocarcinoma (Yu et al. 2005), and ex vivo
breast cancer tissue (Jakobsen et al. 2007). Additionally, Fab MREs have been selected that bind
to T-cell malignancies (Willemsen et al. 2008) and ovarian carcinoma cells (Figini et al. 1998).
Antibody fragment MREs offer the specificity and pharmacological characteristics of
monoclonal antibodies. Additionally however, they offer the selectivity and relative ease in
production provided by the differential cell SELEX process. Their multiple potential uses
therefore make their selection a strong method for cancer cell studies using SELEX.
1.4 Small Molecule Nucleic Acid Molecular Recognition Elements
1.4.1 DNA MREs
Molecular recognition elements in the form of DNA have been obtained for a wide
variety of targets. These include ions of lead, mercury, and arsenic, among others (Kim et al.
2009; Chung et al. 2012). They also include protein targets such as vasopressin, protein kinase
C, VEGF, and many others (Williams et al. 1997; Mallikaratchy et al. 2006; Hasegawa et al.
2008). A variation of this includes the selection of DNAzymes, which are selected to have
enzymatic activity (Zhu et al. 2012). Another is the selection of double-stranded DNA MREs
that bind to transcription factors (Sooter and Ellington 2004).
There have been a large number of MREs selected for small molecule targets for a
variety of purposes. These include the identification of molecules such as ATP within cells
(Huizenga and Szostak 1995), detection of pharmaceutical or illicit drugs such as theophylline
and cocaine in biological contexts (Liu and Lu 2005; Chavez et al. 2010). DNA MREs have
also been selected for environmental monitoring and contaminant detection purposes. Examples
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of this include identifying MREs for pesticides such as acetamiprid or a variety of
organophosphates (He et al. 2011; Wang et al. 2012). It has been shown that small molecules are
specifically able to intercalate between bases of a DNA MRE in a sequence-dependent manner
(Lin and Patel 1997). Additionally, normal antibody production against small molecule haptens
require use of an immunogenic carrier, whereas in vitro selection does not, thus increasing
specificity of the final binding element (Askonas et al. 1970).
DNA MREs offer a simplified and straightforward selection protocol, as discussed
before. Additionally, they are stable as compared to RNA MREs, plus regenerative ability
compared to antibodies. They are also very useful for molecular detection, as many references
utilize them in this manner. Therefore, selection of DNA MREs offers an ideal molecular
detector for detecting small molecules in complex environments.
1.4.2 RNA MREs
RNA MREs were historically the first to be identified (Ellington and Szostak 1990;
Tuerk and Gold 1990). These molecules were originally identified to bind to protein targets, and
many more examples have since been reported. There are also examples of the selection of
ribozymes, which have catalytic activity often reliant on heavy metals (Wilson and Szostak
1999; Robertson et al. 2004).
There have also been numerous examples of RNA MREs for small molecule targets
(Codrea et al. 2010). Similar to DNA, there have also been RNA MREs selected for ATP
(Dieckmann et al. 1996). Additional examples include antibiotics such as chloramphenicol,
tetracycline, and kanamycin, among many other types of targets (Burke et al. 1997; Berens et al.
2001; Goertz et al. 2004). Small molecule binding to RNA MREs is likely to occur similarly to
DNA MREs.
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RNA MREs typically have a high affinity and specificity for their target of interest.
Additionally, these molecules offer many of the same molecular detection applications that DNA
MREs do. They are, however, less straightforward to select and more likely to be degraded if
used to detect their target in complex matrices. There are examples of modifications at their 2'
hydroxyl which lower their degradation, however this often negates their advantage of having a
higher binding affinity (Cui et al. 2004; de-los-Santos-Alvarez et al. 2007). It is therefore more
straightforward with a higher probability of successful detector integration to select DNA MREs
than RNA MREs.
1.5 Molecular Recognition Element Applications
1.5.1 Amino Acid Molecular Recognition Element Applications
1.5.1.1 Therapeutics
Amino acids in the form of monoclonal antibodies have been widely used as therapeutics
(Brekke and Sandlie 2003). Well-known examples include trastuzumab (HerceptinTM:
Genentech Inc.; San Francisco, CA) for HER2 positive breast cancer treatment and bevacizumab
(AvastinTM: Genentech Inc) that binds to vascular endothelial growth factor (VEGF). These
examples, among others, show the potential of amino acid-based therapeutic intervention.
Peptide therapeutics have been developed and used for a variety of diseases. Examples
of these are to inhibit infection (Oyston et al. 2009) and inflammatory diseases (Vally et al.
2006). A review of therapeutic peptides obtained by phage display selection is available (Ladner
et al. 2004). Examples of commercial peptide therapeutics include HumulinTM (Lilly;
Indianapolis, IN) for diabetes treatment and leuprolide (LupronTM: Abbott Laboratories; Abbott
Park, IL) for metastatic prostate cancer treatment. Peptides obtained by cell SELEX are
therefore possible alternatives to antibodies for cancer treatment.
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Antibody fragments have also been used therapeutically. As of 2009, approximately 90
scFvs had been patented in the U.S., with about 30 being specifically for cancer therapeutics
(Pucca et al. 2011). The humanized h5G1.1-scFv specific for complement protein C5
(pexelizumab: Alexion Pharmaceuticals; Cheshire, CT) has undergone clinical trials for its
ability to reduce myocardial infarction after coronary artery bypass surgery (Smith et al. 2011).
This molecule was not selected by SELEX, but was engineered from a previously-selected
monoclonal antibody (Evans et al. 1995). The results of clinical trials are mixed (Lin 2011),
however the pharmacological profile of the antibody fragments does appear to be safe (Fitch et
al. 1999). It is just one of 19 scFvs to reach clinical development as of 2010 (Nelson 2010).
There have also been 22 Fabs to reach clinical trials, 3 of which have been approved (Nelson
2010). While some of these antibody fragments were engineered from monoclonal antibodies, it
is clear that scFv treatments obtained from SELEX will be useful and more specific for cancer
treatment.
Another scFv molecule that binds to the HER2 receptor on the surface of tumor cells has
undergone clinical trials. The antibody fragment was produced similar to the previous one,
however it was conjugated to exotoxin A (scFv-ETA) (Wels et al. 1992). The results of the trials
proved safe, and the drug was moderately effective (von Minckwitz et al. 2005). This use of
antibody fragments in tumor cell treatments shows the potential for specific drug delivery of
various therapeutics.
The use of amino acid MREs is clearly a potentially fruitful field. The experimental
tunability for selectivity and in vivo stability has been previously demonstrated. Recently,
theranostics, or the dual use of single molecules for therapeutic and diagnostic purposes, has
become popular (Goldenberg et al. 1990). There is clearly the possibility of using amino acid
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MREs that have been conjugated to contrast materials as in the previous study. The use of
MREs obtained by cell SELEX in therapeutics and/or diagnostics has only begun to be explored
but represents great potential.
1.5.1.2 Disease Detection
Amino acid MREs for detection of disease is a potential clinical application of these
molecules. For biomarker-based cancer detection, blood is typically extracted and subjected to
immunoassays with monoclonal antibodies. There also lies the potential for magnetic, radio-, or
fluorescent labeling of these antibodies for diagnostics. Antibodies used in these assays do not
always bind to molecules that represent disease states. For example, anti-PSA antibody used in
prostate cancer detection has a false-positive rate over 75% (Thompson et al. 2006). These uses
make it important to obtain molecules that specifically detect malignant cells.
Initial research using peptide MREs obtained by SELEX have been promising. Ex vivo
human and in vivo mice studies using colon cancer-specific peptides have been performed (Kelly
et al. 2004). Using radiolabeled and fluorescent peptides, favorable pharmacological profiles
and detection were observed. Similar results were found using an anti-prostate cancer peptide
selected by phage display (Zitzmann et al. 2005). While not extensively explored for clinical
use, peptide MREs may have great diagnostic potential.
Similar studies to those performed with peptide MREs have been done with antibody
fragments (Goldenberg et al. 1990). Another potential use of antibody MREs is in ex vivo
diagnostics such as immunoassays or microfluidic cell capture. Though using a monoclonal
antibody, previous studies have shown the ability to capture circulating tumor cells with
antibodies in a microfluidic device (Goldenberg et al. 1990). There is the obvious potential for
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application of antibody fragment MREs to a similar device. These and other uses make the
diagnostic potential of amino acid MREs extremely important.
1.5.1.3 Surface Molecule Elucidation and Discovery
Whether the selected MRE is nucleic or amino acid, it can be used to learn more
information about its target cell. An important attribute of cell SELEX is that no a priori
knowledge of the cell surface molecular target is necessary. It is also likely that cells in disease
states will express surface molecules differently than normal cells. No previous knowledge of
this differential expression is necessary however, because the differential cell SELEX process
will take advantage of this fact in selecting MREs.
The cell SELEX process has been used to select MREs which aided in identification of
their own surface ligand. DNA MREs have been selected that bound to tenascin C
overexpressing cells and not unaltered cells (Daniels et al. 2003). As predicted, the MREs bound
to tenascin C. Another study determined that ICAM-1, an intercellular adhesion molecule, was
the target of scFv MREs selected on androgen-insensitive prostate cancer cells (Conrad et al.
2009). DNA MREs have also been used to discover new proteins expressed on the surface of
dendritic cells (Berezovski et al. 2008). These works show that overexpression of a surface
protein does allow MRE selection against them. Additionally, novel or confirmatory roles of
previously described molecules can be determined. There also lies the potential for discovery of
new cell surface molecules or biomarkers. This use of MREs is potentially very important for a
fundamental understanding of disease proteomics.
1.5.2 Nucleic Acid Molecular Recognition Element Applications
Nucleic acid MREs have great potential in multiple settings. Predominant among these is
analyte binding in biosensors. Both DNA and RNA MREs have been incorporated into sensors
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(Cho et al. 2009). Typically, these come in the form of optical, electrochemical, or mass
sensitive sensors, sometimes with the incorporation of various nanoparticles for signal
transduction (Song et al. 2008). As noted previously, nucleic acid MREs function well in this
setting because they can be obtained for most targets, can be modified and incorporated into
devices, are relatively stable, often change shape upon ligand binding, and are reusable.
Nucleic acid MRE-based sensors have been developed utilizing many different
modalities. For example, sensors for just ATP have been developed using DNA MREs
integrated into many types of sensors, including those utilizing field-effect transistors (Goda and
Miyahara 2012), fluorescent detection (Urata et al. 2007; Wang et al. 2008), quantum dot
luminescence (Huang et al. 2010), surface-enhanced Raman scattering (Li et al. 2012), carbon
nanotubes (Zhang et al. 2010), microbalances (Ozalp 2011), electrochemical transducers (Zuo et
al. 2009), and many others. These encompass the three main detection modalities mentioned
above, and give just a small swath of the large spectrum of methods possible with nucleic acid
MREs.
In addition to these many detection methods, MRE-based sensors have been developed
for many different targets. These include small molecules such as ATP as noted above, cocaine
(Zhou et al. 2012), tetracycline (Kim et al. 2010), and many others. They also include proteins
such as thrombin (Cho et al. 2008) and anthrax protective antigen (Cella et al. 2010), and insulin
(Yoshida et al. 2009), among others. It is noteworthy that many of these detection mechanisms
are modular in that a separate MRE can be used within the same design to detect new analytes.
In addition to detection, nucleic acid MREs have been investigated for various
biomedical applications. As noted earlier, Macugen™ (pegaptanib) is in the clinic for macular
degeneration treatment. Other MREs have been used for in vivo therapeutic delivery of drug-
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loaded particles (Wu et al. 2010). They can be integrated into the membrane of lipid-based
particles, or immobilized onto the surface of certain manufactured nanoparticles, each having a
drug-release mechanism (Yu et al. 2011; Li et al. 2012; Sundaram et al. 2012). Furthermore,
they have been complexed with positron emitters, fluorophores, radiolabels, or other transducing
elements for in vivo imaging of molecular expression (Tavitian et al. 2009; Shi et al. 2010; Yu et
al. 2011). In spite of these applications, they have not been as widely moved into clinical
settings as antibodies, largely due to drawbacks previously discussed.
In total, nucleic acid MREs have a wide array of potential applications. They have been
studied for their biomedical uses; however their properties allow them to be more useful in
biosensors. Thus, nucleic acids MREs will be the focus of molecular detection for sensing
applications.
1.6 Conclusions
Selection of MREs using differential cell SELEX represents a powerful method of
differentiating between cell types. This process requires no prior knowledge of cell surface
molecule expression and takes advantage of differential expression profiles. Peptide and
antibody fragment libraries, the host on which the library is displayed, and the selection method
each have advantages and situations in which they are useful. Expansion of host scaffolds has
been performed, even using cereal crops (Stoger et al. 2000) and human HEK-293T cells (Ho
and Pastan 2009) to display engineered scFv molecules. As more MREs are being developed, it
is certain that their uses and clinical investigation will continue to expand.
Nucleic acid MREs have a many ideal applications, and are able to be obtained for a wide
array of targets. They yield a powerful method of molecular binding and differentiation of
molecules. As discussed, they are particularly useful in biosensors for detection of various
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analytes. Increasingly more detection modalities are being developed and are only limited by
creativity of their integration. Therefore, the continued selection and investigation of nucleic
acid MREs is important for a variety of applications.
Therefore, the work discussed herein developed different types of MREs for different
applications. In total, the SELEX process was applied to obtaining MREs for three different
targets. Specifically, this work developed and utilized a novel variation called Decoy-SELEX
which focuses on what the final MRE should not bind to. As in classical SELEX, the library is
enriched for the target of interest, however many stringent negative selections are performed.
Antibody fragment MREs were obtained that could bind to prostate cancer cells and differentiate
between them and benign prostatic cells. These have potential in surface molecule discovery,
cancer detection, and targeted therapy. Separately, DNA MREs were obtained for two small
molecule pesticides, atrazine and malathion. These have potential use as binding molecules in
biosensors for these environmental contaminants. In total, each MRE has strong affinity and
discriminatory power, as well as multiple potential applications building upon this work.
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CHAPTER 2
In Vitro Selection of Single-Stranded DNA Molecular Recognition
Elements for the Herbicide Atrazine
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2.1 Introduction
Atrazine is a chlorotriazine herbicide used widely in crop production. An estimated 76.5
million pounds are used per year in the United States alone (USGS 2002). Its use is estimated to
increase crop yields 4-6% (Ackerman 2007). The economic benefits of atrazine use have led to
its continued application for many agricultural processes.
The widespread application of atrazine, however, leads to contamination of aquatic
ecosystems and water supplies. Dependent upon rainfall, up to 20% of atrazine applied to crops
may run off or be leached from soils (Graymore M 2001). Streams bordering croplands applying
atrazine have been shown to be contaminated at levels up to 1000 μg/L. Additionally, some
drinking water reservoirs in the U.S. have up to 88.4 μg/L. Atrazine has been detected in surface
and ground waters in the state of West Virginia (Pasquarell and Boyer 1996; Ator and Ferrari
1997). Removal of atrazine in water treatment plants is possible, but varies widely throughout
the US (Jiang H 2006). The US Environmental Protection Agency (EPA) Maximum
Contaminant Level (MCL) is 3 μg/L for human exposure to atrazine (USEPA 2011). This level
has been exceeded in many surface waters tested in West Virginia (Ferrari and Assessment
1997). Furthermore, the European Union has banned use of atrazine due to contamination levels
above recommended limits (Sass and Colangelo 2006).
The recommended limit of exposure is based on the potential negative effects of atrazine.
Atrazine exposure at environmentally relevant levels affects aquatic organisms; including
feminization of male frogs (Hayes et al. 2002), salamander desiccation (Rohr and Palmer 2009),
and endocrine disruption in fish (Suzawa and Ingraham 2008). Endocrine disruption is also a
potential mechanism of atrazine action in humans and other mammals (Cooper et al. 2007; Fan et
al. 2007; Albanito et al. 2008). It has been shown to interact with a steroidogenic transcription
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factor and a growth factor receptor, causing signaling pathways to be upregulated. This may
lead to hormonally-linked cancers and reproductive abnormalities. Additionally, atrazine may
affect innate immune function and increase damage caused by other toxins such as arsenic
(Tchounwou et al. 2001; Mizota and Ueda 2006). There is, however, evidence that contradicts
an EPA finding that atrazine is not a potential carcinogen (Mills 1998). It is therefore important
that food and water supplies be routinely monitored for atrazine levels.
The current methods of atrazine detection are either time- and labor-intensive or are not
specific for the herbicide. The most common method is gas chromatography, which requires
extensive sample preparation (Amistadi et al. 1997). Combinatory chromatographic methods
have been used to determine the presence of atrazine in both serum and urine (Brzezicki et al.
2003; Panuwet et al. 2008). Antibody-based assays are also used, however the antibody used
cannot differentiate between atrazine and closely-related molecules (Wortberg et al. 1996; Suri et
al. 2009). It is therefore necessary to identify an easily-synthesized binding element with high
affinity and selectivity. Utilizing Decoy-SELEX (Systematic Evolution of Ligands by
Exponential Enrichment) an atrazine-specific Molecular Recognition Element (MRE) was
identified with sub-nanomolar affinity.
Molecular Recognition Elements are antibody-like molecules that strongly and
selectively bind to a target of interest. They are produced by the in vitro selection process
initially described independently by the laboratories of Gold and Szostak in 1990 (Ellington and
Szostak 1990; Tuerk and Gold 1990). MREs are selected from a large (109-1015) library of
single-stranded DNA or RNA. The library is initially incubated with the target of interest.
Molecules that do not bind to the target are discarded and those that do bind are amplified.
These are then subjected to a series of negative targets, after which molecules that do not bind
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are amplified. This iterative process continues, utilizing increasingly stringent conditions, until a
MRE that specifically binds to the target of interest, but not negative targets, is identified. The
selected MRE may then be used for applications such as detection of the target molecule.
A single-stranded DNA (ssDNA) MRE with high affinity and specificity for atrazine was
isolated using a novel Decoy-SELEX process. This SELEX variation enriches the library for the
target of selection but focuses on stringent negative selections against undesirable binding
targets. Those negative targets are chosen by chemical similarities, such as target metabolites, or
their environmental proximity to which they are found with the target. The selection scheme for
atrazine was designed to ensure the MRE would bind to neither atrazine metabolites diaminochloro-triazine (DACT) or desethyl atrazine nor the closely-related herbicide simazine (Muller et
al. 1997). It was also designed so that the MRE would not bind to propanil, 2,4-D acid, or
malathion, which are pesticides found at similar levels and environments to atrazine (Kucklick
and Bidleman 1994; Coupe et al. 2000; Purcell et al. 2001; McCarthy and Fuiman 2008). These
selected molecules may then be incorporated into a sensing device, allowing for specific atrazine
detection (e.g. (Soh et al. 2009; Yang et al. 2010; Lin et al. 2011)).
2.2 Methods
2.2.1 Selection of Atrazine-Specific MREs
In order to select an atrazine-specific MRE, the Decoy- SELEX process was used (Figure
2.1). A single stranded DNA (ssDNA) library consisting of 1015 different molecules was
screened through 12 rounds of selection. The ssDNA library, termed RMW.N34, consists of two
23 base constant priming regions for polymerase chain reaction (PCR) amplification flanking a
34 base random region (synthesized by Eurofins MWG Operon; Huntsville, AL). From this
library, molecules that have a sequence and tertiary structure that specifically binds to atrazine
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were selected. Molecules in the library which bound to closely-related structures and other
pesticides were removed (Figure 2.2).

Figure 2.1. Scheme depicting the Decoy-SELEX process for atrazine MRE selection. A
library of 1015 ssDNA molecules were incubated with the target atrazine. Those that bound were
amplified and incubated with negative targets. Those that did not bind the negative targets were
amplified and subjected to additional rounds of in vitro selection.
An atrazine derivative, desethyl atrazine (Figure 2b) (Fluka Analytical; St Louis, MO)
was covalently biotinylated by Sulfo-NHS-LC-Biotin (Pierce; Rockford, IL) per manufacturer’s
instructions. Biotinylated desethyl atrazine was then incubated with streptavidin-coated
magnetic beads (New England Biolabs; Ipswich, MA) to immobilize the selection target.
Unbound desethyl atrazine was washed to leave only biotinylated desethyl atrazine bound to
magnetic beads (immobilized target).
For positive immobilized target selection, the ssDNA library was incubated with 50 μL
immobilized target in 500 µL of buffer consisting of 100 mM sodium chloride, 20 mM Tris-HCl,
and 2 mM magnesium chloride (1X selection buffer; SB). After an incubation period with
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rotation at room temperature, the immobilized target was separated from the solution by magnet,
washed three times with 1 mL SB, and resuspended in SB. This suspension served as a template
for PCR amplification of bound ssDNA. PCR conditions were as follows: enriched ssDNA
library, 400 nM forward and biotinylated reverse RMW.N34 primers (Eurofins MWG Operon;
Huntsville, AL) (forward: 5’-TGTACCGTCTGAGCGATTCGTAC-3’, biotinylated reverse: 5’Biotin- GCACTCCTTAACACTGACTGGCT -3’), 250 µM deoxynucleotide triphosphates, 1X
GoTaq Reaction Buffer (Promega; Madison, WI), 3.5 units Taq, and pure water. Reaction
conditions were: initial denaturation of 95°C for 5 minutes; cycling at 95°C for 1 minute, 63°C
for 45 seconds, and 72°C for 1 minute; and final extension of 72°C for 7 minutes. Large-scale
amplification of 4 mL and 2 mL was done preceding positive and negative selection rounds,
respectively. This selection scheme for the desethyl atrazine target occurred for Rounds 1-5 of
selection, each time with a shorter incubation period.
Amplified dsDNA was then purified via the GFX PCR purification kit (GE Healthcare;
Piscataway, NJ). Eluted dsDNA from the column was incubated with streptavidin agarose resin
(Pierce; Rockford, IL). Having used a biotinylated primer for the reverse strand amplification
allowed for binding of the amplified dsDNA to the agarose resin. This was placed into a flowthrough column and washed with 5 volumes of 1X PBS. Five volumes of 1 M sodium hydroxide
were then used to dissociate the DNA strands, eluting the forward strand ssDNA from the
column. This solution was neutralized with 0.1 volume 3 M sodium acetate (pH 5.2), to which
2.5 volumes of cold 100% ethanol were added. Glycogen at 10 μg/mL was added as a coprecipitate for ethanol precipitation, and the solution was frozen. After freezing, this was
centrifuged at 13,000xg for 1 hour, washed with 70% ethanol, and centrifuged again for 15
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Figure 2.2. Chemical structures of molecules used in the Decoy-SELEX scheme and crossbinding assays. (a) Structure of the herbicide and target of selection atrazine. (b) Structure of
atrazine derivative desethyl atrazine, used to immobilize onto magnetic beads. (c) and (d)
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Structures of simazine and diamino-chloro-triazine (DACT): chemically similar to atrazine, and
used in rounds of negative selection. (e), (f), and (g) Structures of propanil, 2,4-D acid, and
Malathion: pesticides found in ecologically relevant environments to atrazine and used in
negative selections. (h), (i), and (j) Structures of propazine, terbuthylazine, and sebuthylazine:
structurally similar metabolites of atrazine used in cross-binding assays. (k) Ribbon structure of
bovine serum albumin (BSA) used in cross-binding assay (Bujacz 2012).
minutes. The supernatant was then decanted and the ssDNA pellet dried under a vacuum. The
purified ssDNA pellet was resuspended in SB and subjected to another selection incubation.
Negative selections were done to ensure the ssDNA MRE is specific for atrazine. SulfoNHS-LC-Biotin (Pierce; Rockford, IL) was blocked with Tris-HCl. Then the blocked biotin
reagent was incubated with streptavidin coated magnetic beads and washed with SB
(immobilization substrate). 50 µL of blocked biotin reagent immobilized onto magnetic beads
was incubated with purified ssDNA from the positive selection in a 100 µL volume. After an
incubation period, the supernatant was removed and beads were washed three times with 25, 25,
and 50 µL SB, with removed supernatant and washes serving as a PCR template. Amplified
dsDNA was then prepared for another selection round as outlined above. Negative selections
done in this manner occurred in Rounds 1, 3, 5, and 11.
Round 6 of selection was done as stated above, however the selection buffer consisted of
10% methanol in 1X selection buffer (methanol selection buffer; MSB) to ensure ssDNA binding
in ensuing selection rounds. For Rounds 7-11 of positive selection, the purified ssDNA library
was incubated with immobilized target as outlined above. However, after three washes, 100 μL
of 1 mM atrazine in MSB was incubated with the beads for decreasing time periods. The ssDNA
bound to the immobilized target was separated from the ssDNA in the solution phase and served
as a template for PCR amplification. Preparation of the library for the ensuing round of selection
was done as noted above.
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The Round 8 negative selection was done as described above, however ssDNA was
competitively eluted with the pesticides propanil, 2,4-D acid, and malathion (Figure 2.2 e-g).
The ssDNA bound to the immobilized target was separated from solution and resuspended,
serving as the template for PCR amplification. Rounds 9 and 10 of negative selection were done
in the same manner, with DACT and simazine (Figure 2.2 c-d) serving as targets for competitive
elution, respectively.
The final round of positive selection, Round 12, was done similar to the competitive
elutions above. However, bound ssDNA was eluted with 100 μL of 100 μM atrazine in MSB.
This eluted ssDNA served as a template for PCR amplification.
2.2.2 Sequencing of Atrazine-Specific MREs
Every third round of selection, the ssDNA library was analyzed for consensus binding
sequences by DNA sequencing. The PCR-amplified (using non-biotinylated primers) library
was ligated into the pCRII vector (Invitrogen, Carlsbad, CA) and cloned into competent bacteria
per manufacturer’s instructions. The plasmid was then extracted using the AxyPrep Plasmid
Prep Kit (Axygen, Union City, CA) and sent for sequencing (Eurofins MWG Operon,
Huntsville, AL) using the M13R primer complementary to a region upstream of the PCR insert
in the pCRII vector. Analyses were done on 30-50 random sequences for each round to identify
consensus sequence binding families.
2.2.3 Atrazine MRE Binding Assays
From the Round 12 sequences, three sequences were chosen for further characterization.
The predicted tertiary structures were obtained using the Mfold DNA web server at 25°C with
buffer salt conditions (SantaLucia 1998; Peyret 2000; Zuker 2003). R12.23, R12.28, and R12.57
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were chosen and synthesized by Eurofins MWG Operon with an AlexaFluor 488 label for use in
binding studies.
Concentrations of 0, 0.25, 0.5, 0.75, 1, 5, 10, 15, 20, and 25 nM MRE were used in
saturation binding studies. In a 200 µL total volume of MSB, 10 uL of immobilized target was
incubated with each concentration for five minutes. Unbound MRE was removed and each
incubation was washed five times with 200 µL MSB, then the immobilized target was
resuspended in 200 µL MSB and heated to 95°C for 10 minutes to denature and elute bound
MRE. Eluted ssDNA in MSB was placed in a 96-well microplate and measured in a Synergy 2
microplate reader equipped with a tungsten halogen lamp with excitation wavelength of 485 nm
and an emission filter at 520 nm using Gen5 1.06 software (Biotek US; Winooski, VT). All
fluorescence readings on the plate were normalized to 100 μL of a 1 nM solution in SB of the
fluorescent MRE and the no ssDNA incubation. For each concentration set, the same was done
with washed streptavidin-coated magnetic beads to ensure binding over background to the beads.
Each set of incubations were performed in triplicate. To determine the dissociation constant of
R12.23, data were analyzed with Origin 8 (OriginLab Corporation; Northampton, MA) using
nonlinear regression analysis and fit with the equation, Y=((B max *X)/(K d + X)) + NS*X, where
B max is the maximum binding, K d is the dissociation constant, and NS is nonspecific binding as
previously described (Langan et al. 2012).
To determine binding of the selected MRE, R12.23, to negative targets used in the
selection, 5 nM fluorescent ssDNA was used. For each elutant used, in a 200 µL total volume of
MSB, 10 µL of immobilized target was incubated with R12.23 for five minutes. The magnetic
beads were washed five times with 200 µL MSB. Then, each incubation was resuspended in 200
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µL of 100 µM of the following in MSB: atrazine, desethyl atrazine, DACT, simazine, propanil,
2-4, D Acid, malathion, and MSB only. An incubation with no R12.23 present and
Table 2.1. Decoy-SELEX scheme for atrazine MRE selection.
Round

Positive Selection

Negative Selection

1

Immobilized Target (IT) 25 hrs

Immobilization Substrate (IS) 23 hrs

2

IT 23 hrs

-

3

IT 18 hrs

IS 18 hrs

4

IT 12 hrs

-

5

IT 10 hrs

IS 16 hrs

6

IT w/ methanol buffer 12 hrs

-

7

IT 10 hrs, Competitive Elution
w/ 1 mM Atrazine (CE) 5 min

-

8

IT 2 hrs, CE 2 min

IT 2 hrs, CE w/ propanil, 2,4-D acid
malathion, 5 min

9

IT 5 min, CE immediate

IT 5 min, CE w/ DACT 5 min

10

IT 1 min, CE immediate

IT 5 min, CE w/ Simazine 5 min

11

IT immediate, CE immediate

IS 18 hrs

12

IT immediate, CE w/ 100 µM
atrazine

-

In vitro selection process for obtaining atrazine-specific MRE. Immobilization target (IT) is
desethyl atrazine bound to magnet beads. Immobilization substrate (IS) is streptavidin-coated
magnetic beads plus blocked biotin reagent. Competitive elution (CE) is removal of bound
ssDNA from target-coated magnetic beads by free pesticide in solution. Times listed are
incubation times in hours (hrs) or minutes (min).
with atrazine as the elutant served as normalization controls. Each elutant was incubated with
the immobilized target for five minutes, and the solution was removed from the beads. This
solution was placed in a 96-well plate and measured in a fluorescence plate reader. Data were
normalized to an internal fluorescent standard and then the no R12.23 control was subtracted.
Each set of specific binding studies were performed in triplicate. Data were averaged and
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standard deviations calculated. For each elutant, a t-test was performed to determine statistical
differences in the means. To determine binding to other molecules not used in the selection, the
same protocol was used. Following incubation of 5 nM fluorescent R12.23 with immobilized
target, each incubation was eluted with 100 uM in MSB of the following: atrazine, propazine,
terbuthylazine, sebuthylazine, and bovine serum albumin (BSA), which was used as a model of
binding to large, globular proteins.
2.3. Results and Discussion
2.3.1 Selection of Atrazine-Specific MREs
Twelve rounds of Decoy-SELEX were completed to obtain ssDNA MREs which
specifically bind to atrazine (Table 2.1). The selection scheme ensured that ssDNA MREs will
bind to atrazine in solution and neither the immobilization substrate nor malathion, propanil, 2,4D acid, DACT, or simazine. PCR cycling numbers and ssDNA recovered after preparation and
used in the ensuing selection round varied with each round of selection. After every third round
of selection (rounds 3, 6, 9, 12 plus after round 10), 30-50 random sequences of the ssDNA
molecules in the library were obtained for consensus sequence family analysis. Additionally,
random sampling of ssDNA sequences binding to both DACT and simazine was performed.
Consensus sequence families were analyzed and tracked throughout the Decoy-SELEX process.
From the round 12 library, three sequences were chosen based on their inclusion in consensus
sequence families and predicted tertiary structures. Those sequences, R12.23, R12.28, and
R12.57 were assayed for their binding affinity to atrazine (Figure 2.3). Those sequences had
Gibb's free energy values of -11.32 kcal/mol, -10.71 kcal/mol, and -10.61 kcal/mol, respectively.
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Figure 2.3. Sequences and structures of atrazine MREs. The ssDNA sequence of selected
atrazine MREs, which is above a representative consensus sequence family, with the secondary
structure as predicted by Mfold below (SantaLucia 1998; Peyret 2000; Zuker 2003). The
sequence and structure of (a) R12.23, (b) R12.28, and (c) R12.57.
2.3.2 Affinity and Specificity of Atrazine-Specific MRE
Fluorescent saturation binding assays were performed to determine the affinity of
R12.23, R12.28, and R12.57 for atrazine. Concentrations of MRE in the high pM to low nM
range were assayed, plotted, and fit by nonlinear regression analysis (Figure 2.4). The
equilibrium dissociation constant (K d ) of R12.23 was determined to be between 0.14 nM and
0.97 nM (Table 2.2). This is in the lower range of MREs targeting small molecules and
comparable to MREs targeting proteins (Hamula et al. 2006; Stoltenburg et al. 2007). Such high
affinity for atrazine is likely due to the multiple rounds of selection with very stringent binding
conditions utilizing the Decoy-SELEX process. Fluorescent binding assays were also performed
for R12.28, which showed a K d between 1.28 nM and 9.20 nM, and R12.57, which showed a K d
between 4.42 nM and 51.74 nM. Therefore, because of its high affinity and reproducible
dissociation constant range, R12.23 was chosen for further binding analysis.
Further sequence analysis on R12.23 determined possible binding sequences. This
sequence had the greatest stability in the round 12 library as predicted by Mfold. It was present
six times in four out of eleven total large round 12 sequence families and was not evident in any
previous round of selection. Interestingly however, one five-base consensus sequence in R12.23
was also found in a very large round 10 consensus sequence family (GCTTT). Another five-base
consensus sequence in R12.23 was found in large families in both round 6 and 9 (TGTTT). This
particular five-base sequence was also found as part of a consensus sequence family for ssDNA
that bound to both DACT and simazine. A second five-base consensus sequence in R12.23 also
had these characteristics (GCACT). These two sequences appeared consecutively in R12.23, and
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were part of a large dual-hairpin in the predicted structure (Figure 2.3a). This therefore suggests
that while this full MRE sequence did not appear in any prior rounds' random sequencing efforts,
components therein were important in binding to atrazine and surviving the Decoy-SELEX
process while others were important in conferring specificity.

Figure 2.4. Fluorescent equilibrium binding assay of R12.23. Representative saturation
binding assay with nonlinear regression best fit. K d R12.23 for atrazine in this data is 0.75 nM
+/- 0.22 nM.
Table 2.2. Equilibrium dissociation constant (K d ) of atrazine MREs.

Plot
1
2
3

R12.23
0.75 +/- 0.22 nM
0.14 +/- 0.04 nM
0.97 +/- 0.61 nM

R12.28
1.28 +/- 0.85 nM
9.20 +/- 3.02 nM
4.81 +/- 1.75 nM

R12.57
51.74 +/- 7.75 nM
6.18 +/- 8.67 nM
4.42 +/- 3.67 nM

R12.23.TRNC1
0.079 +/- 0.065 nM
0.700 +/- 0.777 nM
0.848 +/- 0.826 nM

*All data are presented as K d +/- Standard Error as given by the binding equation.
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B

Figure 2.5. Sequence and structure of R12.23.TRNC1. (a) Designed sequence of
R12.23.TRNC1. (b) Secondary structure of R12.23.TRNC1 as predicted by Mfold.
To further determine the binding site of R12.23 and in an effort to increase binding
affinity, a truncated sequence was designed and termed R12.23.TRNC1 (Figure 2.5). It is
comprised of a 34 base sequence which composes the major dual hairpin-loop structural
component of the full-length R12.23 discussed in the previous paragraph (Figure 2.5)
(synthesized by Katherine Hickey and Peter Gannett of WVU Basic Pharmaceutical Sciences).
Fluorescent saturation binding assays using a fluorescein-labeled MRE were performed with this
sequence as described above. These assays showed R12.23.TRNC1 had a K d 0.079 and 0.848
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nM (Table 2.2) (data generated by Eamonn Maher and Ginger He of the Sooter Lab). The
affinity of the truncated sequence is overall as good as or better than the full-length sequence.
This is similar to previous work that has assayed binding affinity of truncated MRE sequences
(Kaur and Yung 2012). Therefore, it is likely that this is the binding domain of R12.23.

Figure 2.6. Cross-binding studies of R12.23 atrazine MRE to other molecules. Data were
normalized to atrazine binding which was set to 100%, with error bars representing standard
deviations. Statistical significance levels of p<0.05 are designated by ‘*’, while levels of p<0.01
are designated by ‘**’ (a) Atrazine is the target of selection, desethyl atrazine is the derivitave
used for immobilization to magnetic beads. DACT and simazine are metabolites of atrazine.
Propanil, 2-4, D acid, and malathion are pesticides found in close environmental proximity to
atrazine. (b) Propazine, terbuthylazine, and sebuthylazine have closely-related chemical
structures, but were not used in the selection scheme. Bovine serum albumin (BSA) readily
binds many molecules and was used as a model of the MRE binding to proteins.
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Fluorescent specificity binding assays were also performed on the atrazine MRE using
elution from immobilized target beads. Analysis showed significantly higher binding of R12.23
to atrazine in solution than to four of the five negative targets used in the selection (Figure 2.6a).
These included DACT, simazine, propanil, and 2-4,D Acid (Figure 2.2). Binding to malathion in
solution did occur but was highly variable. This may be because malathion is known to be
reactive toward DNA by cleaving the strand (Pluth et al. 1996; Reus et al. 2008; Moore et al.
2010). This reactivity of malathion may not affect signal of a field- deployable sensor if it is
designed to function based on MRE folding and not cleavage. It is important to note that R12.23
is selective for atrazine over simazine, as current molecular recognition elements for atrazine are
not (Wortberg et al. 1996). Also, the MRE has no affinity for desethyl atrazine in solution. This
is noteworthy because this atrazine derivative was immobilized on magnetic beads and used for
the initial positive rounds of selection. Additionally, even though binding to atrazine is
approximately two-fold higher than it is to DACT or simazine, the dissociation constant may be
much higher than twice that of R12.23 for atrazine. Therefore, incorporation into a sensor may
lead to much greater specificity than it appears here. It is clear that stringent competitive
elutions selected for an MRE that has high specificity for atrazine in solution compared to the
negative targets.
Interestingly, structurally similar molecules (Figure 2.2) which were not used as negative
targets bound to the selected MRE (Figure 2.6b). This may be due to the structural complexity
of the MRE. Binding is statistically as strong to propazine, terbuthylazine, and sebuthylazine.
This suggests that R12.23 requires the chlorotriazine base, as do antibodies that bind to atrazine
(Herranz et al. 2008). It also suggests that it requires a certain level of complexity on the aminelinked side-groups of the chlorotriazine base. Based on the structures, it seems binding requires
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at least four total carbons in the side-groups. As simazine also meets this requirement, it seems a
second requirement is having at least one side-group with three carbons. This is evidenced by
the lack of binding to simazine, DACT, and desethyl atrazine, which do not meet these
complexity requirements. Propazine, with two amine-linked isopropyl groups, terbuthylazine,
with an amine-linked ethyl and an amine-linked tert-butyl, and sebuthylazine, with an aminelinked sec-butyl, exceed these complexity requirements. It is unclear how more complex
chlorotriazines would be bound by the MRE. Exceedingly-complex chlorotriazines, however,
likely would be too large to fit in the MRE binding pocket. Bovine serum albumin (BSA) was
used as an example of potential MRE binding to proteins. The MRE did not show significant
binding to BSA. It is likely that, in spite of some cross-reactivity to more complex
chlorotriazines, R12.23 will be useful in a sensor for a class of molecules. After rapid, fieldbased detection with the MRE, more rigorous analytical approaches such as gas chromatography
can be used to identify all present contaminants.
The high affinity and specificity of the atrazine MRE are both important characteristics
for its further use in detection applications, such as contaminated ecosystems or individuals.
Nucleic acid MREs have previously been developed and used in environmental biosensing for
small molecules (Strehlitz et al. 2012; Yildirim et al. 2012). They have also been used for
detection of analytes in serum (Soh et al. 2009). In both contexts, it is necessary for the MRE to
differentiate between the target and closely-related molecules or other contaminants. The novel
selection method reported herein is capable of generating such MREs. Once atrazine-polluted
environments or contaminated at-risk individuals are identified, they can be actively remediated
or treated with chemical, physical or biological methods (Mandelbaum et al. 1995; Saltmiras and
Lemley 2002; Herzberg et al. 2004).
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2.4 Conclusions
A novel variation of the SELEX process, called Decoy-SELEX, is presented to select a
molecular recognition element with high affinity and specificity for the herbicide atrazine. The
MRE binds with a sub-nanomolar equilibrium dissociation constant and is selective for atrazine
over several metabolites and other pesticides. The results validate the Decoy-SELEX process
while identifying a new mechanism for atrazine detection in environmental and biological
mediums. This work will improve upon current analysis of atrazine contamination and allow for
informed remediation and treatment efforts.
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CHAPTER 3
Introduction to the Properties and Applications of Single-Wall
Carbon Nanotubes
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3.1 Introduction
Carbon nanotubes are cylindrical fullerenes that can be visualized as rolled graphene
sheets with walls of single atom thickness. Their discovery stemmed from the discovery of
buckminsterfullerene in 1985 (Kroto et al. 1985). Sumio Iijima originally described multi-wall
carbon nanotubes (MWCNT) in 1991 (Iijima 1991; Ajayan 1999). Single-wall carbon nanotubes
(SWCNT) were independently described by Iijima and Ichihashi as well as an IBM team in 1993
(Bethune et al. 1993; Iijima and Ichihashi 1993). Since this time, research into their production,
properties, and applications has increased.
In those original investigations by Iijima the carbon nanotubes were produced by the arcdischarge method. MWCNT were discovered as a deposit on the graphite cathode tip of this
chamber (Iijima 1991; Ando and Zhao 2006). In contrast, SWCNT were discovered as a soot
from the gas phase of an arc-discharge chamber using either an iron or cobalt catalyst (Bethune
et al. 1993; Iijima and Ichihashi 1993; Ando and Zhao 2006). Characterization and confirmation
of the products was performed using transmission electron microscopy and electron diffraction.
There have since been new production and characterization methods but these remain useful in
the field.
Physical differences between MWCNT and SWCNT confer unique properties. The
diameter of an individual SWCNT is typically in a narrow range between 0.5 and 2 nm, while
that of a MWCNT is 2-25 nm (Ajayan et al. 1999). This is because SWCNT have walls only one
atom thick, while MWCNT have concentric walls approximately 0.34 nm apart (Ajayan 1999).
Both, however, have a high aspect ratio, with individual tubes typically having lengths in the
micron range. Due to variations in how the edges of graphene sheet meet, walls of both carbon
nanotube forms may have helicity, which plays a large role in their physical properties. The
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walls of MWCNT may have different helicity, and therefore less uniform with less ideal optical
and electronic properties for individual tubes (Ajayan 1999). Individual SWCNT species,
however, have uniform and characteristic properties which give them greater potential for
application. The helicity of a SWCNT species is also referred to as its chirality, or its (n,m)
species (Figure 3.1). This designation derives from the angle at which the tube is rolled. Achiral
carbon nanotubes are either in the armchair (n,n) or zigzag (n,0) conformations. Some properties
have been investigated, however there is much yet to be determined.

Figure 3.1. Derivation of SWCNT (n,m) chiral species. A visual representation of a graphene
sheet depicts the derivation of SWCNT chirality. Carbon bonds form hexagons, and SWCNT
can be visualized as rolled-up graphene sheets. The angle at which the sheet is rolled determines
the chirality, or the (n,m) designation of the tube. Some n,m species are shown here, with the
lines from which zigzag and armchair chiral species are derived. Image is derived from
previously-published depiction (Weisman 2010).
The potential application of SWCNT has led to an increase in their production and use.
There has been a push to determine their interaction with biological materials. This is because
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they have enormous potential in biological sensors and medical treatments. It is also true,
however, because there will be an increase in environmental contamination by these particles. It
is therefore necessary to understand the production of SWCNT, their special properties, and the
applications of SWCNT.
3.2 SWCNT Production
The initial synthesis of SWCNT by the arc-discharge method with a catalyst is still one of
the three major forms of their industrial synthesis. Synthesis by laser-ablation and chemical
vapor deposition for catalytic growth has since been adopted.
3.2.1 Arc-Discharge Method
The arc-discharge method of SWCNT product was the first developed and remains to be
in use because it is simple and has a relatively high yield (Baddour and Briens 2005). To produce
SWCNT, a chamber is filled with an inert gas and contains two graphite electrodes (Bethune et
al. 1993; Iijima and Ichihashi 1993). A metallic catalyst such as iron or cobalt is placed on either
of the electrodes. Then a direct current is applied between the electrodes and SWCNT are
deposited from the vapor phase of the chamber. The resulting SWCNT products are relatively
short, bundled, and need purification due to impurities (Saifuddin et al. 2013). This method was
scaled-up from initial production in 1997 by the work of Journet et al. (Journet et al. 1997),
however larger-scale production remains difficult.
3.2.2 Laser-Ablation Method
Laser-ablation synthesis of SWCNT is the most expensive method of SWCNT
production, however the product is of relatively high purity (Baddour and Briens 2005). A target
of graphite with metal catalysts is inserted into a furnace with an inert gas in this method (Guo et
al. 1995; Thess et al. 1996). High-intensity laser pulses are then directed at the graphite and
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SWCNT are deposited on a water-cooled collector (Popov 2004). This method is only useful for
production of SWCNT and not MWCNT. Additionally, it can be more finely tuned by laser and
gas properties to produce SWCNT with specific characteristics (Saifuddin et al. 2013).
However, the product is tangled and needs purification. This coupled with the high cost makes
this method is not as extensively used as the other two.
3.2.3 Chemical Vapor Deposition Method
Synthesis of SWCNT by chemical vapor deposition (CVD) is the most inexpensive and
easiest method to scale up for industrial purposes. This method involves the production of
SWCNT by flowing hydrocarbons and an inert gas over a metal catalyst in a furnace (Popov
2004). It was initially used for production of carbon filaments before the discovery of SWCNT
(Baker 1989). Since then, however, it has been adapted and scaled up for industrial carbon
nanotube production (Joseyacaman et al. 1993; Amelinckx et al. 1994; Ivanov et al. 1994; Li et
al. 1996). This process generally favors the production of MWCNTs, however the
characteristics of SWCNT are highly controllable under specific conditions (Kong et al. 1998;
Baddour and Briens 2005; Saifuddin et al. 2013). Overall, the CVD method typically has high
purity and produces longer nanotubes. The only drawback to this method is that the SWCNT
typically have many defects (Saifuddin et al. 2013). Despite this, the simplicity, costeffectiveness, and scalability of the CVD method make it the most widely-used for industrial
purposes.
3.2.4 Purification and Enrichment
After synthesis of SWCNT, they may undergo multiple processes before their study and
application. These include purification of the nanotubes from synthesis contaminants and
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enrichment of particular SWCNT types. Both of these steps may affect the SWCNT properties
and neither of them is completely optimized.
Purification of SWCNT is necessary after the synthetic process due to carbonaceous and
catalytic metal impurities. The most commonly-used methods for this are oxidation, filtration
and chromatography, chemical functionalization, and microwave heating (Haddon et al. 2004;
Park et al. 2006). There are, however, other techniques that may be used in conjunction with
these, such as centrifugation, ultrasonication, and magnetic separation (Saifuddin et al. 2013).
Another possible form of post-synthetic processing is enriching SWCNT of a particular
diameter, length, or chirality It is important to be able to do this because these characteristics are
strong determinants of SWCNT physical properties (Zhang and Zheng 2010). This may be
partially done through controlled synthesis with specific temperatures, catalysts, or substrates
(Bandow et al. 1998; Kukovitsky et al. 2002). However, it is also possible to enrich particular
SWCNT types by oxidation and etching (Zhang et al. 2006; Miyata et al. 2007). Enrichment of
SWCNT by chirality and diameter is possible through ultracentrifugation (Arnold et al. 2006).
Finally, the affinity of particular surfactants for individual (n,m) species has been used to
separate SWCNT (Ju et al. 2008; Marquis et al. 2008). Of these, DNA is the most promising, as
individual sequences have greater affinity for particular diameters and chiralities (Huang et al.
2005; Albertorio et al. 2009; Tu et al. 2009; Tu et al. 2011). Obtaining pure SWCNT chiral
species is important for many applications, however the process remains difficult to obtain
highly pure samples (Komatsu and Wang 2010; Zhang and Zheng 2010).
3.3 Properties of SWCNT
Single-wall carbon nanotubes have many properties that make them ideal for a range of
applications (Table 3.1). These include special mechanical, electrical, and optical characteristics.
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As mentioned previously, the properties depend strongly on the SWCNT diameter, chirality, and
length.
Table 3.1. Special properties of single-wall carbon nanotubes (SWCNT) and their
correlation to applications.
Property
Description
Application
-Very strong
-Replacement of carbon
Mechanical
-High stiffness
fibers for material
-Flexible
reinforcement
-Large surface area
-Polymer integration for
-Low density
flexibility and strength
-Individual chiralities are
-Conductors in electronics
Electrical
either metallic or
-Signal transducers in
semiconducting
sensors
Optical

Functionalization

-Fluorescence in the nearinfrared region
-Exact fluorescence
properties dependent on
chirality and length
-Ability to be chemically
modified
-Ability to be wrapped or
adsorbed to by biological
molecules

-Optical fluorescence
sensors
-In vivo imaging
-Chirality, length, and
dispersion characterization
-Potential for aiding in all
previous applications
-Biological sensors

3.3.1 Mechanical Properties
The mechanical properties of SWCNT have made them of high interest for many
industrial applications. They are considered very strong with high stiffness due to characteristic
sp2 carbon bonding (Robertson et al. 1992; Popov 2004). Individual SWCNT have an average
Young's modulus value of 1.8 TPa, which is an extraordinarily large measure of stiffness for a
material (Jacobsen et al. 1995). Important for engineering and industrial purposes, the value for
bundled SWCNT is estimated to be 600 GPa; lower due to weaker associations and formations
of individual tubes (Salvetat et al. 1999). This, however, can theoretically be up to 38 TPa for
identical achiral SWCNT, which could be extremely useful in engineering applications (Popov et
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al. 2000). They are unique in that they also have a high flexibility in spite of their strength and
stiffness (Coleman et al. 2006). Additionally, SWCNT have a very high surface area and a
relatively low density of 0.6 g/cm3 (Ajayan 1999).
3.3.2 Electrical Properties
Single-wall carbon nanotubes may be metallic or semiconducting based on their chirality.
Of all possible SWCNT species, 33% are metallic and 67% are semiconducting (Saito et al.
1992; Zhang and Zheng 2010), with all armchair conformations being metallic and zigzag and
chiral being either (Ajayan 1999). These properties make it possible to use individual species or
broad classes of SWCNT in electronics or sensors. Additionally, it is possible to use nanotubes
to create intramolecular electronic junctions (Ouyang et al. 2002). Overall, the electronic
properties of SWCNT have been studied largely by scanning tunneling microscopy (STM)
(Ouyang et al. 2002). Due to these properties, SWCNT have a great deal of potential in
electronic and sensing applications.
3.3.3 Optical Properties
The specialized optical properties of SWCNT make them particularly important for
sensing and biomedical applications. Semiconducting nanotubes have optical absorption peaks
corresponding to excitation of electrons from valence to conduction bands, a separation referred
to as the band gap (Weisman 2010). These well-defined peaks are referred to as E 11 , E 22 , and so
on, which fall in the near-infrared (IR) and visible light regions, respectively. Fluorescence has
been observed across the near-IR band gap of SWCNT (O'Connell et al. 2002). As this is highly
dependent on the diameter and chirality of the SWCNT, it is possible to characterize the
nanotubes present in a sample based on its optical properties (Bachilo et al. 2002). Furthermore,
the near-IR region is relatively unabsorbed by tissue, thus making SWCNT of great potential for
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biological imaging and therapeutics (Welsher et al. 2011). SWCNT can generate and detect light
while functioning as a transistor, and therefore have great potential for combined electronic and
optical devices (Avouris et al. 2008). It is also possible to use absorbance versus fluorescence as
a relative measurement of SWCNT dispersion in solution. This is because bundled SWCNT
absorb light, but their fluorescence output is dampened (Weisman 2010). It is therefore obvious
that optical characterization and applications of SWCNT have great potential.
3.4 SWCNT Applications
Stemming from these properties of SWCNT is the ability to use them in a variety of
applications (Table 3.1). They have been integrated into industrial, electronic, sensing, and
biomedical processes, among others. It is also important to note that for many applications, it is
necessary to have pure or enriched SWCNT species in order to have uniform properties.
3.4.1 Industrial Applications
Due to their unique mechanical properties, SWCNT have been incorporated into
polymers to form composites with desirable properties (Breuer and Sundararaj 2004). They are
often used instead of carbon fibers, which are used to reinforce and enhance materials for
aerospace, automotive, or sporting and protective equipment. They can also be integrated into
composites for their ability to dissipate electrostatic interactions, which can be important in safer
materials. Considerable research has gone into optimizing the interface of SWCNT and
polymers to extract ideal properties (Thostenson et al. 2001). This work has significantly
increased the stiffness of composite materials and led to an increase of SWCNT-related products
in the marketplace (Coleman et al. 2006).
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3.4.2 Electronic Applications
The application of SWCNT in electronics has also become more widespread. This is
because of their excellent conductivity, surface area, and ability to take different macroscopic
shapes (Schnorr and Swager 2011). SWCNT have thus been studied for use in lithium ion
batteries and transparent electrodes, which are components of organic solar cells and organic
light-emitting diodes (OLEDs) (Ng et al. 2005; Kim et al. 2009; Landi et al. 2009; Chien et al.
2010). Additionally, they can be used as capacitors and even to build smaller and more efficient
electronic circuits, among many other uses (Franklin et al. 2001; Baughman et al. 2002; Du and
Pan 2006; Schnorr and Swager 2011).
3.4.3 SWCNT in Sensors
The use of SWCNT in sensors can be closely related to their electronic applications.
However, SWCNT-based sensors may also rely on their optical properties. An example of an
electronic-based SWCNT sensor is a field effect transistor (FET) (Tans et al. 1998). The
nanotubes can adsorb, be wrapped by, or covalently bound to sensing molecules, which changes
the conductance of the nanotube upon binding (Pengfei et al. 2003; So et al. 2008; Schnorr and
Swager 2011). They have also been used for detection of gases and chemical vapors through
chemically reactive coatings (Novak et al. 2003; Snow et al. 2005). As mentioned above,
polymers or other biological sensing molecules can be attached to SWCNT. This includes
adsorption or the covalent attachment of antibodies as well as covalent attachment or wrapping
of DNA around nanotubes (Zhang et al. 2009). These can function in sensors as described
above, or can be part of optical SWCNT sensors (Huang et al. 2011). An important example of
this is the near-infrared detection of analytes with DNA and DNA molecular recognition
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element(MRE)-wrapped SWCNT (Jeng et al. 2006; Chen et al. 2009). These are among many
other examples of research being done to develop SWCNT-based sensors.
3.4.4 Biomedical Applications
One area of great potential for SWCNT use is in biomedical applications, which draws on
multiple properties of this material. An important necessity of this use is that the nanotubes are
not toxic to humans. Multiple studies have shown that SWCNT functionalized or non-covalently
altered with biological molecules reduce their toxic effects (Vardharajula et al. 2012). Therefore,
they have been developed for use as in vitro and in vivo imaging tools, as their near-infrared
fluorescence is detectable through cells and tissue (Welsher et al. 2011; Kang et al. 2012).
Additionally, they have been used to deliver small molecule and biologic drugs as well as genes
to specific diseases (Pantarotto et al. 2004; Portney and Ozkan 2006; Bhirde et al. 2010).
Research is ongoing to ensure the safety of SWCNT in biomedical applications, which will lead
to an invaluable tool for clinical diagnostics and therapeutics.
3.5 Conclusions
Single-wall carbon nanotubes are an extraordinary and relatively new class of materials
into which research is ongoing and increasing constantly. This is due to their unique and
desirable properties, which are drawn from their production, purification, and enrichment. They
have particular value in both biomolecular sensing and biomedical applications. Both of these
uses require further work into understanding the interactions of SWCNT and biological
molecules and systems.
The work described here was completed to further determine specific properties of
SWCNT. As noted, their interaction with DNA is of particular interest for sorting and
separation, sensors, and other applications. The effect of multiple chiralities of DNA wrapped
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with different DNA sequences on the polymerase chain reaction was determined. This will
allow for future work in separation of SWCNT and in sensors. Additionally, the effect of
SWCNT on a green algae model organism was determined. This will help to determine future
environmental impacts of widespread DNA-wrapped SWCNT use and whether these constructs
are safe for use. Together, these investigations into the interactions of biological systems and
DNA-wrapped SWCNT have elucidated properties of SWCNT important for their future use.
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CHAPTER 4
Investigation of the Effects of DNA-dispersed Single-Wall Carbon
Nanotubes on the Polymerase Chain Reaction
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4.1 Introduction
Single-wall carbon nanotubes (SWCNT) are cylindrical fullerenes with walls of single
carbon atom thickness (Iijima 1991; Iijima and Ichihashi 1993; Ajayan 1999). They have
enormous potential in industrial, sensing, and biomedical applications due to their unique
physical, electronic, and optical properties (Heller et al. 2005; Wang 2005; Coleman et al. 2006;
Huang et al. 2011). SWCNT may be either metallic or semiconducting, with 33% and 67%,
respectively, of all potential species having those characteristics (Saito et al. 1992; Zhang and
Zheng 2010). The unique properties of SWCNT are dependent upon the chirality and diameter
of the SWCNT, however purification of individual species remains difficult (Zhang and Zheng
2010). Individual types of semiconducting SWCNT have unique optical fluorescence properties
(O'Connell et al. 2002). Therefore, in applying SWCNT, it is possible to take advantage of their
electrical or optical properties, separately or combined (Avouris et al. 2008).
Single-stranded DNA has been used to disperse hydrophobic SWCNT in solution (Zheng
et al. 2003). The interaction of DNA sequences with SWCNT may have implications in sensing
and purification techniques. Individual sequences have been identified that preferentially wrap
certain SWCNT chiralities (Huang et al. 2005; Albertorio et al. 2009; Tu et al. 2009; Tu et al.
2011). DNA-associated SWCNT have also been used in molecular sensing (So et al. 2005; Jeng
et al. 2006; So et al. 2008). The potential use of a DNA-wrapped SWCNT (DNA:SWCNT)
platform shows promise in multiple applications; however research is continuing to optimize use
of these complexes.
In sensing applications and analysis of environmental samples, it is useful to employ
polymerase chain reaction (PCR) techniques in order to exponentially amplify the SWCNTassociated DNA sequence.

Additionally, there has been work to develop PCR-based
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microfluidic sensing devices (Khandurina et al. 2000), as well as DNA-functionalized SWCNT
sensing devices (So et al. 2005). Integration of these two sets of technologies would create new
potential analyte detection mechanisms. Therefore, it is important to determine the effect of
DNA-associated SWCNT on the polymerase chain reaction.
The aim of this study was to investigate amplification of DNA by the polymerase chain
reaction (PCR) in the presence of DNA-dispersed SWCNT. Factors investigated include DNA
sequence-dependence, SWCNT chirality-dependence, and DNA:SWCNT concentrationdependence; amplification of the wrapping sequence itself; and age of the DNA-SWCNT
preparation. This work will provide a basis for further DNA-dispersed SWCNT studies which
require PCR amplification.
4.2 Methods
4.2.1 DNA-Dispersed SWCNT Preparation
DNA:SWCNT preparations were made similarly to previously described methods (Zheng et al.
2003; Lahiji et al. 2007). Briefly, 2 mg CoMoCAT SWCNT were mixed with 2 mg DNA in 2 mL
phosphate-buffered saline (PBS).

SWCNT used were: without chiral purification “Mix” or (6,5)

chirality-enriched (Sigma-Aldrich; St. Louis, MO). DNA sequences used were: estradiol (E2) Molecular
Recognition Element (MRE) (Table 4.1) (Kim et al. 2007), TG15 (Table 4.1) (Eurofins MWG Operon;
Huntsville, AL), or salmon testes genomic DNA (Sigma-Aldrich; St. Louis, MO). This mixture was
sonicated on ice for two hours with a Virsonic XL2020 ultrasonic liquid processor (Misonix;
Farmingdale, NY) equipped with a 3.2 mm microtip at approximately 20% power. The resulting solution
was centrifuged at 16,000xg for 90 minutes to remove insoluble SWCNT. The solution was then filtered
through an Amicon Ultra-4 Centifugal Filter unit with 100,000 molecular weight filter (Millipore;
Billerica, MA) three times at 4000 RPM for 15 minutes each to remove DNA that did not associate with
the SWCNTs. The recovered DNA:SWCNT solution was brought to a volume of 500 µL with PBS. The
concentration of the DNA:SWCNT sample was obtained by gravimetric analysis of 10 µL of the solution
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weighed on an Ohaus Discovery Microbalance (Ohaus; Parsippany, NJ). Samples were stored in screwtop containers at room temperature before use. To determine the effect of DNA:SWCNT preparation age
on PCR, samples were used that were prepared between four and ten months before assayed or less than
one month before assayed. In total, 12 DNA:SWCNT samples were prepared.
Table 4.1. Synthesized DNA sequences used in DNA:SWCNT PCRs.
Sequence Name

DNA Sequence Used

Estradiol (E2)
MRE

5′-GCTTCCAGCTTATTGAATTACACGCAGAGGGTAGCGGCTCTGCGCAT
TCAATTGCTGCGCGCTGAAGCGCGGAAGC-3′

TG15

5’-TGTGTGTGTGTGTGTGTGTGTGTGTGTGTG-3’

F.E2

5′-GCTTCCAGCTTATTGAATTACACGCAGAGGGTAGC-3′

R.E2

5’-GCTTCCGCGCTTCAGCGCGC-3’

4.2.2 SWCNT Characterization
Absorption and near-infrared (NIR) fluorescence measurements were performed as previously
described with few modifications (Weisman 2010). Briefly, each DNA:SWCNT preparation was diluted
to a 1% solution with distilled-deionized water (Millipore; Billerica, MA). This solution was added to a
10 mm path length cuvette (Starna Cells; Atascadero, CA) and analyzed on a NanoSpectralyzer 1 (NS1)
(Applied NanoFluorescence; Houston, TX). The absorbance spectrum was collected from 400 - 1600 nm.
Additionally, fluorescent emission spectra were measured using excitation wavelengths of 638 nm, 690
nm, and 784 nm. The resulting spectra were analyzed with ANFSoft (Applied NanoFluorescence;
Houston, TX). Fluorescence efficiency measurements, which are fluorescence intensity (RFU) collected
across the emission spectrum for a single wavelength divided by the absorbance spectrum, are reported as
a relative measure of SWCNT dispersion in solution.
4.2.3 Polymerase Chain Reaction in the Presence of DNA-Dispersed SWCNT
In total, 16 sets of PCR experiments were performed involving 7 individual PCR reactions per
set. PCR reactions were composed of: 60 nM E2 MRE, 400 nM forward and reverse E2 MRE primers
(F.E2 and R.E2) (Table 4.1), 250 µM deoxyribonucleotide triphosphates, 1X GoTaq Reaction Buffer
(Promega; Madison, WI), 3.5 units Taq DNA Polymerase, DNA:SWCNT suspension, and Milli-Q water
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to 50 µL. DNA:SWCNT were added to final concentrations of: 0.01 mg/mL, 0.1 mg/mL, 1 mg/mL, 5
mg/mL, 10 mg/mL. For each set, a negative control was performed with no E2 MRE or DNA:SWCNT
and a positive control was performed with no DNA:SWCNT added. Reactions were performed on an MJ
Mini Thermal Cycler (Bio-Rad; Hercules, CA) with conditions: initial denaturation of 95°C for 5
minutes; 20 cycles of 95°C for 1 minute 30 seconds, 68°C for 45 seconds, and 72°C for 1 minute 30
seconds; and final extension of 72°C for 7 minutes. Amplification of DNA directly associated with
SWCNT was performed using E2 MRE:SWCNT preparation with no additional E2 MRE added to the
reaction mix.

4.2.4 PCR Analysis by Agarose Gel Electrophoresis
Each set of control and DNA:SWCNT PCRs was run on a 4% agarose gel for 30 minutes
at 135 volts in 1X Tris:Borate:EDTA buffer. Five µL of each PCR and 3 µL of 100bp and 25bp
ladder (Promega), were mixed with 2 µL 6X loading dye (Promega) prior to loading in the well.
Gels were pre-stained with 5 µg/mL ethidium bromide and imaged with UV illumination on a
BioRad Gel Doc System and analyzed on Quantity One Software (Bio-Rad; Hercules, CA).
4.3 Results and Discussion
4.3.1 Analysis of DNA:SWCNT Preparations
All DNA:SWCNT samples were analyzed by absorbance and NIR fluorescence
spectroscopy to determine their SWCNT chirality composition and dispersion in solution
(singly-dispersed SWCNTs) (Figures 4.1 and 4.2). DNA:SWCNT samples greater than four
months old were more well-dispersed than the identical DNA:SWCNT preparation of less than
one month. This would suggest that dispersion of SWCNT in solution with DNA increases with
time. Additionally, for both old and new samples, TG15 and E2 MRE dispersed the (6,5)enriched SWCNT better than mixed chirality SWCNT (Figures 4.1 and 4.2, fluorescence
efficiency). These results are consistent with previously published results that have shown short,
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synthetic DNA sequences rich in thymine and guanine have a high affinity for (6,5) chiral
SWCNTs (Kim et al. 2008). Conversely, the salmon testes genomic DNA:Mix SWCNT samples
were more well-dispersed than Salmon testes genomic DNA:(6,5) SWCNT. These results
suggest that although the genomic DNA shows the highest association with (6,5)-chiral
SWCNTs (Figures 4.1 and 4.2, topography plots) it also forms stable associations with other
chiralities.
4.3.2 Agarose Gel Analysis of Old DNA:SWCNT PCRs
Agarose gel analysis of PCRs performed with increasing concentrations of
DNA:SWCNT preparations between four and ten months old suggest that accurate amplification
products of 76 base pairs (bp) can be obtain at concentrations of 0.1 mg/mL and below for all
preparations (Figure 4.1 agarose gels). In most cases, efficiency of PCR amplification is either
unaffected or slightly aided at 0.01 and 0.1 mg/mL compared to the positive control reaction
(Figure 4.1 relative intensities). The exception to this is the TG15:(6,5) sample (Figure 4.1b),
where a very faint band is produced at 0.1 mg/mL. Additionally, bands are produced at 1 mg/mL
for TG15:Mix and E2:(6,5) PCRs. No distinct bands are produced at 5 or 10 mg/mL
concentration PCRs for any preparation. Prior work has shown that SWCNT sonicated in water
just before being added to a PCR reaction increased amplification efficiency of a 410 bp product
at concentrations up to 3 mg/mL (Cui et al. 2004). The same study showed that SWCNT in a
PCR reaction interacts with both the DNA template as well as Taq DNA Polymerase. This
study, however, has DNA wrapped around SWCNT, so this is unlikely to be the source of
inhibition. Another study showed that that SWCNT functionalized with carboxylic groups
produce stronger interactions with Taq and more inhibition of PCR than did pristine SWCNT at
0.1-0.8 mg/mL (Yi et al. 2007). Therefore, it is possible there is some interaction between
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Figure 4.1. (a-d). Agarose gel electrophoresis images and analysis of PCRs with old (4-10 months)
DNA:SWCNT samples. For each set, top left is agarose gel image with lanes and quantitized boxes
shown, top center is intensity line graph, top right is NS1 synthesized fluorescence intensity plot of
DNA:SWCNT samples (y-axis is excitation wavelength, x-axis is emission wavelength), bottom left is
bar graph of relative intensity within boxes on gel (normalized to 100 bp marker of 25 bp ladder), bottom
center is fluorescence efficiency at each wavelength in NS1 analysis (higher numbers correlate with
greater dispersion). Lanes in agarose gel images and relative intensity bar graph: 1. 25 bp ladder (black)
2. empty (dark blue) 3. negative control (red) 4. positive control (green) 5. 0.01 mg/mL DNA:SWCNT
(purple) 6. 0.1 mg/mL (neon blue) 7. 1 mg/mL (orange) 8. 5 mg/mL (light blue) 9. 10 mg/mL (pink)10.
100 bp ladder (black). Intensity line graph colors correlate with bar graph colors in relative intensity
graph. (a) TG15:Mix (b) TG15:(6,5) (c) Salmon:Mix (d)Salmon:(6,5).
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Figure 4.1. (e-h). Agarose gel electrophoresis images and analysis of PCRs with old (4-10 months)
DNA:SWCNT samples. For each set, top left is agarose gel image with lanes and quantitized boxes
shown, top center is intensity line graph, top right is NS1 synthesized fluorescence intensity plot of
DNA:SWCNT samples (y-axis is excitation wavelength, x-axis is emission wavelength), bottom left is
bar graph of relative intensity within boxes on gel (normalized to 100 bp marker of 25 bp ladder), bottom
center is fluorescence efficiency at each wavelength in NS1 analysis (higher numbers correlate with
greater dispersion). Lanes in agarose gel images and relative intensity bar graph: 1. 25 bp ladder (black)
2. empty (dark blue) 3. negative control (red) 4. positive control (green) 5. 0.01 mg/mL DNA:SWCNT
(purple) 6. 0.1 mg/mL (neon blue) 7. 1 mg/mL (orange) 8. 5 mg/mL (light blue) 9. 10 mg/mL (pink)10.
100 bp ladder (black). Intensity line graph colors correlate with bar graph colors in relative intensity
graph. (e) E2 MRE:Mix (f) E2 MRE:(6,5) (g) E2 MRE:Mix, No MRE (h) E2 MRE:(6,5), No MRE.
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DNA:SWCNT and Taq, but it is unlikely to be as strong of an interaction and inhibitory effect as
with carboxylic SWCNT.
It is also possible to PCR amplify E2 MRE target which is only present in the reaction
wrapped around SWCNT (Figure 4.1g and h). These concentration-dependence patterns follow
a similar pattern to reactions performed with the addition of free E2 MRE. This is important in
that it shows the ability to directly amplify DNA which is associated with SWCNT.
It is also clear that addition of DNA:SWCNT to PCR reactions has effects on amplicons
produced. In both Salmon:SWCNT samples (Figure 4.1c and d intensities), smears are visible in
lanes which there is no distinct E2 MRE band. This is likely due to degradation of the genomic
DNA present in the sample. In both E2:SWCNT samples amplification of a product just less
than 50 bp increases with E2:SWCNT concentration. This is also true for E2:SWCNT PCRs
performed with no free E2 MRE in the reaction (Figure 4.1e and f). This is likely due to an
excess of the amplification target itself in the reaction. However, in the TG15:SWCNT PCRs,
no amplicons appeared that were not present in the control reaction.
4.3.3 Agarose Gel Analysis of New DNA:SWCNT PCRs
Analysis of PCRs performed with DNA:SWCNT samples made less than a month before
use show amplification in the presence of 0.01 mg/mL (Figure 4.2 agarose gels). At this
concentration, all PCRs performed in the presence of free E2 MRE showed an increase in
efficiency of amplification (Figure 4.2 relative intensities). However, in contrast to PCRs with
old DNA:SWCNT samples, no amplification of E2 MRE was seen at or above concentrations of
0.1 mg/mL. This interesting result suggests that more well-dispersed SWCNT, as seen in the
older samples, is less inhibitory to PCR reactions. This may be because more agglomerated
SWCNT hinder the reaction ingredients from encountering each other. This is supported by the
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Figure 4.2. (a-d). Agarose gel electrophoresis images and analysis of PCRs with new (<1 month)
DNA:SWCNT samples. For each set, top left is agarose gel image with lanes and quantitized boxes
shown, top center is intensity line graph, top right is NS1 synthesized fluorescence intensity plot of
DNA:SWCNT samples (y-axis is excitation wavelength, x-axis is emission wavelength), bottom left is
bar graph of relative intensity within boxes on gel (normalized to 100 bp marker of 25 bp ladder), bottom
center is fluorescence efficiency at each wavelength in NS1 analysis (higher numbers correlate with
greater dispersion). Lanes in agarose gel images and relative intensity bar graph: 1. 25 bp ladder (black)
2. empty (dark blue) 3. negative control (red) 4. positive control (green) 5. 0.01 mg/mL DNA:SWCNT
(purple) 6. 0.1 mg/mL (neon blue) 7. 1 mg/mL (orange) 8. 5 mg/mL (light blue) 9. 10 mg/mL (pink)10.
100 bp ladder (black). Intensity line graph colors correlate with bar graph colors in relative intensity
graph. (a) TG15:Mix (b) TG15:(6,5) (c) Salmon:Mix (d)Salmon:(6,5).
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Figure 4.2. (e-h). Agarose gel electrophoresis images and analysis of PCRs with new (<1 month)
DNA:SWCNT samples. For each set, top left is agarose gel image with lanes and quantitized boxes
shown, top center is intensity line graph, top right is NS1 synthesized fluorescence intensity plot of
DNA:SWCNT samples (y-axis is excitation wavelength, x-axis is emission wavelength), bottom left is
bar graph of relative intensity within boxes on gel (normalized to 100 bp marker of 25 bp ladder), bottom
center is fluorescence efficiency at each wavelength in NS1 analysis (higher numbers correlate with
greater dispersion). Lanes in agarose gel images and relative intensity bar graph: 1. 25 bp ladder (black)
2. empty (dark blue) 3. negative control (red) 4. positive control (green) 5. 0.01 mg/mL DNA:SWCNT
(purple) 6. 0.1 mg/mL (neon blue) 7. 1 mg/mL (orange) 8. 5 mg/mL (light blue) 9. 10 mg/mL (pink)10.
100 bp ladder (black). Intensity line graph colors correlate with bar graph colors in relative intensity
graph. (e) E2 MRE:Mix (f) E2 MRE:(6,5) (g) E2 MRE:Mix, No MRE (h) E2 MRE:(6,5), No MRE.
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fact that higher concentrations have an inhibitory effect on PCR efficiency. However, in both
old and new samples, there seems to be no difference in PCR efficiency between Mix or (6,5)enriched SWCNT samples. This is in spite of a difference in dispersion based on DNA
sequence.
In PCR experiments with new E2:SWCNT samples and absent of free E2 MRE, the MRE
was amplified from the SWCNT scaffold (Figure 4.2g and h. Amplification of the 76 bp product
is observed in the presence of 0.01 mg/mL E2:SWCNT, but not at higher concentration. This
follows the same pattern seen as PCRs done in the presence of free E2 MRE. There is, however,
a reduction in efficiency at this concentration, which contradicts amplification of free E2 MRE at
this concentration.
Amplicons produced from PCRs in the presence of new DNA:SWCNT followed the
same general pattern as those with old samples. Previous studies have shown SWCNT increase
the specificity of long PCR (14 kb) up to the point that the reaction is inhibited (Zhang et al.
2008). The difference in results may be a function of size of the reaction product, or may be due
to the method of SWCNT dispersion, which was sonication in water. Another study has shown
that different concentrations of carbon nanopowder (CNP) does not affect amplicons produced in
a PCR reaction (Zhang et al. 2007). Therefore, the effects are likely due to degradation of
genomic DNA or excess target present in the reaction as previously discussed.
4.4 Conclusions
This work shows differential inhibitory concentrations for old and new DNA:SWCNT
preparations of varying dispersion levels in PCR reactions of 0.1 and 0.01 mg/mL, respectively.
This work also shows that it is possible to amplify a DNA sequences that is directly associated
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with SWCNTS through sonication-mediated dispersion. This is important for purification of
SWCNT chiralities using DNA as well as use of DNA:SWCNT-based molecular sensors and
environmental sample testing applications.
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CHAPTER 5
Investigation of the Effects of DNA-Dispersed Single-Wall Carbon Nanotubes
and Sodium Cholate-Dispersed Single-Wall Carbon Nanotubes on the Green
Algae Chlamydomonas reinhardtii
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5.1 Introduction
The increased use of manufactured nanomaterials has led to a need for a better
understanding of their potential effects on natural systems. Among these products are carbon
nanotubes, which can be represented by sheets of cylindrically-rolled graphene, originally
described in 1991 by Iijima (Iijima 1991; Ajayan 1999). The widespread commercialization of
single-wall carbon nanotubes (SWCNT) is due to their enormous potential in industrial,
biomedical, and electronic sensing applications. This potential is derived from their unique
physical, electronic, and optical properties (Wang 2005; Coleman et al. 2006; Huang et al. 2011).
The environmental release and transport of SWCNT at all stages of their production and use will
lead to environmental concerns (Köhler et al. 2008; Petersen et al. 2011). It is because of their
potential that it is necessary to study their interaction with organisms in the environment.
Previous work has shown possible toxic effects of carbon nanomaterials on model
organisms. Graphite, C60 fullerene, SWCNT, and multi-wall carbon nanotubes (MWCNT) have
been shown to inactivate various Gram-negative and Gram-positive bacteria (Kang et al. 2009).
This was shown to increase with incubation times up to four hours. While in the aforementioned
work the SWCNT contacted bacteria on a solid support, SWCNT dispersed in solution with
various surfactants have shown to be toxic to both bacterial types (Liu et al. 2009). In the model
organism Daphnia magna, SWCNT suspended in water with no surfactant were the most toxic
among other carbon nano- and bulk- materials (Zhu et al. 2009). These previous works make it
clear that SWCNT may have toxic environmental effects, but further exploration of various
preparations is necessary.
The unicellular green alga Chlamydomonas reinhardtii has been developed as a model
for the effects of nanomaterials on photosynthetic and microorganisms, as well as an indirect
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assessment of ecosystem-level effects (Harris 2001). Work using this model organism has
shown toxicity of silver nanoparticles, quantum dots, and titanium dioxide nanoparticles
(Navarro et al. 2008; Wang et al. 2008). A subsequent study has shown that this species takes up
quantum dots, which cause changes in its transcription profile (Domingos et al. 2011).
Additionally, C. reinhardtii has been used in finding toxic effects of SWCNT in solution with no
surfactant (Matorin et al. 2010). This work showed a negative effect on growth and
photosynthetic output of these algae due to SWCNT aggregates in solution. It specifically tested
concentrations of 2 µg/mL for SWCNT and 1 and 2 µg/mL of MWCNT, finding varying
negative effects of each. Thus, C. reinhardtii is an established system for studying the direct
toxic effects of nanomaterials and for inferring environmental impact of their release.
This study aimed to determine the effects of well-dispersed SWCNT on the model
species Chlamydomonas reinhardtii. The system was designed to mimic a stagnant algal growth
environment that is similar to natural systems. This design is ideal for well-dispersed SWCNT,
however non-dispersed SWCNT would agglomerate and form a precipitate in such a system.
Thus, only well-dispersed SWCNT were utilized, mimicking the environmental release of some
SWCNT (Köhler et al. 2008). Additionally, agglomerated SWCNT are known to become more
well-dispersed over time through interaction with natural organic matter (Lou et al. 2011;
Schierz et al. 2012). Therefore, the effects of a wide range of well-dispersed SWCNT in solution
with algal growth media on growth and chlorophyll content of green algae was assessed.
Furthermore, differences in surfactants used to disperse SWCNTs were explored.
Deoxyribonucleic acid (DNA) has been utilized to wrap around SWCNT and disperse them
individually in solution (Zheng et al. 2003), while sodium cholate (SC) is a biocompatible
surfactant which disperses SWCNT well in solution (Wenseleers et al. 2004; Arnold et al. 2006).
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Herein, DNA-and SC-dispersed SWCNT are characterized by near-infrared (NIR) spectroscopy
and their toxicity to C. reinhardtii is determined.
5.2 Methods
5.2.1 SWCNT Preparation
Single-wall carbon nanotubes dispersed by either DNA or SC (DNA:SWCNT or
SC:SWCNT) preparations were made similar to as previously described (Zheng et al. 2003;
Lahiji et al. 2007). Briefly, 2 mg CoMoCAT SWCNT of mixed chirality (Sigma-Aldrich; St.
Louis, MO) were mixed with 2 mg salmon testes genomic DNA or SC in 2 mL 1X phosphatebuffered saline (PBS). This mixture was sonicated on ice for two hours with a Virsonic XL2020
ultrasonic liquid processor (Misonix; Farmingdale, NY) equipped with a 3.2 mm microtip at
approximately 20% power. The resulting solution was centrifuged at 16,000Xg for 90 minutes
to remove insoluble SWCNT. For DNA:SWCNT samples, the solution was then filtered through
a 100,000 molecular weight centrifugal filter (Millipore; Billerica, MA) three times at 4000 RPM
for 15 minutes each to remove DNA that did not associate with SWCNTs. The recovered
DNA:SWCNT solution was brought to a volume of 500 µL with 1X PBS, while SC:SWCNT
samples remained in 2 mL. The concentration of the DNA: or SC:SWCNT samples were
obtained by gravimetric analysis of 10 µL of the solution weighed on an Ohaus Discovery
Microbalance (Ohaus; Parsippany, NJ).
5.2.2 SWCNT Characterization
Absorption and NIR fluorescence measurements were performed essentially as
previously described (Bachilo et al. 2002; Weisman 2010). Briefly, each SWCNT preparation
was diluted to a 1% solution with Milli-Q water (Millipore; Billerica, MA). This solution was
added to a 10 mm path length cuvette (Sterna Cells; Atascadero, CA) and analyzed on a
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NanoSpectralyzer 1 (NS1) (Applied NanoFluorescence; Houston, TX). The absorbance
spectrum was collected from 400 - 1600 nm. Additionally, integrated fluorescent emission
spectra were obtained using excitation wavelengths of 638 nm, 690 nm, and 784 nm. The
resulting spectra were analyzed with ANFSoft (Applied NanoFluorescence; Houston, TX) and
prepared in Origin 8 (OriginLab Corporation; Northampton, MA). Fluorescence efficiency
measurements, which are fluorescence power collected across the emission spectrum for a single
excitation wavelength divided by the absorbance spectrum, are reported as a relative measure of
SWCNT dispersion in solution.
5.2.3 Algae Culture
Chlamydomonas reinhardtii wild-type strain cc-1690 was obtained from the
Chlamydomonas Resource Center (St Paul, MN). Received algae were initially plated onto 1.5%
Sueoka's high salt medium (HSM) agar prepared as previously described (Sueoka 1960). This
was used to seed small liquid cultures of HSM for outgrowth, which was kept in a continuous
culture of 100 mL HSM. Every 1-2 weeks, the existing culture was diluted to 10% in HSM to
allow continuous outgrowth. Culture conditions were sustained at 22-25°C with continuous
ambient light and daily mixing.
5.2.4 SWCNT Treatments
Treatments of C. reinhardtii in liquid culture with SWCNT preparations or controls were
performed in a total volume of 10 mL in 50 mL conical tubes with loosened lids. At day zero, 9
mL HSM was seeded with 1 mL stock algal culture and the appropriate treatment was added.
Treatments were: 0, 0.1, 1, 2, 10, or 100 µg/mL DNA:SWCNT or SC:SWCNT, and 100 µg/mL
sonicated DNA or SC. Contamination and absorbance controls consisted of 10 mL of just HSM
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or HSM with 1 µg/mL DNA:SWCNT or SC:SWCNT. Each treatment and control was
performed in triplicate and grown for ten days at the above-noted culture conditions.
5.2.5 Growth Measurements
Every 24 hours, from day one to day 10, each sample was mixed and 300 µL was
removed. The optical density of this solution was measured at 750 nm with a Synergy 2
microplate reader and the software Gen5 1.06 (Biotek US; Winooski, VT). The optical density
at 750 nm was also measured for prepared absorbance controls of HSM with each individual
treatment. The optical density of algae was determined by subtracting control from sample
optical density. On the tenth day, optical density of Chlorophyll β and α at 663 nm and 645 nm
respectively was obtained. A portion of each sample was centrifuged and resuspended in
methanol. This was centrifuged, and optical density of chlorophyll extracted in the liquid phase
was measured at 663 nm and 645 nm as previously described (Chochois et al. 2010). At the end
of treatments, algae were placed onto microscope slides with a cover slip and imaged using a
Leica ATC 2000 light microscope (Leica Microsystems; Wetzlar, Germany) and a TCA 5.0
microscope camera (Ample Scientific; Norcross, GA).
5.3 Results and Discussion
5.3.1 SWCNT Preparation and Characterization
Single-wall carbon nanotubes were dispersed in solution with either DNA or SC. As
determined by gravimetric analysis, concentrations of prepared SWCNT solutions ranged from
10 µg/µL to 30 µg/µL. Absorbance and NIR fluorescence spectroscopy was then performed on
dilutions of each sample to determine SWCNT chirality composition, diameter, and dispersion in
solution (Figures 5.1a and 5.1b). The DNA:SWCNT showed an average SWCNT diameter of
0.83 nm, ranging from 0.6 to 1.4 nm (Figure 5.1c). Based on an integrated fluorescence
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emission spectrum, the sample of mixed chirality was composed of largely (6,5), (8,4), and (7,5)
armchair SWCNT (Figure 5.1e). The SC:SWCNT sample had an average of 1.248 nm, with
SWCNT being mostly between 1.2 and 1.3 nm (Figure 5.1d). The integrated fluorescence
emission spectrum of this sample showed a majority of SWCNT being of (11,7) armchair
chirality (Figure 5.1f). Additionally, efficiency of fluorescence output of the DNA:SWCNT was
much higher than SC:SWCNT, which were negative values (Figures 5.1g and 5.1h). NIR
fluorescence is only emitted from monodisperse SWCNT suggesting DNA is more effective
at dispersing individual SWCNTs than SC (Zheng et al. 2003; Wenseleers et al. 2004; Liu et al.
2009). DNA gives more monodisperse SWCNT by wrapping around the SWCNT in a helical
manner masking the hydrophobic surface of the SWCNT. In contrast, SC forms micelles which
disperse SWCNT as bundles. Therefore, fluorescence efficiency and SWCNT diameter of each
SWCNT sample confirms that DNA:SWCNT are more well-dispersed than SC:SWCNT.
5.3.2 Effects of SWCNT and Dispersion Method on Algal Growth
Chlamydomonas reinhardtii were grown in liquid culture with either DNA:SWCNT,
SC:SWCNT, or controls and the culture optical density was measured for ten consecutive days.
Results show no normalized optical density for either the high salt medium or 1 µg/mL
DNA:SWCNT only controls, meaning no contamination of media or SWCNT sample was
present (Figure 5.2). From culture concentrations of 0.1 µg/mL to 100 µg/mL, there are no
effects of DNA:SWCNT on optical density of the algae. For all cultures, a plateau in algal
growth was reached in the sixth day. There is also no difference with treatment of 100 µg/mL
sonicated DNA only.
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638 nm 690 nm 784 nm
SC:SWCNT
1.09507 0.75541
1.6632 Efficiency
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Figure 5.1. Characterization of DNA:SWCNT and SC:SWCNT. (a) and (b) Synthesized
fluorescence intensity plot of DNA:SWCNT and SC:SWCNT output respectively. (c) and (d)
Calculated density distribution of DNA:SWCNT and SC:SWCNT respectively. (e) and (f)
SWCNT chirality distribution of DNA:SWCNT and SC:SWCNT samples respectively. (g) and
(h) Fluorescence efficiency measurements at excitation wavelengths of 638, 690, and 784 nm of
DNA:SWCNT and SC:SWCNT respectively. Higher numbers represent better dispersion.
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Results of algae grown in the presence of SC:SWCNT also show no difference in algal
growth optical density at 750 nm due to SC:SWCNT treatment (Figure 5.3). A plateau in growth
is evident beginning at day four. There is an initial difference in growth of algae treated with
just 100 µg/mL SC at the plateau, which subsides by the ninth day. At the ninth and tenth day,
there is an increase in growth of algae treated with 0.1 µg/mL, however this is not significant.
Growth of SC only-treated algae plateaus at day 6; however standard deviations also overlap
with the control at these days suggesting no true difference.

Normalized OD 750

DNA:SWCNT Algae Treatment
0.6

0 ug/ml

0.5

0.1 ug/ml

0.4

1 ug/ml

0.3

2 ug/ml

0.2

10 ug/ml
100 ug/ml

0.1

1 ug/ml No Algae

0
-0.1

Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day
10

HSM Only
DNA Control

Figure 5.2. Ten day growth curve of Chlamydomonas reinhardtii with DNA:SWCNT
treatments or controls. Treatments were 0, 0.1, 1, 2, 10, or 100 µg/mL, DNA:SWCNT only
control, media only control (HSM), or 100 µg/mL DNA control. Errors bars for each point
represent (+/-) standard deviation.
After the tenth day, extraction of chlorophyll and absorbance measurements at 663 nm
and 645 nm gave chlorophyll content measurements of the algal cultures. At 663 nm,
absorbance of chlorophyll β showed no difference between either DNA:SWCNT or SC:SWCNT
and their control (Figure 5.4). Additionally, there is no difference between DNA and SC
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dispersed SWCNT at any treatment concentration. There is a decrease in SC-only treated algae,
however. This may be due to some mitigation by SWCNT being complexed with SC.
Chlorophyll α absorbance at 645 nm showed similar results (Figure 5.5). There is no difference
between controls and treatments of DNA:SWCNT and SC:SWCNT at any treatment level.

SC:SWCNT Algae Treatment
0 μg/ml

0.6

0.1 μg/ml

Normalized OD 750

0.5

1 μg/ml

0.4
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0.3
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100 μg/ml

0.1
0
-0.1

Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10

1 μg/ml No
Algae
HSM Only
SC Control

Figure 5.3. Ten day growth curve of Chlamydomonas reinhardtii with SC:SWCNT
treatments or controls. Treatments were 0, 0.1, 1, 2, 10, or 100 µg/mL, SC:SWCNT only
control, media only control (HSM), or 100 µg/mL SC control. Errors bars for each point
represent (+/-) standard deviation.
There seems to be no difference in Chlamydomonas reinhardtii growth or chlorophyll
output for DNA:SWCNT or SC:SWCNT treatment relative to control. This is in opposition to
previously-reported data showing negative growth effects of SWCNT. Previous findings using 2
µg/mL SWCNT with no surfactant showed a negative effect on growth of algae up to five days
(Matorin et al. 2010). This report also showed clear evidence of algal association with SWCNT
agglomerations. Non-dispersed SWCNT have also shown to be toxic to bacteria (Kang et al.
2009). Furthermore, a LC 50 of 2.4 µg/mL has been obtained with Daphnia magna. This level
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and almost 50 times greater caused no growth effects in the current study. While the stagnant
growth conditions used in this study were not conducive to using non-dispersed SWCNT due to
hydrophobic precipitation, the previously-reported studies are a comparative benchmark for their
toxic effects. The use of well-dispersed SWCNT is environmentally relevant as agglomerations
are known to associate with organic matter and become more well-dispersed over time (Lou et
al. 2011; Schierz et al. 2012). The extensive studies reported herein suggest there is no negative
effect of well-dispersed SWCNT on algal growth.
The reported toxic effect of SWCNT may be due to agglomeration and shading, which
was mitigated in this study with more effective dispersion of the SWCNTs. It has been reported
that SWCNT toxic effects on the green algae Pseudokirchneriella subcapitata were lost with
higher concentrations of the surfactant Gum Arabic (Youn et al. 2011). Another study
specifically investigating the effects of agglomeration and shading found that SWCNT partially
dispersed by natural organic matter had EC 50 values of 1.8 µg/mL and 20 µg/mL on the algae
Chlorella vulgaris and P. subcapitata (Schwab et al. 2011). That work suggests that toxic
effects may be due to indirect effects on local growing conditions of algae within SWCNT
agglomerations, such as competition for resources and reduced light availability.
In the current study, agglomeration and shading by SWCNT did not seem to be as
prevalent. No agglomeration of DNA:SWCNT samples were seen either in culture or in
micrographs (Figure 5.6). At the highest level of SC:SWCNT treatment, 100 µg/mL, there was
some visible agglomeration in culture and under the microscope, but this was not extensive nor
was it found at any lower levels. However, microscopic examination shows only a small portion
of algae are agglomerated with SC:SWCNT, not nearly as prevalent as with the P. subcapitata
study. Furthermore, growth at the 100 µg/mL treatment level was not affected.
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Figure 5.4. Extracted Chlorophyll β content at OD 663 for DNA:SWCNT and SC:SWCNT
treatments. Treatments are 0, 0.1, 1, 2, 10, or 100 µg/mL, DNA:SWCNT or SC:SWCNT only
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Figure 5.5. Extracted Chlorophyll α content at OD 645 for DNA:SWCNT and SC:SWCNT
treatments. Treatments are 0, 0.1, 1, 2, 10, or 100 µg/mL, DNA:SWCNT or SC:SWCNT only
control, media only control (HSM), or 100 µg/mL DNA or SC control. Error bars for each point
represent (+/-) standard deviation.
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Additionally, the chosen strain can grow in the presence of nitrogen in the dark and therefore
may not be affected by SWCNT shading effects. Results of chlorophyll content measurements
however show no difference due to SC:SWCNT at any level. Future work may determine
possible effects on chlorophyll efficiency due to agglomeration and shading. Hence, the lack of
toxic SWCNT effects is likely due to the well-dispersed nature of DNA:SWCNT and
SC:SWCNT. Indeed, work with SWCNT well-dispersed in various surfactants on rat liver cells
and human lung fibroblasts showed no toxic effects (Alpatova et al. 2010; Wang et al. 2010).
Furthermore, DNA:SWCNT and SC:SWCNT showed no toxic effect on human astrocytoma
cells (Dong et al. 2008). A lack in difference of growth between DNA:SWCNT and
SC:SWCNT, even though DNA:SWCNT are more well-dispersed, may be because SC:SWCNT
do not agglomerate to the point of causing a wide-scale effect on growth.

Figure 5.6. Micrograph of algae grown with SWCNT. Representative image of
Chlamydomonas reinhardtii after ten days in culture with 100 µg/mL DNA:SWCNT. Algae
appear healthy and no SWCNT agglomerations are visible.
A detraction from this hypothesis is a study showing that SWCNT act as 'nano darts'. In
this, well-dispersed SC:SWCNT effectively punctured bacterial membranes (Liu et al. 2009).
This work states that softer bacterial membranes were more susceptible to puncturing by
SWCNT, and therefore may not be a factor with the prominent glycoprotein cell wall of C.
reinhardtii (Harris 2001). It was also noted that a higher rate of bacterial death was obtained by
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faster shaking speeds with SWCNT. This was not a factor here as cultures were only mixed once
a day. Future studies may be directed to investigate increased shaking speeds of DNA:SWCNT
and SC:SWCNT treated cultures. The presented work does, however, agree with other
toxicological studies using DNA:SWCNT and SC:SWCNT to treat human cells (Dong et al.
2008). It is therefore unlikely that SWCNT punctured the cell wall of the algae or had any other
negative effects. Future work may further investigate the nature of the interaction seen in
SC:SWCNT agglomerations and investigate the ability of monodisperse SWCNT to penetrate
algal cell walls.
5.4 Conclusions
This study presents findings that SWCNT well-dispersed with DNA or SC does not have
an effect on growth or chlorophyll content of Chlamydomonas reinhardtii at concentrations of
0.1-100 µg/mL. This is in opposition to previous work that has shown SWCNT can be toxic to
algae, bacteria, or other model organisms. However, this supports other research that suggests
there is no toxic effect of well-dispersed SWCNT on model organisms or mammalian cells.
Thus, increasingly widespread use of SWCNT may have toxic environmental impacts if the
materials are poorly dispersed in solution. However, well-dispersed SWCNT, such as those with
DNA or SC, may have minimal environmental consequences.
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Appendix A
In Vitro Selection of Antibody Fragment Molecular Recognition
Elements for Prostate Cancer Cells
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A.1 Introduction
Prostate cancer is the most-diagnosed non-skin cancer in the United States, with an
estimated 241,740 new diagnoses in 2012 alone (Siegel et al. 2012). It is the second leading
cause of cancer-related deaths among males in the U.S., with an estimated 28,170 mortalities in
2012 (Siegel et al. 2012). Approximately one in six U.S. men will get prostate cancer in their
lifetime, with one in 30 dying from the disease (Ries et al. 1997). It is therefore important to
develop new diagnostic and therapeutic approaches for clinical prostate cancer treatment.
Currently, prostate cancer diagnosis has shifted away from the standard of care: prostate
specific antigen (PSA) blood levels. Initially discovered in 1979, serum PSA levels were shown
to be higher in men with prostate cancer than those with normal prostates (Wang et al. 1979;
Kuriyama et al. 1980). After U.S. Food & Drug Administration approval for prostate cancer
detection in 1986, there was an initial increase in number of prostate cancer-related deaths,
largely due to more diagnoses (Catalona et al. 1991; Baade et al. 2004). This mortality rate
began to decrease due to better awareness, however, as PSA had become the standard bearer in
cancer biomarkers (Baade et al. 2004).
In spite of this promise, PSA testing is no longer recommended for use by the United
States Preventative Services Task Force (USPSTF) (Chou et al. 2011; Lin et al. 2011; Moyer
2012). This is because serum PSA levels are raised not only due to cancerous prostates, but due
to benign prostatic conditions such as prostatic intraepithelial neoplasia (PIN), benign prostate
hyperplasia (BPH), and prostatitis (Woolf 1995). Indeed, studies have shown the specificity of
the PSA test in prostate cancer diagnosis to be just 24%, meaning there is a 76% over-diagnosis
rate (Thompson et al. 2006). Calculations have shown that PSA screening will prevent just one
prostate cancer-related death in greater than 1000 men (Moyer 2012). For that small number is
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does help, it is estimated to cause many unnecessary biopsies, treatments, and individual stress
(Carlsson et al. 2012; Moyer 2012). For that reason, the USPSTF officially gave it a grade ‘D’
in 2012; however some primary care physicians continue to use the test due to its high sensitivity
(Barry 2009; Moyer 2012; Pollack et al. 2012).
The promise of PSA, despite its pitfalls, has led to a great deal of research in identifying
other diagnostic mechanisms. There have been many biomarkers identified that may have some
diagnostic potential (Herness and Naz 2001; Williams and Naz 2010). Many of these, however,
do not differentiate between prostate cancer and other prostatic diseases, similar to PSA. Others
are expressed in other tissues and are not useful for identification of prostate cancer. The moststudied among these is prostate-specific membrane antigen (PSMA), which has entered into the
clinic as a diagnostic and therapeutic tool (Horoszewicz et al. 1987). PSMA, however, is
expressed in other non-prostatic normal and malignant tissues (Maraj et al. 1998; Renneberg et
al. 1999). Thus, clinical prostate cancer diagnosis relies on digital rectal exams, which can miss
tumors, relies on diagnosis after palpable tumors have formed, and misses more prostate tumors
than PSA screening (Catalona et al. 1994). Additionally, biopsies are performed, which are
invasive and have inherent infection risks (Rodriguez and Terris 1998). Therefore, it is
necessary to develop a minimally invasive diagnostic molecular test for the early and specific
detection of prostate cancer.
In addition to non-specific diagnostics, current treatments for prostate cancer are partially
effective, but have many unwanted side effects. Early-stage, localized prostate cancer is
typically either managed with watchful waiting or treated with prostatectomy, radiation therapy,
androgen deprivation, cryotherapy, or ultrasonogrpahy (Chou et al. 2011). Long-term studies
have found that radical prostatectomy confers a significant decrease in mortality compared to
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watchful waiting, from 21% to 15% in one trial (Wong et al. 2006; Albertsen et al. 2007; BillAxelson et al. 2008; Bill-Axelson et al. 2011). In total, radiotherapy, including external beam
radiation therapy and internal brachytherapy, significantly reduces prostate cancer-related
mortality compared to no treatment (Tewari et al. 2007; Zhou et al. 2009; Ladjevardi et al. 2010;
Stattin et al. 2010). Conversely, androgen deprivation therapy is actually associated with
increased risk of mortality, however one study found a slight decrease after a seven year
followup period (Lu-Yao et al. 2008; Zhou et al. 2009).
Each of the localized prostate cancer treatment modalities is associated with multiple
side-effects. These include urinary incontinence, erectile dysfunction, and quality of life, among
others (Chou et al. 2011). In fact, depending on the treatment, a 14-33% higher proportion of
men, compared to watchful waiting, suffered from erectile dysfunction and a 20% higher
proportion of men had urinary incontinence (Chou et al. 2011). For prostatectomy, operationrelated mortality and cardiac events are possible (Yao and Lu-Yao 1999). Additionally,
recurrence is possible with all of these treatments. This can be in a more aggressive, androgenindependent form, or other hard-to-treat forms (Feldman and Feldman 2001). For many nonlocalized cancers, chemotherapy is also used. This is in spite of the fact that many advanced,
hormone-refractory prostate cancers are difficult to treat with chemotherapeutics (Yagoda and
Petrylak 2006). For prostate cancer, historically 5-fluorouracil (5-FU) was used and had fewer
side effects compared to those used today (Yagoda and Petrylak 2006). Currently, docetaxel is
the first-line chemotherapeutic, with mitoxantrone sometimes being used in that role based on
side effects (Pienta 2001; Pienta and Smith 2005). These are often used with combinations of
other agents as well (Pienta and Smith 2005). However, whether alone or in combination, these
cause many side effects due to non-specific action. A 70% response rate has been shown for
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patients on docetaxel, however as many as 70% of all patients also experienced neutropenia
(Extra et al. 1993). Other main side effects include thrombosis, fatigue, hyperglycemia, nausea,
vomiting, and others (Pienta and Smith 2005). Clearly, these drugs can be effective, however
more specific therapeutics would be more effective and have fewer side effects.
It is possible to utilize molecular targeting to diagnose and specifically deliver
therapeutics to prostate cancer. Identification of a Molecular Recognition Element (MRE) is
achieved through the process of Selective Evolution of Ligands by EXponential Enrichment
(SELEX), also known as in vitro selection (Ellington and Szostak 1990; Tuerk and Gold 1990).
This process utilizes a large library of random molecules which are screened for their ability to
bind to a target of interest. Those that do not bind to the target are removed, and those that do
are amplified. Amplified molecules are then subjected to closely-related negative targets to
which binding is not desired. Molecules that do not bind to this target are amplified, completing
a round of selection. Rounds continue until one or a few strongly-binding and specific molecules
are selected. This process has been adapted for use in identifying molecules that bind to wholecell targets (Morris et al. 1998; Guo et al. 2008). It has also been adapted to incorporate a
protein library displayed on various microbiological host surfaces, including yeast (Huse et al.
1989; Gunneriusson et al. 1996; Boder and Wittrup 1997). It is therefore possible to combine
these methodologies to identify protein MREs from a yeast-displayed library which bind to the
surface of prostate cancer cells.
The work described here utilized a novel variation of SELEX called Decoy-SELEX.
This scheme enriches the initial library for molecules which bind to the target of interest similar
to SELEX. It focuses, however, on stringent negative selections using targets to which the MRE
should not bind. This work has identified MREs which bind to a prostate cancer cell line, and
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not to various benign prostate cells lines. It utilized a human non-immune single-chain Fragment
variable (scFv) library displayed on the surface of Sacchoromyces cerevisiae. The obtained
MREs will be useful for both specific diagnosis and treatment of prostate cancer.
A.2 Methods
The Decoy-SELEX process was used in order to obtain a prostate cancer cell-specific
MRE (Figure A.1). A library of non-immune human single-chain Fragment variable (scFv)
antibody fragments was displayed on the surface of yeast. Seven rounds of selection were
completed, enriching for those scFvs which bound to the androgen-dependent prostate cancer
cell line LNCaP and subtracting those that bound to the benign prostate cell lines HGPIN, BPH1, and BHPrE1, as well as the protein PSMA (Table A.1).

Figure A.1. Scheme depicting the Decoy-SELEX process. A library of 109 yeast-displayed
scFv molecules are incubated with the target LNCaP cell line. Those that bind are amplified and
incubated with negative targets. Those that do not bind the negative targets are amplified and
subjected to additional rounds of in vitro selection.
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A.2.1 Cell Culture and Materials
In order to obtain a prostate cancer cell-specific MRE, prostatic cell lines were used. For
general maintenance, each line was passaged every 5-7 days in a T75 cell culture dish with
media changed every 2-3 days. The cells were grown in a 37°C incubator with 5% carbon
dioxide and humidity. The androgen-dependent prostate cancer cell line LNCaP was obtained
from the American Type Culture Collection (ATCC) (Manassas, VA) and cultured in RPMI
1640 with L-Glutamine and 25 mM HEPES (Cellgro; Manassas, VA) and 10% Fetal Bovine
Serum (FBS) (Fisher Scientific; Pittsburgh, PA) and 1X antibiotic/antimycotic mixture (ab/am)
(Cellgro) (Horoszewicz et al. 1983). The HPV-18-immortalized High Grade Prostatic
Intraepithelial Neoplasia (HGPIN) cell line was a generous gift from Dr. Mark Stearns (Drexel
University; Philadelphia, PA) and was cultured in Defined KSFM (Gibco; Grand Island, NY)
with 5% FBS and 1X ab/am (Wang et al. 1999). The SV40T-immortalized Benign Prostate
Hyperplasia (BPH-1) cell line was a generous gift from Dr. Simon Hayward (Vanderbilt
University; Nashville, TN) and was cultured in RPMI-1640 with L-Glutamine and 25 mM
HEPES and 10% FBS and 1X ab/am (Hayward et al. 1995). The spontaneously-immortalized
intermediate prostate stem cell line BHPrE1 was also obtained as a generous gift from Dr. Simon
Hayward (Vanderbilt University) and cultured in DMEM/F12 (Cellgro) supplemented with 5%
FBS, 1X ab/am, 1% insulin/transferrin/selenium (Gibco), 0.4% bovine pituitary extract (Sigma;
St. Louis, MO), 5 ng/mL epidermal growth factor (Gemini Bio-Products; West Sacramento,
CA), and 1X ab/am (Jiang et al. 2009). The androgen-independent DU-145 prostate cancer cell
line was obtained from ATCC and cultured in EMEM (Cellgro) with 10% FBS and 1X ab/am
(Stone et al. 1978). The androgen-independent prostate cancer cell line PC-3 was also obtained
from ATCC and cultured in F12K media (Cellgro) with 10% FBS and
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Table A.1. Decoy-SELEX scheme for identification of prostate cancer cell-specific MREs.

Target
LNCaP
HGPIN
BPH-1
BHPrE1
LNCaP
HGPIN
BPH-1
BHPrE1
LNCaP
HGPIN
BPH-1
BHPrE1

Human
Yeast
% Yeast
Cell
Number Expression Number
1 X 1010 34.2
~8 X 106
~7 X 106
1 X 1010 38.5
~9 X 106
~7.5 X 106
1 X 1010 7.04
~9 X 106
~8.5 X 106
1 X 1010 6.34
~9.5 X 106
~8 X 106
1 X 1010 8.85
~9 X 106
~7 X 106
1 X 1010 6.7
~9 X 106
~8 X 106

Incubation
Time
3 hours
30 minutes
30 minutes
30 minutes
2 hours
1 hour
1 hour
1 hour
1 hour
2 hours
2 hours
2 hours

Separation
Volume Method
15 mL Panning

4 (+)
4 (-) a
4 (-) b
4 (-) c

LNCaP
HGPIN
BPH-1
BHPrE1

1 X 107
1 X 107
1 X 107
1 X 107

29.65
6.31
7.65
4.78

4 (-) d

PSMA*

1 X 107

5 (+)
6 (+)
6 (-) a
6(-) b

LNCaP
LNCaP
HGPIN
BPH-1

1 X 107
1 X 107
1 X 107
1 X 107

17.3
24.02
(Lo)/21.72
(Hi)
21.2/19.36
16.73/13.5
7.86/11.92

1 X 106
1 X 106
1 X 106
1 X 106
1 nmol
protein

6(-) c

BHPrE1

1 X 107

6(-) d

PSMA*

1 X 107

Selection
Round
1 (+)
1 (-)

15 mL

Panning

15 mL

Panning

15 mL

Panning

15 mL

Panning

15 mL

Panning

30 minutes
30 minutes
30 minutes
30 minutes

2.5 mL
1.5 mL
2 mL
1.5 mL

FACS
FACS
FACS
FACS

30 minutes

1 mL

FACS

1 X 106
1 X 105
1 X 106
1 X 106

30 minutes
30 minutes
30 minutes
30 minutes

5 mL
2.75 mL
2.5 mL
2.5 mL

FACS
FACS
FACS
FACS

41.42/48.85 1 X 106
1 nmol
37.26/8.53 protein

30 minutes

2.5 mL

FACS

30 minutes

2 mL

FACS

7 (+)
LNCaP
1 X 107 25.67/15.63 1 X 103
*PSMA is prostate-specific membrane antigen.

30 minutes

2.5 mL

FACS

2 (+)
2 (-)
3 (+)
3(-)

1X ab/am (Kaighn et al. 1979). The HPV-18-immortalized normal prostatic epithelium cell line
RWPE-1 was obtained from ATCC and cultured in Defined KSFM (Gibco) plus 1X ab/am
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(Bello et al. 1997). The spontaneously-immortalized early prostate stem cell line NHPrE1 was a
generous gift from Dr. Simon Hayward (Vanderbilt University) and cultured in the same media
as BHPrE1 (Jiang et al. 2009).
A.2.2 scFv Library and Growth
A human non-immune scFv library displayed on the surface of Sacchoromyces cerevisiae
with 109 diversity was a gift from Dr. Dane Wittrup (Massachusetts Institute of Technology;
Cambridge, MA) (Boder and Wittrup 1997; Feldhaus et al. 2003). The library had a full
diversity of at least 109 antibody fragments and has the ability to be serially propagated without
loss of diversity (Feldhaus et al. 2003). The full library was cloned into the pPNL6 plasmid in
the EBY100 yeast strain. It was originally amplified in standard dextrose media with casamino
acids (SD+CAA), which contains 0.5% casamino acids, 2% dextrose, 0.17% yeast nitrogen base
without ammonium sulfate amino acids, 0.53% ammonium sulfate, 1.019% sodium dihydrogen
phosphate, 0.856% sodium monophosphate, and supplemented with 10 U/mL penicillin, 10
μg/mL streptomycin, and 80 μg/mL ampicillin that had been vacuum filtered through a 0.22 µm
filter. The library was amplified to an OD of approximately 1.5 at 30°C with shaking at 250
RPM. Surface expression of the library was achieved by expressing the scFv under control of a
galactose promoter in standard galactose plus casamino acids media (SG+CAA), which
substituted 2% galactose, 2% raffinose, and 0.1% dextrose for the dextrose in SD+CAA. An
initial input of 0.5 OD was amplified to approximately 1.5 OD with shaking at 250 RPM at
20°C. After each induction growth period, surface expression of the library was confirmed by
flow cytometry analysis. The monoclonal anti-HA tag antibody clone 16B12 conjugated to
either DyLight 488 (Columbia Biosciences; Columbia, MD) or AlexaFluor 488 (Invitrogen;
Grand Island, NY) was used to stain scFv-expressing yeast in yeast wash buffer (YWB)
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consisting of phosphate-buffered saline (PBS), 0.5% bovine serum albumin, and 2 mM EDTA.
The samples were run on either a Cell Lab Quanta SC (Beckman Coulter; Brea, CA) or a
FACSCalibur (BD Biosciences; San Jose, CA) flow cytometer equipped with a 488 nm argon
laser and 525 nm emission filter. At least 5% partial induction of the surface library was
confirmed and deemed sufficient for selection incubations.
A.2.3 In Vitro Selection
Seven rounds of Decoy-SELEX were performed in order to obtain a scFv MRE specific
for the LNCaP prostate cancer cell line. The first three rounds of selection were performed by
panning and the last four by fluorescence-activated cell sorting (FACS). The first three rounds
of panning-based selection were performed directly in a T75 cell culture flask. For Round 1(+)
selection, LNCaP cells were grown to 80-90% confluence and the media was removed. The
cells were gently washed with calcium- and magnesium-free phosphate-buffered saline (PBS),
which was removed. The cells were then incubated with 1010 yeast to ensure total representation
of the library diversity. The naïve yeast library was amplified as discussed previously and scFv
surface expression was induced. After surface expression confirmation, the library was
suspended in 15 mL YWB. The library was placed into the flask containing LNCaP cells and
placed on a 37°C shaker at 25 RPM for three hours. After incubation, yeast not bound to LNCaP
cells were removed, and the LNCaP cells were gently washed three times with 15 mL YWB. It
was then noticed, however, that LNCaP cells were less than 25% confluent in the flask, likely
due to EDTA metal chelation and subsequent cell removal.
To determine optimal buffer conditions, separate 90% confluent LNCaP T75 flasks were
incubated with the following six buffers at 37°C with shaking at 25 RPM for three hours: 1)
YWB, 2) YWB with no EDTA, 3) YWB with no EDTA and 0.1% FBS, 4) YWB with no EDTA
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and 0.5% FBS, 5)YWB with no EDTA and 1% FBS, and 6) YWB with no EDTA and 10% FBS.
After incubation, remaining attached cells were visually estimated and compared to before
incubation. Buffer 1 caused less than 25% of LNCaP to be attached, while Buffers 2-4 resulted
in approximately 50% attachment, and Buffers 5 and 6 caused almost no detachment (90%
confluent LNCaP cells), likely due to the FBS supplement. Therefore, Buffer 5 was chosen as an
appropriate incubation buffer and named yeast selection buffer (YSB).
After determination of an appropriate incubation buffer, the Round 1(+) incubation was
performed as described above, however with expressing yeast suspended in YSB. After three
washes, 100 mL SD+CAA was added to the flask to allow for amplification of yeast bound to
LNCaP cells. This was grown overnight, and this enriched library was prepared for a round of
negative selection. For Round 1(-) selection, scFv-expressing yeast were suspended in YSB and
incubated with rinsed HGPIN cells at 80-90% confluence for 30 minutes at 37°C with shaking at
25 RPM. The supernatant containing yeast-displayed scFvs not bound to HGPIN cells was
removed and added to rinsed BPH-1 cells under the same conditions, removed again and added
to rinsed BHPrE1 cells under the same conditions. The serially-incubated supernatant was
centrifuged to obtain yeast, which were suspended in SD+CAA for amplification. Two more
rounds of panning-based selection were performed in this manner, with decreasing incubation
times for positive rounds and increasing incubation times for negative rounds.
The ensuing four rounds of selection were performed using FACS-based sorting. For
Round 4(+) selection, LNCaP cells grown to 80-90% confluence were fluorescently dyed with
CFSE (Invitrogen) according to manufacturer’s instructions. They were then dissociated from
the flask with CellStripper reagent (Cellgro) to prevent cell surface protein digestion associated
with trypsinization. Cells were then suspended in YSB and counted with a Scepter equipped
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with 60 μm sensors (Millipore; Billerica, MA). In Round 4, all yeast were fluorescently dyed
with Syto61 (Invitrogen) according to manufacturer’s instructions. A total of 107 yeast were
suspended in YSB and mixed with 106 LNCaP in a volume of approximately 2.5 mL. They were
mixed by inversion for 30 minutes at 37°C and placed on ice before FACS sorting. The sample
was then sorted with a FACSAria (BD Biosciences), with excitation at 488 nm from a sapphire
solid state laser and 633 nm from a HeNe laser and 525 nm and 650 nm emission filters. Events
identified as bound yeast and LNCaP cells were collected. In Round 4(+), there were two
separate populations of bound cells which were collected and amplified separately. These were
called the ‘Hi’ and ‘Lo’ populations and kept separate through the following rounds of selection
and subjected to the same growth and selection conditions.
In Round 4(-)a, for each of the Hi and Lo populations, yeast were prepared for selection
in the same manner and incubated with 106 HGPIN cells dyed the same with inversion for 30
minutes at 37°C in YSB. The sample was subjected to FACS and events that indicated yeast that
were not bound to HGPIN cells were collected and amplified. Those were then prepared for
selection and incubated with 106 dyed BPH-1 cells for Round 4(-)b and subjected to FACS with
unbound yeast collected and amplified. The enriched library was then prepared for Round 4(-)c
and subjected to FACS after incubation with 106 dyed BHPrE1 cells. Unbound yeast were
collected and amplified, then prepared for selection and incubated with 1 nmol recombinant fulllength PSMA protein, which is expressed in non-prostatic normal and tumor tissue, as well as
normal prostate cells (Silver et al. 1997) (Abnova; Walnut, CA), pre-incubated with AlexaFluor
488-conjugated anti-GST tag antibody (Invitrogen). The yeast which showed single
fluorescence corresponding to Syto61 were kept and amplified.
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After post-Round 4 amplification, yeast from the Hi and Lo populations were prepared
for Round 5(+) selection. They underwent the same process as before, however they were
fluorescently labeled with anti-HA monoclonal antibody 16B12 conjugated to AlexaFluor 647
(Invitrogen). This was done for the following rounds to ensure only strongly-expressing yeast
were collected. For Round 5(+) selection, 107 yeast were incubated with 106 LNCaP cells. The
yeast bound to LNCaP cells were collected, amplified, and prepared for Round 6(+) selection. A
total of 105 dyed LNCaP cells were used to increase stringency. Round 6(-) was performed
similar to Round 4(-) with the exception of antibody-labeled yeast to increase stringency.
Unbound yeast were collected, amplified, and prepared for Round 7(+). In that round, 103 yeast
were used to increase stringency and select the scFvs with highest affinity.
A.2.4 Fluorescent Imaging of scFv Library Enrichment
To visualize enrichment of the scFv library after 7 rounds of selection, fluorescent
micrographs were obtained. LNCaP cells were grown in a 6-well culture dish with number 1.5
microscopic cover glasses to ~90% confluency and fluorescently labeled with CFSE as described
above. Yeast from the Round 0, post-Round 7(+) Lo, and post-Round 7(+) Hi libraries were
cultured as described above. Surface expression of the scFv was confirmed by antibody labeling
and flow cytometry as described. 107 yeast were then labeled with anti-HA antibody conjugated
to AlexaFluor 647 (Invitrogen) and incubated with LNCaP cells in 1 mL YSB in the 6-well dish.
Cells were incubated at 37°C for 30 minutes with shaking at 25 RPM. The supernatant was
removed and the cells were washed three times with 2 mL YSB. The cells were then fixed with
10% formalin (Azer Scientific; Morgantown, PA) for 5 minutes and washed three times with 1
mL PBS then three times with 1 mL double-distilled water. Cover slips were dried and flipped
onto a microscope slide prepared with 20 uL Fluorogel (Electron Microscopy Sciences; Hatfield,
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PA), and dried. Mounted cells were imaged on a Zeiss LSM 510 Confocal Microscope (Zeiss;
Thornwood, NY) using an Argon laser at 488 nm and a HeNe laser at 688 nm for excitation with
emission filters at 505-530 nm band pass and 650 nm. Images were processed with Zeiss LSM
Image Browser (Zeiss).
A.2.5 Sequencing of scFv Library
A representative sample of scFv-genes from the naïve library (Round 0) was sequenced
to determine diversity of the library. Additionally, this was completed for the enriched postRound 2(-) and post-Round 3(-) libraries. It was also performed for each of the Hi and Lo
populations following Round 4(-), Round 6(-) and Round 7(+) selections. To do this, yeast
amplified from the previous round of selection were plated onto 2% agar plates containing 1%
yeast extract, 2% peptone, and 2% dextrose (YPD). Yeast were grown for 36-48 hours at 30°C,
and individual colonies were chosen for polymerase chain reaction (PCR) amplification.
Yeast colonies were picked and placed into double distilled water and boiled, which
served as template for the PCR reaction. The reaction ingredients were as follows:400 nM
forward (5’-GTACGAGCTAAAAGTACAGTG-3’) and reverse (5’TAGATACCCATACGACGTTC-3’) pPNL6 primers (Eurofins MWG Operon), 250 µM
deoxynucleotide triphosphates, 5% dimethyl sulfoxide, 1X Phusion Reaction Buffer (New
England Biolabs, Ipswich, MA), 2 units Phusion High-Fidelity DNA polymerase (New England
Biolabs), and double distilled water to 100 μL. Reactions conditions were: initial denaturation at
98°C for 30 seconds; 35 cycles of 98°C for 10 seconds, 50°C for 30 seconds, and 72°C for 30
seconds; and final extension at 72°C for 10 minutes. Results were analyzed using agarose gel
electrophoresis and those PCRs that contained bands corresponding to the scFv gene were
prepared for sequencing. They were purified using a PCR purification kit (IBI Scientific; Peosta,
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IA) and sent for DNA sequencing (Eurofins MWG Operon; Huntsville, AL) using both the
forward and reverse pPNL6 primers. In total, at least 30 sequences were obtained for each
enriched library noted above. Analysis was then performed by translating the DNA sequence to
protein using the ExPASy translate tool (Swiss Institute of Bioinformatics;
http://web.expasy.org/translate/). Hemagluttanin, c-Myc, and linker protein tag sequences,
landmarks of the scFv expression scaffold, were identified to ensure sequence quality (Boder and
Wittrup 1997). Sequences were compared for similarities and duplicates within an enriched
library were identified to determine diversity of the library.
A.2.6 Secretion and Purification of Selected scFvs
From the Rounds 6(-) and 7(+) sequences, three scFvs were chosen for further study due
to their abundance in the enriched libraries: HiR6.8, HiR7.6, and HiR7.8. Sequences were PCR
amplified with the same ingredients and under the same conditions as above; however pPNL9
primers were used. For full length scFv sequences (HiR6.8), the forward pPNL9 (5’GACGTTCCAGACTACGCTGGTGGTGGTGGTTCTGCTA-3’) and reverse pPNL9 (5’GGGTTAGGGATAGGCTTACCCTGTTGTTCTAGAATTCCG-3’) were used. For truncated
scFv sequences (HiR7.6 and HiR7.8) containing only the heavy chain, forward pPNL9 and
modified reverse pPNL9 (5’GGGTTAGGGATAGGCTTACCGAACTCTGAAGAGACGGTGACC-3’) were used. The
PCR product was analyzed by agarose gel electrophoresis and the desired scFv-encoding gene
was excised from the gel. DNA was purified from the gel using the GFX gel purification kit (GE
Healthcare; Piscataway, NJ). Purified scFv-encoding DNA was then used for transformation of
scFv-secreting yeast.
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To express and secrete the scFv, the encoding gene was cloned into the pPNL9 plasmid
which was transformed into the YVH10 strain yeast, both generous gifts from Dr. Dane Wittrup
(Massachusetts Institute of Technology). Prior to cloning, the pPNL9 plasmid was double
digested with the restriction enzymes NotI and SfiI (New England Biolabs) and analyzed by
agarose gel electrophoresis. The plasmid was prepared for further studies by phenol/chloroform
extraction and ethanol precipitation. Transformation was performed by gap repair cloning and
the LiAc TRAFO method as previously described (Gietz and Woods 2002). Briefly, YVH10
yeast with no plasmid were grown in YPD broth. A fresh sample was taken and centrifuged,
then resuspended in the following: 67% of 50% polyethylene glycol 3350, 0.1 M lithium acetate,
13.9% of 2 mg/mL boiled carrier DNA (salmon testes genomic DNA; Sigma), approximately 1
μg purified pPNL9-amplified scFv DNA, and approximately 0.3 μg double-digested pPNL9
plasmid, with water to 360 μL. The yeast were incubated at 42°C for 1.5 hours, centrifuged, and
suspended in water. They were then plated on selective SD+CAA agar with 0.8% tryptophan
(Trp) and grown at 30°C for 48-96 hours until individual colonies formed.
Individual colonies were chosen and subjected to colony PCR amplification as previously
described, with the appropriate pPNL9 primer set used. The purified PCR product was sent for
DNA sequencing to confirm the insert. The colony was then amplified in selective
SD+CAA+Trp media overnight at 30°C with shaking at 250 RPM. Approximately 5 X 108 yeast
were then centrifuged and suspended in 50 mL expression media containing 1% yeast extract,
2% peptone, 2% galactose, 2% raffinose, and 0.1% dextrose, plus antibiotics as listed above
(YPG/R). Yeast were grown for approximately 72 hours with shaking at 250 RPM at 20°C for
secretion of scFv.
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After scFv secretion, supernatant was removed from the yeast by centrifugation. The
supernatant was concentrated with a 9 kDa centrifugal filter (Pierce). The concentrated scFv
solution was then brought to a volume of 10 mL with PBS, 0.5 M NaCl, and 0.05% Tween 20.
Then, 200 μL Ni-NTA agarose resin (Qiagen; Valencia, CA) was added and mixed with
inversion at 4°C for 2 hours for purification of 6-His tagged scFvs. The mixture was centrifuged
and supernatant removed and washed three times with 10 mL PBS, 0.5 M NaCl, and 0.05%
Tween 20 solution. The scFv was then eluted from the agarose resin three times with 250 μL of
200 mM imidazole in PBS. Pre-incubation, wash, and elution fractions were then concentrated
using a 3 kDa molecular weight centrifugal filter (Pierce).
Concentrated fractions were then analyzed using sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE). Samples were mixed with loading dye, denatured and loaded
into a 4-20% Tris-HEPES gel. Samples were run and the gel was stained with Coomassie blue
staining buffer. The gel was imaged, in which proper secretion and purification was confirmed
by obtaining bands of the appropriate size for each scFv. Remaining elution fractions were
combined, with extra imidazole removed with 3 kDa centrifugal columns. The concentration of
the scFv was determined using spectroscopy with a NanoDrop (Thermo Scientific; West Palm
Beach, FL). The scFv was then diluted to a working concentration of 10 μM in PBS.
A.2.7 Affinity Binding Assays with scFvs
In order to determine the binding affinity of each secreted scFv with the LNCaP cell line,
saturation binding assays were performed with flow cytometry with few modifications to
previous work (Benedict et al. 1997; Boder et al. 2000). LNCaP cells were grown to 80-90%
confluency and removed from the flask with CellStripper reagent. The cells were counted with a
Scepter equipped with 60 μm sensors. Then, 2 X 105 cells were placed into a 500 μL total
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volume of YSB. LNCaP cells incubated with no antibody served as a negative fluorescent
control, and LNCaP cells incubated with 1 μL anti-PSMA antibody conjugated to AlexaFluor
488 (BioLegend; San Diego, CA) served as a positive fluorescent control. For saturation binding
assays, the appropriate amount of each scFv was incubated on ice for 30 minutes with 2 μL of
the monoclonal anti-HA antibody clone 16B12 conjugated to DyLight 488 (Columbia
Biosciences). Concentrations of 0, 1, 10, 100, 1000, 10000, 50000, 100000, 150000, 200000 pM
of the scFv were used. The pre-incubated scFv and secondary antibody were mixed with LNCaP
cells and placed on a rotisserie at 37°C for 30 minutes. After this period, the cells were
centrifuged for 7 minutes at 300xg at 4°C. The supernatant was removed and the cells were
resuspended in 500 μL YSB.
Samples were run on a FACSCalibur (BD Biosciences) as previously described. The
mean fluorescence intensity (MFI) for each sample was recorded. The MFI for the 0 pM
incubation, which had only the secondary fluorescent antibody, served as background
fluorescence and was subtracted from the MFI of each incubation. These data were graphed
using Origin 8 software (OriginLab Corporation; Northampton, MA). The data were fit with a
nonlinear regression model of single-event binding given by the equation, Y=((B max *X)/(K d +
X)) + NS*X, where B max is maximum binding, K d is the dissociation constant, and NS is
nonspecific binding. Binding assays for HiR6.8 and HiR7.8 were performed in triplicate, with
average dissociation constants calculated and standard errors derived from the equation. Binding
assays for HiR7.6 will be performed in the future in triplicate.
A.2.8 Specificity Binding Assays of scFvs
In order to determine the specificity of MRE binding, cross-binding assays were
performed with the cell lines used as negative targets in the selection. LNCaP, HGPIN, BPH-1,
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and BHPrE1 cells were grown to 80-90% confluency and removed from the flask with
CellStripper reagent. Cells were then counted with a Scepter using 60 μm sensors and 2 X 105
cells were placed into a final volume of 500 μL YSB. For each cell line, cells with no antibody
served as a negative control. Concentrations of 0 or 100000 pM scFv were incubated with the
secondary anti-HA AlexaFluor 488 antibody for 30 minutes on ice. Each of these were then
mixed with each cell line and incubated on a rotisserie at 37°C for 30 minutes. The cells were
then centrifuged, the supernatant removed, and they were resuspended in 500 μL YSB. Each
sample was then run on a FACSCalibur as previously described and the MFI recorded. The MFI
of the 0 pM incubation, which had only the secondary fluorescent antibody, served as
background fluorescent labeling and was subtracted from the 100000 pM incubation. Data were
normalized to LNCaP binding, which was set to 100%, and graphed to show comparative
binding between the cell lines. HiR6.8 and HiR7.8 assays have been performed in triplicate,
with average values calculated and Student's T-tests performed to determine statistical
significance. HiR7.6 will be assayed in the future in triplicate.
In order to determine binding to other prostatic cell lines used not used in the selection,
cross-binding assays were performed. LNCaP, the androgen insensitive prostate cancer cell lines
DU-145 and PC-3, and the normal prostatic cell lines RWPE-1 and NHPrE1 were used for this
experiment. The cells were prepared as noted for the other cross-binding assays and incubated
with the scFv as described above. Samples were run on a FACSCalibur and the MFI was
normalized and graphed as noted. HiR6.8 and HiR7.8 have been performed in triplicated, with
average values calculated and Student's T-tests performed to determine statistical significance.
HiR7.6 will be assayed in the future in triplicate.
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A.2.9 Fluorescent Imaging of scFv Binding
In order to visualize binding of each scFv, fluorescent images were taken. LNCaP cells
were grown in a 6-well culture dish with number 1.5 microscopic cover glasses to ~90%
confluency. For each scFv, a 100 nM concentration was pre-incubated with anti-HA antibody
conjugated to DyLight 488 as described for binding assays, in addition to LNCaP cells with antiPSMA antibody, and those with secondary antibody only in a total volume of 500 µL YSB.
Cells were incubated at 37°C for 30 minutes with shaking at 25 RPM. The supernatant was
removed and the cells were washed once with 2 mL YSB. The cells were then fixed with 10%
formalin (Azer Scientific; Morgantown, PA) for 5 minutes and washed three times with 1 mL
PBS then three times with 1 mL double-distilled water. Cover slips were dried and flipped onto
a microscope slide prepared with 20 uL Fluorogel (Electron Microscopy Sciences; Hatfield, PA),
and dried. Mounted cells were imaged on a Zeiss AxioImager Z2 Fluorescent Microscope
(Zeiss; Thornwood, NY) using an Argon laser at 488 nm for excitation with a band pass
emission filter at 505-530 nm.
A.3 Results and Discussion
A.3.1 Selection of MREs
In order to obtain prostate cancer cell-specific MREs, seven rounds of the Decoy-SELEX
process were completed. Sequencing of the scFv-encoding plasmid in the initial naïve library, as
well as after Round 2 and Round 3 of panning selection, was performed. Out of at least 30
sequences obtained, there were no duplicate sequences in any library. Additionally, there were
no duplicates between the libraries. This suggests that all three libraries were highly diverse,
with no particular sequence having been selected for.
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After three rounds, FACS-based selections were performed. In Round 4 (+), there were
two separate populations of yeast binding to LNCaP cells. One was characterized by having
relatively high Syto61 (yeast) fluorescence with low CFSE (LNCaP) fluorescence, and this was
designated the ‘Hi’ population. The other was characterized by having relatively low Syto61
(yeast) fluorescence with high CFSE (LNCaP) fluorescence, and was designed the ‘Lo’
population. These were sorted separately and kept separate through the remaining rounds of
selection, while each was subjected to identical growth and selection conditions.
After the negative selections in Round 4, sequencing of the scFv-encoding genes in the
library revealed duplicate sequences within individual libraries. The Lo population was
comprised of 29% HiR7.8 and between 3% and 13% of 13 other molecules (Figure A.2).

Figure A.2. Enrichment of the Lo and Hi yeast-displayed scFv populations after FACSbased selection rounds. Evolution of library diversity after Round 4, the first round of FACSbased selection, Round 6, and Round 7. Lo population is the top row the Hi population on the
bottom. The names of the sequences represented by each color in the pie charts are shown to the
left of Round 4.
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Interestingly, HiR7.6 and HiR6.8 were not present in the Lo population. In the Hi population,
however, HiR7.6 comprised 52% of the population, while HiR6.8 was 26%. One other scFv was
3% and a final molecule was 19%. Interestingly, HiR7.8 did not appear in the Round 4 Hi
population. It is also of note that HiR7.6 and HiR7.8 did not appear in any previous library
sequencing, however HiR6.8 did appear once in the Round 3 library.
Following the sixth round of selection, the Lo and Hi libraries were sequenced. In the Lo
population, 30 out of 30 (100%) of the sequenced molecules were HiR7.8, and there were no
longer any other detectable scFvs in the library (Figure A.2). This suggests that, within this
population, HiR7.8 was strongly enriched for in Rounds 5 and 6 of selection. In the Hi
population, 77% of the library was HiR7.6 while 3% was HiR6.8. Interestingly, HiR7.8 now
comprised 20% of the library, and no other molecules were present. This suggests that HiR7.6

Figure A.3. Fluorescent micrographs of yeast binding enrichment. Confocal microscope
images at 200X of LNCaP cells (green) incubated different scFv-displaying yeast libraries. (a)
LNCaP incubated with Round 0 library. (b) LNCaP incubated with Round 7(+)Lo library. (c)
LNCaP incubated with Round 7(+) Hi library. Images show enrichment of yeast library through
seven rounds of selection for yeast-displayed scFv specific for LNCaP cells.

107

outcompeted HiR6.8 within this population. It also suggests that HiR7.8 was present previously
in the library, but not detected, and had outcompeted HiR6.8.
Following a very stringent Round 7(+) selection, using 10,000 fewer target cells than
yeast, and 1,000 times fewer LNCaP that Round 6(+), sequencing further revealed the scFvs
present in the library. In the Lo population, 100% of the molecules present were again HiR7.8
(Figure A.2). While there may have been other scFvs in the library, it is unlikely after two
consecutive rounds of not detecting any besides HiR7.8. In the Hi population, HiR6.8 was no
longer detected, while HiR7.6 was now just 16% of the library. HiR7.8 comprised 84% of the
library, suggesting it strongly outcompeted HiR7.6. It is possible that if more rounds of selection
were completed under more stringent conditions, HiR7.8 would totally comprise the Hi
population as well.
Visualization of library enrichment for scFvs binding to LNCaP cells was performed.
This provided evidence that few or none of the molecules in the Round 0 library were binding to
LNCaP cells (Figure A.3). However, after seven rounds of selection, both the Lo and Hi
populations were strongly specific for LNCaP cells (Figure A.3). This, along with the sequence
evolution, validates the sequence enrichment capabilities of the novel Decoy-SELEX process.
From this obvious enrichment through seven rounds of Decoy-SELEX, HiR7.8 was chosen as
the most likely prostate cancer cell-specific MRE and underwent further characterization.
However, to determine why it outcompeted HiR6.8 and HiR7.6, those molecules were also
chosen for further characterization. It is also important to note that HiR6.8 is a full-length scFv,
comprising both a heavy and light chain, with a predicted molecular weight of approximately
30.6 kDa for the scFv itself (Table A.2). HiR7.8 and HiR7.6, however, only contain a heavy
chain, as they are truncated just before the chain linker. They have a predicted molecular weight
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of approximately 16.0 and 15.6 kDa, respectively, and have 81% sequence identity and 86%
sequence similarity. Truncated sequences containing only heavy chains were found in
sequencing of the naïve library in the original published description (Feldhaus et al. 2003). This
may be relevant in vivo, as it has been shown that smaller scFvs have greater tumor penetration
ability than larger antibodies (Colcher et al. 1998).
Table A.2. Amino acid sequence of selected prostate cancer cell MREs.
Sequence Sequence*
Name

Predicted
Molecular
Weight

HiR6.8

DVPDYALQASGGGGSGGGGSGGGGSASQVQLVQSGAEVKKPGASVKVSCKASGY
TFTDYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYM
ELSSLRSDDTAIYYCARDADSGSMSAIYWYFNLWGRGTLVTVSSGILGSGGGGS
GGGGSGGGGSDIQLTQSPSSLSASVGDRVTITCRASQSISRFLNWYQQKPGKAP
KLLIYGGSSLQSGVPSRFSGGGSGTDFTLTISSLQPEDFATYYCQQSYSKFWTF
GQGTKVEIKSGILEQKLISEEDL

30.6 kDa

HiR7.6

DVPDYALQASGGGGSGGGGSGGGGSASQVQLQESGPGLVKPSGTLSLTCAVSGG
SISSSNWWSWVRQPPGKELEWIGEIHHSGSTNYNPSLKSRVTISVDKSKNQFSL
KMRSVTAADTAVYYCARVEEWPYDALDMWGQGTMVTVSSEF

15.6 kDa

HiR7.8

DVPDYALQASGGGGSGGGGSGGGGSASQVQLQESGPGLVKPSQTLSLTCTVSGD
SIYSSGHYWSWVRQHPGKGLEWIGYIYASGRTYYNPSLESRVTMSVDTSKNQSS
LKLTSVTAADTAVYYCARDDSRTWYKAFDTWGQGTMVTVSSEF

16.0 kDa

*Underlined amino acids represent the heavy chain. Double underlined amino acids represent the
light chain. HiR7.6 and HiR7.8 do not contain a light chain. Non-underlined amino acids
represent scFv structural elements.
A.3.2 Affinity Binding Assays of scFvs
Once HiR6.8, HiR7.6, and HiR7.8 were identified for further characterization, each was
cloned into a secretion vector, expressed, and purified. HiR6.8 and HiR7.8 were used in
fluorescent saturation binding assays with LNCaP cells as described above, plotted, and fit with
nonlinear regression analysis (Figure A.4). HiR6.8 exhibited an equilibrium dissociation
constant (K d ) of 33.19 +/- 22.18 nM (Table A.3). The binding affinity of HiR7.6 for LNCaP
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cells will be assayed in the future. The binding affinity of HiR7.8 is 27.28 +/- 15.85 nM. The
slightly higher affinity of HiR7.8 for LNCaP cells may be a partial explanation as

Figure A.4. Plot of fluorescent equilibrium binding assay of HiR6.8 and LNCaP cells.
Calculated dissociation constant (K d ) of this assay is 30.52 +/- 27.08 nM.
Table A.3. Equilibrium dissociation constant (K d ) of prostate cancer cell MREs.
HiR6.8
HiR7.6
HiR7.8
33.19 +/- 22.18 nM

*

27.28 +/- 15.85 nM

Data are reported as K d +/- Standard Error as given by the binding equation. “*” denotes that the
data are yet to be acquired.
to why it was enriched for throughout Decoy-SELEX. The dissociation constants for each of
these scFvs is in the low-nanomolar range, which is similar to previous reports of scFvs isolated
from the selection process (Schier et al. 1996; Benedict et al. 1997; Böldicke et al. 2001). More
importantly, it is in a range that has previously been shown to confer strong pharmacokinetic
properties (Adams et al. 1998; Jackson et al. 1998). It is possible that further mutagenesis and
screening may select for scFvs with higher affinity for the cell surface target (Schier et al. 1996;
Boder et al. 2000).
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Binding of both HiR6.8 and HiR7.8 to LNCaP cells is further evidenced by fluorescent
micrographic analysis. Binding of each scFv is clear when pre-incubated with a secondary
fluorescent antibody then with LNCaP cells and imaged for fluorescent staining (Figure A.5).
Fluorescence is much brighter than LNCaP cells incubated with fluorescent secondary-only
control. Interestingly, both antibodies have a semi-circular or horseshoe-like staining pattern for
each cell. Therefore, fluorescence may be visualized in the cytosol surrounding the nucleus. It
may be possible that the images represent cellular uptake of the scFv-secondary antibody
complex. This has previously shown to be possible and even likely with scFvs alone or in
complex with other molecules (Gao et al. 2003; Nielsen et al. 2006; He et al. 2010). This may
have an important role in the clinical application of these MREs. The potential ability to use
these scFvs as therapeutic targeting agents in the form of antibody-drug conjugates (ADCs) is
enhanced by scFv internalization (Schrama et al. 2006). Potential uptake of the scFv by LNCaP
cells may be explored in future studies. First, confirming cytoplasmic staining using a nuclear
dye such as DAPI would be useful. This could then be furthered by subcellular fractionation
experiments. These are potentially interesting further directions stemming from fluorescent
imaging of scFv binding.
A.3.3 Specificity Binding Assays of scFvs
Purified HiR6.8 and HiR7.8 were each assayed for their ability to bind to cell lines other
than LNCaP. HiR7.6 will be assayed in the future for its binding to other cell lines. These
included the negative targets in the selection process, HGPIN, BPH-1, and BHPrE1 (Figure A.6
a and Figure A.7a). They also included androgen-independent prostate cancer cell lines DU-145
and PC-3 as well as normal prostate epithelium cell lines RWPE-1 and NHPrE1 (Figure A.6b
and Figure A.7b).
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Figure A.5. Micrographs of scFv binding to LNCaP cells. Each panel shows micrographs at
630X of fluorescence from AlexaFluor 488 in green (left) and combined fluorescent plus
brightfield image (right). (a) LNCaP cells incubated with only secondary antibody. (b) LNCaP
cells incubated with HiR6.8 plus secondary fluorescent antibody. (c) LNCaP cells incubated with
HiR7.8 plus secondary fluorescent antibody.
From these experiments, it is clear that HiR6.8 binds to all three negative cell lines as
well as the other two androgen-dependent prostate cancer cell lines assayed. Binding to many of
these lines was as good as or better than binding to LNCaP cells. This is a likely explanation as
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to why HiR6.8 was eventually eliminated from both populations, in spite of its low dissociation
constant (Figure A.6). HiR7.8, however, showed excellent selectivity for LNCaP cells (Figure
A.7). Binding to HGPIN, BPH-1, and BHPrE1 cells all was much less than to LNCaP, in fact
they were negative. This means that the MFI of cells incubated with 100000 pM HiR7.8 and
secondary fluorescent antibody was less fluorescent than cells incubated with secondary
fluorescent antibody only. This can be explained by pre-incubation and binding of the scFv with
the secondary antibody, causing background non-specific binding of the secondary antibody to
the cells to be less. Therefore, the negative relative MFI suggests that the antibody is present and
binding to the secondary antibody, but not to the cells. Additionally, binding to the four cell
lines not used in the selection was either negative or much less relative to binding to LNCaP
cells. In sum, this suggests that HiR7.8 is highly specific to LNCaP cells and therefore useful in
both the therapeutic targeting and disease detection of prostate cancer.
Biologically, the selectivity of HiR7.8 for LNCaP cells is important. There is a complete
absence of binding to all benign cell lines studied, whether they represent normal prostatic cells,
BPH, or PIN. This suggests that the cell surface molecule HiR7.8 is binding to is not displayed
on the surface of benign prostatic cells. This is supported by previous studies that have
identified many genes differentially expressed between the benign conditions represented here
and prostate cancer cells (Chakrabarti et al. 2002; Zeng et al. 2004; Chen et al. 2011).
Additionally, there is no binding to the androgen-independent prostate cancer cell lines
DU-145 or PC-3. This leads to the conclusion that the cell surface antigen is displayed in the
earlier, androgen-dependent stage of prostate cancer. This is possible considering previous
studies have found a wide array of genes that are differentially expressed from androgen
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Figure A.6. Cross-binding of HiR6.8 to negative targets and other cell lines. Binding of
HiR6.8 to (a) each cell line used in the selection or (b) or prostatic cell lines. Data are normalized
to LNCaP binding at 100% for comparison. "*" represents p < 0.05, "***" represents p < 0.001.
A

B

Figure A.7. Cross-Binding of HiR7.8 to negative targets and other cell lines. Binding of
HiR7.8 to (a) each cell line used in the selection or (b) other prostatic cell lines. Data are
normalized to LNCaP binding at 100% for comparison. "*" represents p < 0.05, "**" represents
p < 0.01, "***" represents p < 0.001.
dependent to independent disease progression, many of which are downregulated (Amler et al.
2000; Karan et al. 2002; Chen et al. 2006). In fact, downregulation of expression levels from
LNCaP to both DU-145 and PC-3 cells has been found before (Yang et al. 1998; Aalinkeel et al.
2004; Okamura et al. 2008; Liu et al. 2009) It is unclear if HiR7.8 would bind to other
androgen-dependent prostate cancer cells, or cells earlier in the progression of the disease,
however future work may determine this. Determining binding will be aided by identifying the
exact cell surface molecule to which HiR7.8 is binding, as has been done before with other
MREs (Robert et al. 2006; Rérole et al. 2011). This type of work has even identified novel cell
surface molecules previously unknown to be involved in disease progression (Berezovski et al.
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2008). It is therefore possible that this work not only created a novel targeting agent, but also
identified a novel target.
HiR6.8, however, is not specific for any one type of cell. This may be because it is
binding to some widely-expressed prostate-specific gene such as PSMA (Wright et al. 1995), or
because it is binding to any one of a number of common cell surface molecules. Determining the
cell surface antigen for HiR6.8 will be important as it may be useful as a broad marker of
prostatic cells similar to PSCA or p63 (Signoretti et al. 2000; Tran et al. 2002), or it may be
useful in marking a particular cell surface antigen such as previous scFvs for ICAM-1 (Conrad et
al. 2009). Therefore, in spite of its spectrum of binding, the high affinity of HiR6.8 for its cell
surface target will allow the scFv to be useful for future applications, even if it is not useful in
the specific targeting of prostate cancer cells.
The high affinity and specificity of HiR7.8 for LNCaP prostate cancer cells suggest it has
potential in future therapeutic and diagnostic applications in prostate cancer. It is unclear
whether it will bind to prostate cancer tissue, however it is likely that it will based on binding
specificity and affinity similar to previously-selected MREs (Ni et al. 2011). This will rely on
surface expression of its cognate antigen. The selective scFv will likely be useful for drug
delivery as part of an antibody-drug conjugate (Senter 2009), for chemotherapeutic delivery
(Sievers and Linenberger 2001), for radiotherapy delivery (Regino et al. 2009), or possibly even
as a therapeutic by itself, depending on the function of the cell surface molecule (Stebbing et al.
2000). Additionally, it will likely have use in specific diagnosis of prostate cancer, whether
coupled with an in vivo imaging agent (Elsässer-Beile et al. 2009; Veiseh et al. 2010), a capture
agent for circulating tumor cells (Nagrath et al. 2007), or as a tissue stain after biopsy (Johnston
et al. 1986). Finally, identification of the cell surface markers which these MREs bind to may
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possibly identify novel proteins, new functions, or expression patterns that aid in treatment and
diagnosis of prostate cancer.
A.4 Conclusions
This work has selected a MRE with high affinity for the androgen-dependent prostate
cancer cell line LNCaP. Furthermore, the selected MRE has a high selectivity for the androgendependent prostate cancer cell line, and not for benign prostatic cell lines or for androgenindependent prostate cancer cells. These characteristics will allow the selected scFv to be useful
for both therapeutic and diagnostic applications in the clinical treatment of prostate cancer. With
targeted therapeutics and more specific diagnostics, it is possible that the disease burden of the
most-diagnosed cancer among males in the United States will be lessened.
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Appendix B
In Vitro Selection of Single-Stranded DNA Molecular Recognition
Elements for the Pesticide Malathion
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B.1 Introduction
Malathion is the mostly commonly-used organophosphate pesticide in the United States.
Approximately 16.7 million pounds are used annually, with 12 million pounds being applied to
crops (Wilson et al. 2003). Many other uses include in sewage systems, plant nurseries, home
use, and recreational land maintenance (Wilson et al. 2003). Three major historical applications
in the U.S. were Boll Weevil eradication, Medfly suppression, and mosquito suppression
(Newhart 2006). Its widespread use portends the benefits of malathion usage.
Due to its many uses, malathion has become an environmental contaminant with multiple
routes of exposure. Aerial applications often drift to non-target locations, including waterways,
up to 200 meters away (LeNoir et al. 1999; Newhart 2006). This method can also lead to
volatilization of up to 22.6% of that applied, leading to reduced air quality levels and vaporized
contamination spread potentially over large distances (Turner et al. 1991; LeNoir et al. 1999;
Ferrari et al. 2003). After one large application, malathion was found in freshwater ponds at
levels up to 49.4 μg/L (Segawa et al. 1991). Additionally, runoff due to storms after application
has led to levels up to 787.1 μg/L being found (Ando et al. 1996). Detection in groundwater and
surface water has also occurred at levels up to 6 µg/L during normal conditions (Newhart 2006).
In the state of West Virginia, malathion has been found at levels that exceed guidelines for
environmental contamination (Ferrari and Assessment 1997; Ator 1998). Furthermore, one
study found that 33.7% of corn grain, 27.8% of cultivated and frozen blueberries, 24.6% of
strawberries, and 19.3% of celery samples on the market tested had detectable levels of
malathion (USDA 2009). Clearly, release of malathion into the environment and its interaction
with humans and other organisms is occurring.

118

The presence of malathion in the environment is of particular concern to human health.
The U.S. Environmental Protection Agency categorizes the pesticide as having "suggestive
evidence of carcinogenic potential" (USEPA 2012). This is supported by studies showing
induction of mammary epithelial cell proliferation and other carcinogenic effects by malathion
through acetylcholinesterase inhibition in rats (Cabello et al. 2001). Additionally, there is a
55%-72% increase in the odds of Attention-Deficit/Hyperactivity Disorder (ADHD) being
diagnosed in children that have ten-fold higher malathion exposure levels (Bouchard et al. 2010).
Higher concentrations have also been found to have cytotoxic and genotoxic effects on human
and other mammalian cells (Giri et al. 2002; Moore et al. 2010). These effects suggest that
increased levels of environmental malathion concentrations are detrimental from a public health
perspective.
Ecologically, non-target effects of malathion also have severe negative impacts. To
various fish species, malathion is highly toxic, with LC 50 values as low as 0.1 µg/L for brown
trout (USGA 2000). Many aquatic invertebrates are also highly susceptible to exposure, with
LC 50 values below environmentally relevant levels, down to 0.5 µg/L (USEPA 2006). It also
has other negative effects at sublethal concentrations to a variety of aquatic species (Key et al.
1998; Beauvais et al. 2000; Nguyen and Janssen 2001). Furthermore, the pesticide has been
shown to have negative survival effects at environmentally relevant concentrations on tadpoles
and frogs (Fordham et al. 2001), small mammals (Newhart 2006), reptiles (Holem et al. 2008),
and non-target beneficial insects (Gary and Mussen 1984). It is therefore important that
individual species and entire ecosystems are protected from malathion exposure.
Currently, detection of malathion in biological and environmental samples is mostly
achieved using gas chromatography (GC). While this method is sensitive and methods for
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malathion detection have been improved upon, it is also time- and labor-intensive and requires
expensive and expertly-used equipment (Zweig and Devine 1969; Fournier et al. 1978; Wilson et
al. 2003). Other methods of malathion exposure include monitoring blood cholinesterase activity
or excretion of metabolites (Fenske and Leffingwell 1989; Wilson et al. 2003). There have also
been antibody assays developed for malathion detection, however these antibodies have not been
assayed for their affinity or only assayed for cross-reactivity to a few of malathion's major
chemically-related metabolites (Nishi et al. 2003; Brun et al. 2005; Vera-Avila et al. 2005). As
the antibodies were not identified for their selectivity, it is likely that they bind to major
metabolites. This is similar to an antibody which binds to a whole class of molecules similar to
malathion (Yan et al. 2009). Therefore, it is necessary to identify a molecule that has been
identified for its high affinity and specificity for malathion and not its metabolites.
Identification of such a molecule can be accomplished using the Selective Evolution of
Ligands by EXponential Enrichment (SELEX). Binding molecules identified with this process
are termed Molecular Recognition Elements (MREs). This in vitro selection process was
originally described by two separate laboratories and MREs are selected from a large library
(109-1015) of different molecules (Ellington and Szostak 1990; Tuerk and Gold 1990). This
library is incubated with the target of interest, and those molecules that do not bind to it are
removed. Those that do are amplified and can be subjected to negative selections. In those,
molecules that do not to the negative targets are amplified. This iterative process continues with
increasingly stringent selection conditions until one or a few highly selective molecules with
high affinities are identified. A novel variation of this process developed in our laboratory is
termed Decoy-SELEX. Using this method, the library is enriched for the target of interest.
However, the focus of the selection is on what the MRE should not bind to utilizing stringent
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negative selections. Therefore, the Decoy-SELEX method is ideal for identifying MREs with
both high affinity and selectivity for the target of interest.
In this work, the Decoy-SELEX method was utilized to identify an MRE for the pesticide
malathion. The selection scheme was designed to enriched a single-stranded DNA (ssDNA)
library for molecules which bind to malathion. Those molecules which bound to major
metabolites of malathion were removed. Those metabolites included dimethyl thiophosphate
(DMTP), dimethyl dithiophosphate (DMDTP), malathion dicarboxylic acid (MDA), and
malaoxon (Buratti et al. 2005). The MRE was also designed to not bind to other pesticides found
in similar amounts and environments as malathion including propanil (Köck et al. 2010), 2,4-D
acid (Baker et al. 2000), and atrazine (McCarthy and Fuiman 2008). Additionally, bovine serum
albumin (BSA) was used as a negative target as a model for large, globular proteins. The
selected MRE may be used as a sensor in a rapid, field-deployable detection device (Soh et al.
2009; Yang et al. 2010; Lin et al. 2011).
B.2 Methods
B.2.1 Decoy-SELEX for Malathion-Specific MREs
Twelve rounds of the Decoy-SELEX process were performed to obtain a MRE specific
for the pesticide malathion (Figure B.1). A ssDNA library with a diversity of 1015 molecules
was enriched for those that bound to malathion and not the negative targets of selection (Figure
B.2). The library was designed within our laboratory and designated RMW.N34. The ssDNA
library was commercially synthesized and consists of two 23 base constant regions for
polymerase chain reaction (PCR) amplification that flank a 34 base random region (Eurofins
MWG Operon; Huntsville, AL).
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The malathion derivative malathion monocarboxylic acid (Figure B.2b) was covalently
biotinylated using EDC-NHS chemistry. It was reacted with 1-ethyl-3-[3dimethylaminopropyl]carbodiimide (EDC) (ThermoScientific; Rockford, IL) and then incubated
with Amine-PEG 2 -Biotin (Pierce; Rockford, IL) according to manufacturer's instructions. The
biotinylated derivative was bound to streptavidin-coated magnetic beads (New England Biolabs;
Ipswich, MA) and washed to provide the immobilized target (IT).

Figure B.1. Decoy-SELEX scheme for selection of a malathion MRE. 1015 different ssDNA
molecules were incubated with malathion. Those that bound were amplified and subjected to
closely-related targets. Those do not bind those were amplified and re-subjected to malathion
under more stringent conditions. This process continued for 12 rounds.
For Round 1(+) selection, the ssDNA library was incubated with 50 µL IT in a total of
500 µL selection buffer containing 100 mM sodium chloride, 20 mM Tris-HCl, and 2 mM
magnesium chloride (1X selection buffer; SB). The mixture was incubated at room temperature
on a rotisserie for 48 hours. The IT with bound ssDNA was removed from the solution by
magnetic separation, washed three times with 1 mL SB, and resuspended in SB. This was used
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Figure B.2. Chemical structures of molecules used in selection of a malathion-specific
MRE. (a) Structure of the target of selection, malathion. (b) Structure of malathion
monocarboxylic acid, a malathion derivative used in magnetic bead immobilization. (c) and (d)
Structures of dimethyl thiophosphate and dimethyl dithiophosphate used as negative targets in
Round 8(-). (e) Chemical structure of malathion dicarboxylic acid, used in Round 9(-) selection.
(f) Structure of malaoxon, used in Round 10(-) selection. (g), (h), and (i) Structures of propanil,
2,4-D acid, and atrazine, used successively in Round 7(-) of selection. (j) Ribbon structure of
123

bovine serum albumin (BSA) used as a negative target in Round 11(-) of selection (Bujacz
2012).
as a template for PCR amplification of ssDNA bound to the IT. PCR amplification was
performed with the following reaction ingredients: enriched ssDNA library, 400 nM forward and
biotinylated reverse RMW.N34 primers (Eurofins MWG Operon) (forward: 5’TGTACCGTCTGAGCGATTCGTAC-3’, biotinylated reverse: 5’-BiotinGCACTCCTTAACACTGACTGGCT -3’), 250 µM deoxynucleotide triphosphates, 1X GoTaq
Reaction Buffer (Promega; Madison, WI), 3.5 units Taq, and pure water to 100 µL. Thermal
cycling conditions were: initial denaturation of 95°C for 5 minutes; cycling at 95°C for 1 minute,
63°C for 45 seconds, and 72°C for 1 minute; and final extension of 72°C for 7 minutes.
Amplification for carrying the library to the next round of selection was performed using either a
4 mL or a 2 mL total volume PCR, which respectively preceded positive and negative selection
rounds.
The amplified DNA was then purified by agarose gel electrophoresis using the GFX PCR
purification kit (GE Healthcare; Piscataway, NJ). Recovered dsDNA was then incubated with
streptavidin agarose resin (Pierce) for separation of single strands. The biotinylated reverse
primer used in PCR amplification allowed for binding of the reverse strand to the agarose resin.
This mixture was placed in a flow-through column and washed with five column volumes of
phosphate-buffer saline (PBS). The single forward strand of amplified DNA was eluted from the
column using five column volumes of 1 M sodium hydroxide. The elute ssDNA was prepared
for ethanol precipitation by adding 0.1 volume of 3 M sodium acetate (pH 5.2), 2.5 volumes of
cold 100% ethanol, and glycogen at 10 µg/mL. The solution was frozen and then centrifuged at
13,000xg for 1 hour, the pellet washed with 70% ethanol, and centrifuged again for 15 minutes.
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The pellet was dried under a vacuum and resuspended in SB. The amount of ssDNA present was
verified to be at least 1013 sequences using a NanoDrop spectrometer (ThermoScientific).
Following Round 2(+) selection, the DNA was prepared for the next round as specified
above. However, it was then incubated with immobilization substrate (IS) for Round 2(-)
selection for 16 hours in 100 µL total volume of SB. To prepare the IS, Amine-PEG 2 -Biotin
(Pierce) was incubated with streptavidin-coated magnetic beads (New England Biolabs) and
washed to remove unbound biotin reagent. After the incubation period, the IS with bound
ssDNA was separated from the solution by magnet. Washes with 25, 25, and 50 µL of SB were
performed and pooled with the total 100 µL of incubation supernatant. This served as a template
for PCR amplification, which was performed as previously described. The subtracted library
was then prepared for Round 2(+) selection as described above.
Round 2(+) selection proceeded similar to Round 1(+), however the incubation period
was 22 hours. Positive selections occurred in this manner, with decreasing incubation period for
increased stringency, through Round 6(+). Negative selections similar to Round 1(-) were
performed in Round 3 and 5, with longer incubation periods, to remove molecules binding to
anything in the incubation that was not the malathion metabolite.
Beginning in Round 7(+), a competitive elution was performed in order to obtain a MRE
which bound to malathion in solution. For this, the enriched library was incubated with 50 µL of
IT in a total volume of 500 µL SB for 3 hours. The beads were then washed three times with 1
mL SB. However, in this round, 100 µL of 10 mM malathion in SB was then added to the IT
and incubated for 5 minutes. The IT was then removed from the solution by magnet, and the
supernatant served as the template for PCR amplification. The enriched and amplified library
was then prepared for Round 7(-) selection as noted above. This method of selection by
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competitive elution was performed through Round 12 (+) with decreasing incubation times.
Concentrations of malathion used for elution were also decreased, until finally in Round 12(+)
the library incubation with the IT was immediate, and elution with 100 μL of 100 nM malathion
was immediate.
In Round 7(-), competitive elutions were performed with other pesticides found in
similar environmental locations as malathion. The enriched library was incubated with the IT,
the supernatant removed, and the beads washed 3 times. Then, the beads were incubated for 24
hours at room temperature on the rotisserie with 500 µL of 1 µM propanil in SB. The
supernatant was removed and the beads were washed twice with 1 mL SB. The IT was then
incubated with the same volume and concentration of 2,4-D Acid, washed, incubated with
atrazine, and washed. The beads were then resuspended in SB and used as a template in PCR
amplification. The DNA was then prepared for the next positive round of selection.
After Round 8(+) selection, Round 8(-) selection was done similar to the previous
negative round, however dimethyl thiophosphate, then dimethyl dithiophosphate were used as
negative targets. Following Round 9(+), Round 9(-) was performed with 500 µL of 1 mM
malathion dicarboxylic acid for 15 minutes. Round 10(-) selection was performed with 500 µL
of 1 mM malaoxon with an incubation period of 1 minute. The final negative selection, Round
11(-), was performed in the same manner with bovine serum albumin as the elutant.
B.2.2 Sequencing of the Enriched ssDNA Library
Following every third round of selection, a random sample of at least 30 ssDNA
molecules present in the enriched library was taken. The library was PCR amplified with nonbiotinylated primers as described above and ligated into the pCR2.1 vector (Invitrogen; Carlsbad,
CA) according to manufacturer's instructions. This was cloned into competent bacteria, which
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were plated onto selective agar. Colonies with inserts were amplified, and plasmids containing
individual library inserts were purified using the AxyPrep Plasmid Prep Kit (Axygen; Union
Table B.1. Decoy-SELEX outline for identification of malathion MRE
Round

Positive Selection

Negative Selection

1

Immobilized Target (IT) 48 hrs

Immobilization Substrate (IS) 16 hrs

2

IT 22 hrs

-

3

IT 16 hrs

IS 24 hrs

4

IT 10 hrs

-

5

IT 6.5 hrs

IS 23 hrs

6

IT 3 hrs

-

7

IT 3 hrs, 5 min Competitive
Elution (CE) w/ 10 mM
Malathion (100 uL)

IT 3 hrs, 24 hr CE w/ 1 µM Propanil,
2,4-D Acid, Atrazine in succession
(500 uL)

8

IT 1 hr, 5 min CE w/ 1 mM Mal
(100 uL)

IT 1 hr, 24 hr CE w/ 1 µM dimethyl
thiophosphate, dimethyl
dithiophosphate in succession (500 uL)

9

IT 15 min, 5 min CE w/ 100 uM
Mal (100 uL)

IT 15 min, 15 min CE w/ 1 mM
Malathion Dicarboxylic Acid (500 uL)

10

IT 1 min, 1 min CE w/ 10 uM
Mal (100 uL)

IT 1 min, 1 min CE w/ 1 mM
Malaoxon (500 uL)

11

IT 1 min, immediate CE w/ 1 uM
Mal (100 uL)

IT 1 min, 15 min CE w/ 1 mM BSA
(500 uL)

12

IT immediate, immediate CE w/
100 nM Mal (100 uL)

-

Immobilization target (IT) is malathion monocarboxylic acid bound to magnetic beads.
Immobilization substrate (IS) is streptavidin-coated magnetic beads with biotin reagent.
Competitive elution (CE) is removal of bound ssDNA from IT with target or negative target in
solution. Times listed are incubation periods in hours (hrs) or minutes (min).
City, CA). Purified plasmids were sent for sequencing (Eurofins MWG Operon) using the
M13R primer complimentary to a region upstream of the pCR2.1 vector. At least 30 sequences
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were obtained for each enriched library. These were then analyzed for consensus sequence
families to identify structures binding to malathion.
B.2.3 Determination of MRE Binding Affinity
The Round 12 sequences were analyzed to produce consensus sequence families, and
from those three were chosen for further characterization. These were chosen based on their
inclusion in consensus families as well as their structure and stability as predicted by the Mfold
DNA web server using buffer salt and 25°C as binding conditions (SantaLucia 1998; Peyret
2000; Zuker 2003). The chosen sequences were designated R12.20, R12.14, and R12.29. These
sequences were subjected to fluorescent saturation binding assays to determine their affinity for
malathion.
Concentrations of 0, 0.25, 0.5, 0.75, 1, 5, 10, 15, 20, and 25 nM MRE were used in
saturation binding studies. In a 200 µL total volume of SB, 10 uL of IT was incubated with each
concentration for five minutes. Unbound MRE was removed and each incubation was washed
five times with 200 µL SB, then the immobilized target was resuspended in 200 µL SB and
heated to 95°C for 10 minutes to denature and elute bound MRE. Eluted ssDNA in SB was
placed in a 96-well microplate and measured in a Synergy 2 microplate reader equipped with a
tungsten halogen lamp with excitation wavelength of 490 nm and an emission filter at 520 nm
using Gen5 1.06 software (Biotek US; Winooski, VT). All fluorescence readings on the plate
were normalized to 100 μL of a 1 nM solution in SB of the fluorescent MRE and the no ssDNA
incubation. For each concentration set, the same was done with washed streptavidin-coated
magnetic beads to ensure binding over background to the beads. Each set of incubations were
performed in triplicate. To determine the dissociation constant (K d ) of the MRE, data were
analyzed with Origin 8 (OriginLab Corporation; Northampton, MA) using nonlinear regression
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analysis and fit with the equation, Y=((B max *X)/(K d + X)) + NS*X, where B max is the maximum
binding, K d is the dissociation constant, and NS is nonspecific binding as previously described
(Langan et al. 2012).
To determine binding of the selected MRE, R12.20, to compounds used in the selection,
50 nM fluorescent ssDNA was used. For each elutant used, in a 200 µL total volume of SB, 10
µL IT was incubated with R12.20 for five minutes. The magnetic beads were washed five times
with 200 µL SB. Then, each incubation was resuspended in 200 µL of 1 µM in SB of the
following in SB: malathion, malathion monocarboxylic acid, dimethyl thiophosphate, dimethyl
dithiophosphate, malathion dicarboxylic acid, malaoxon, propanil, 2-4, D acid, atrazine, and
BSA. Each elutant was incubated with the immobilized target for ten minutes, and the solution
was removed from the beads. This solution was placed in a 96-well plate and measured in a
fluorescence plate reader. Data were normalized to an internal fluorescent standard of 1
nMMRE in 100 µL SB and background fluorescence of each elution buffer. Each set of binding
studies were performed in triplicate. Data were averaged and standard deviations calculated.
For each elutant, a one-tailed t-test was performed to determine statistical differences in the
means.
B.3 Results and Discussion
B.3.1 Identification of a Malathion-Specific MRE
In order to identify a MRE with high affinity for malathion that did not bind to other
pesticides or closely-related structures, twelve rounds of Decoy-SELEX were completed (Table
B.1). The selection ensured that the final MRE would not bind to the immobilization substrate,
propanil, 2,4-D acid, atrazine, dimethyl thiophosphate, dimethyl dithiophosphate, malathion
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Figure B.3. Sequences of malathion MREs chosen from Round 12 library. For each, the
sequence is above an example of a representative consensus sequence family of which the
sequence is a member, and the structure as predicted by Mfold is on the bottom (SantaLucia
1998; Peyret 2000; Zuker 2003). Sequence and structure of (a) R12.14, (b) R12.20, and (c)
R12.29.
dicarboxylic acid, malaoxon, or bovine serum albumin. Following Rounds 3, 6, 9, and 12, at
least 30 random sequences were chosen from the enriched library for consensus sequence
analysis. Sequences were analyzed and tracked throughout the in vitro selection. Three
sequences were chosen, R12.14, R12.20, and R12.29 based on their presence in consensus
families, structure, and stability as predicted by the Mfold DNA web server (Figure B.3). These
sequences have a predicted Gibb’s free energy value of -8.84 kcal/mol, -5.84 kcal/mol, and -7.89
kcal/mol, respectively.
B.3.2 Affinity and Specificity of Malathion-Specific MRE
Fluorescence saturation binding assays identified R12.20 as having the highest affinity
and specificity (Figure B.3b). After assaying concentrations in the pM to low nM range, the
dissociation constant (K d ) of this MRE was determined to be between 1.14 nM and 3.21 nM
(Figure B.4). This is in the lower range of previously-selected ssDNA MREs for small-molecule
targets (Hamula et al. 2006; Stoltenburg et al. 2007). This high affinity is likely to be a product
of the increasingly stringent incubation conditions used in the Decoy-SELEX process.
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Figure B.4. Fluorescence equilibrium binding assays of R12.20 for malathion. (a)
Representative saturation binding curve of R12.23 with nonlinear regression best fit. (b)
Equilibrium dissociation constants (K d ) with standard error of three R12.23 binding assays.
The cross-reactivity of R12.20 for negative targets used in the selection was also
determined. The ssDNA MRE binds to malathion significantly greater than it does to DMTP,
DMDTP, malaoxon, propanil, and 2,4-D acid (p<0.05) (Fig. 5). The binding of R12.20 to
malathion is much higher than it is to atrazine (100% compared to 49%). Large variation,
however, render this result statistically insignificant (p = 0.06). Binding to malathion
monocarboxylic acid (MMA) is 70% that of malathion, however there is no difference in these
samples (p = 0.06). This is expected as MMA was the molecule used to create the immobilized
target used in all rounds of selection. Binding of the MRE to malathion dicarboxylic acid
(MDA) is 60% that to malathion, however this is not significantly different (p = 0.11). The
similarity of MMA and MDA explain the binding of R12.20 to MDA (Fig. 2b and 2e). Binding
of the MRE is also as strong to BSA as it is to malathion. This may be due to the large, globular
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nature of the protein and its interaction with ssDNA. This therefore suggests that R12.20 would
be most successful as a sensing element in the presence of mostly small molecules. Additionally,
even though binding to malathion is approximately two-fold higher than it to DMTP for
example, the dissociation constant may be much higher than twice that of R12.20 for malathion.
Therefore, incorporation into a sensor may lead to much greater specificity than it appears here.

Figure B.5. Cross-binding studies of malathion MRE to other molecules used in the
selection. Data were normalized to atrazine binding which was set to 100%, with error bars
representing standard deviations. Statistical significance levels of p<0.05 are designated by ‘*’,
while levels of p<0.01 are designated by ‘**’, and levels of p<0.001 are designated by ‘***’.
Malathion is the target of the selection and MMA was used to create immobilized target. DMTP,
DMDTP, MDA, and malaoxon are molecules similar to malathion used as negative targets. BSA
was also used as a negative target as model of a large, globular protein. Propanil, 2,4-D acid,
and atrazine are other pesticides which were used as negative targets. MMA = malathion
monocarboxylic acid; DMTP = dimethyl thiophosphate; DMDTP = dimethyl dithiophosphate;
MDA = malathion dicarboxylic acid; BSA = bovine serum albumin.
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The cross-binding results are particularly interesting as the MRE differentiates malathion from
three closely-related structures, including malaoxon, that some antibodies cannot discern
between (Yan et al. 2009). It is expected that even though the previously-selected antibodies
were not tested for binding affinity or for binding to some of the metabolites tested here, the
MRE will have higher affinity and specificity than antibodies previously identified for malathion
(Nishi et al. 2003; Brun et al. 2005; Vera-Avila et al. 2005). This is because the in vitro
selection process allows the investigator more control over final binding parameters than
antibody selection. Furthermore, the Decoy-SELEX process allows the investigator greater
control over which closely-related molecules the MRE will bind to.
The selected malathion ssDNA MRE will be useful for environmental sensing.
Previously-developed nucleic acid MREs have been used as the sensing element in this capacity
(Strehlitz et al. 2012; Yildirim et al. 2012). It is possible that design of the sensor will allow for
a rapid, field-usable malathion detection device that will be quicker, cheaper, and easier to
operate than current mechanisms. With easier detection of malathion, a greater sampling of
contaminated environments will be possible. It is then possible to actively remediate these
contaminated environments by biological, chemical, or physical methods (Nair and Pradeep
2007; Xie et al. 2009; Singhal et al. 2012).
B.4 Conclusions
Decoy-SELEX, a novel variation of in vitro selection, has been utilized to obtain a MRE
for the pesticide malathion. Twelve rounds of selection were completed, with consensus
sequence families identified and potential MREs obtained. The selected ssDNA MRE, R12.20,
has a very high affinity malathion and selectivity compared to various other pesticides and
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metabolites of malathion. This MRE will allow for rapid, cheap, and specific detection of
malathion, which will lead to potential remediation of contaminated environments.

135

References
Aalinkeel, R., M. P. N. Nair, et al. (2004). Gene expression of angiogenic factors correlates with
metastatic potential of prostate cancer cells. Cancer Res 64(15): 5311-5321.
Abbineni, G., S. Modali, et al. (2010). Evolutionary Selection of New Breast Cancer Cell-Targeting
Peptides and Phages with the Cell-Targeting Peptides Fully Displayed on the Major Coat and
Their Effects on Actin Dynamics during Cell Internalization. Mol Pharm.
Ackerman, F. (2007). The Economics of Atrazine. Int J Occup Environ Health 13: 441-449.
Adams, G. P., R. Schier, et al. (1998). Increased affinity leads to improved selective tumor delivery of
single-chain Fv antibodies. Cancer research 58(3): 485-490.
Ahn, J. Y., M. Jo, et al. (2011). A Sol-Gel-Based Microfluidics System Enhances the Efficiency of RNA
Aptamer Selection. Oligonucleotides 21(2): 93-100.
Ajayan, P. M. (1999). Nanotubes from carbon. Chemical Reviews 99(7): 1787-1799.
Ajayan, P. M., J. C. Charlier, et al. (1999). Carbon nanotubes: From macromolecules to nanotechnology.
Proc Natl Acad Sci U S A 96(25): 14199-14200.
Albanito, L., R. Lappano, et al. (2008). G-Protein–Coupled Receptor 30 and Estrogen Receptor-〈 Are
Involved in the Proliferative Effects Induced by Atrazine in Ovarian Cancer Cells. Environ Health
Perspect 116(12): 1648-1655.
Albertorio, F., M. E. Hughes, et al. (2009). Base dependent DNA-carbon nanotube interactions: activation
enthalpies and assembly-disassembly control. Nanotechnology 20(39): 395101.
Albertorio, F., M. E. Hughes, et al. (2009). Base dependent DNA-carbon nanotube interactions: activation
enthalpies and assembly-disassembly control. Nanotechnology 20(39).
Albertsen, P. C., J. A. Hanley, et al. (2007). 13-year outcomes following treatment for clinically localized
prostate cancer in a population based cohort. The Journal of urology 177(3): 932.

136

Alpatova, A. L., W. Q. Shan, et al. (2010). Single-walled carbon nanotubes dispersed in aqueous media
via non-covalent functionalization: Effect of dispersant on the stability, cytotoxicity, and
epigenetic toxicity of nanotube suspensions. Water Research 44(2): 505-520.
Amelinckx, S., X. B. Zhang, et al. (1994). A FORMATION MECHANISM FOR CATALYTICALLY GROWN HELIXSHAPED GRAPHITE NANOTUBES. Science 265(5172): 635-639.
Amistadi, J. K., J. K. Hall, et al. (1997). Comparison of gas chromatography and immunoassay methods
for the detection of atrazine in water and soil. J Environ Sci Health B 32(6): 45-60.
Amler, L. C., D. B. Agus, et al. (2000). Dysregulated expression of androgen-responsive and
nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1.
Cancer Res 60(21): 6134-6141.
Ando, C., R. Gallavan, et al. (1996). Environmental Monitoring Results of the Mediterranean Fruit Fly
Eradication Program, Riverside County 1994. EH95-02.
Ando, Y. and X. L. Zhao (2006). Synthesis of carbon nanotubes by arc-discharge method. New Diamond
and Frontier Carbon Technology 16(3): 123-137.
Arnold, M. S., A. A. Green, et al. (2006). Sorting carbon nanotubes by electronic structure using density
differentiation. Nat Nanotechnol 1(1): 60-65.
Askonas, B. A., Williams.Ar, et al. (1970). SELECTION OF A SINGLE ANTIBODY-FORMING CELL CLONE AND
ITS PROPAGATION IN SYNGENEIC MICE. Proceedings of the National Academy of Sciences of the
United States of America 67(3): 1398-&.
Ator, S. W. (1998). Water Quality in the Potomac River Basin, Maryland, Pennsylvania, Virginia, West
Virginia, and the District of Columbia, 1992-96, US Geological Survey.
Ator, S. W. and M. J. Ferrari (1997). Nitrate and selected pesticides in ground water of the Mid-Atlantic
Region, US Geological Survey.

137

Avouris, P., M. Freitag, et al. (2008). Carbon-nanotube photonics and optoelectronics. Nature Photonics
2(6): 341-350.
Baade, P., M. Coory, et al. (2004). International trends in prostate-cancer mortality: the decrease is
continuing and spreading. Cancer causes and control 15(3): 237-241.
Bachilo, S. M., M. S. Strano, et al. (2002). Structure-assigned optical spectra of single-walled carbon
nanotubes. Science 298(5602): 2361-2366.
Baddour, C. and C. Briens (2005). Carbon Nanotube Synthesis: A Review. International Journal of
Chemical Reactor Engineering 3: R3.
Baker, R. T. K. (1989). CATALYTIC GROWTH OF CARBON FILAMENTS. Carbon 27(3): 315-323.
Baker, S. E., D. B. Barr, et al. (2000). Quantification of selected pesticide metabolites in human urine
using isotope dilution high-performance liquid chromatography/tandem mass spectrometry.
Journal of Exposure Science and Environmental Epidemiology 10: 789-798.
Bandow, S., S. Asaka, et al. (1998). Effect of the growth temperature on the diameter distribution and
chirality of single-wall carbon nanotubes. Physical Review Letters 80(17): 3779-3782.
Barry, M. J. (2009). Screening for prostate cancer—the controversy that refuses to die. New England
Journal of Medicine 360(13): 1351-1354.
Baughman, R. H., A. A. Zakhidov, et al. (2002). Carbon nanotubes - the route toward applications.
Science 297(5582): 787-792.
Beauvais, S. L., S. B. Jones, et al. (2000). Physiological measures of neurotoxicity of diazinon and
malathion to larval rainbow trout (Oncorhynchus mykiss) and their correlation with behavioral
measures. Environmental Toxicology and Chemistry 19(7): 1875-1880.
Bello, D., M. Webber, et al. (1997). Androgen responsive adult human prostatic epithelial cell lines
immortalized by human papillomavirus 18. Carcinogenesis 18(6): 1215-1223.

138

Benedict, C. A., A. J. MacKrell, et al. (1997). Determination of the binding affinity of an anti-CD34 singlechain antibody using a novel, flow cytometry based assay. Journal of immunological methods
201(2): 223-231.
Berens, C., A. Thain, et al. (2001). A tetracycline-binding RNA aptamer. Bioorganic & Medicinal Chemistry
9(10): 2549-2556.
Berezovski, M. V., M. Lechmann, et al. (2008). Aptamer-facilitated biomarker discovery (AptaBiD).
Journal of the American Chemical Society 130(28): 9137-9143.
Berezovski, M. V., M. Lechmann, et al. (2008). Aptamer-facilitated biomarker discovery (AptaBiD).
Journal of the American Chemical Society 130(28): 9137-9143.
Bessette, P. H., J. J. Rice, et al. (2004). Rapid isolation of high-affinity protein binding peptides using
bacterial display. Protein Eng Des Sel 17(10): 731-739.
Bethune, D. S., C. H. Kiang, et al. (1993). COBALT-CATALYZED GROWTH OF CARBON NANOTUBES WITH
SINGLE-ATOMIC-LAYERWALLS. Nature 363(6430): 605-607.
Bhirde, A. A., S. Patel, et al. (2010). Distribution and clearance of PEG-single-walled carbon nanotube
cancer drug delivery vehicles in mice. Nanomedicine 5(10): 1535-1546.
Bill-Axelson, A., L. Holmberg, et al. (2008). Radical prostatectomy versus watchful waiting in localized
prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. Journal of the
National Cancer Institute 100(16): 1144-1154.
Bill-Axelson, A., L. Holmberg, et al. (2011). Radical prostatectomy versus watchful waiting in early
prostate cancer. New England Journal of Medicine 364(18): 1708-1717.
Blank, M., T. Weinschenk, et al. (2001). Systematic evolution of a DNA aptamer binding to rat brain
tumor microvessels. selective targeting of endothelial regulatory protein pigpen. J Biol Chem
276(19): 16464-16468.

139

Boder, E. T., K. S. Midelfort, et al. (2000). Directed evolution of antibody fragments with monovalent
femtomolar antigen-binding affinity. Proc Natl Acad Sci U S A 97(20): 10701-10705.
Boder, E. T., K. S. Midelfort, et al. (2000). Directed evolution of antibody fragments with monovalent
femtomolar antigen-binding affinity. Proceedings of the National Academy of Sciences 97(20):
10701-10705.
Boder, E. T. and K. D. Wittrup (1997). Yeast surface display for screening combinatorial polypeptide
libraries. Nature biotechnology 15(6): 553-557.
Boder, E. T. and K. D. Wittrup (1997). Yeast surface display for screening combinatorial polypeptide
libraries. Nat Biotechnol 15(6): 553-557.
Böldicke, T., M. Tesar, et al. (2001). Anti‐VEGFR‐2 scFvs for Cell Isolation. Single‐Chain Antibodies
Recognizing the Human Vascular Endothelial Growth Factor Receptor‐2 (VEGFR‐2/flk‐1) on the
Surface of Primary Endothelial Cells and Preselected CD34+ Cells from Cord Blood. Stem Cells
19(1): 24-36.
Bouchard, M. F., D. C. Bellinger, et al. (2010). Attention-deficit/hyperactivity disorder and urinary
metabolites of organophosphate pesticides. Pediatrics 125(6): e1270-e1277.
Breaker, R. R. and G. F. Joyce (1994). A DNA enzyme that cleaves RNA. Chem Biol 1(4): 223-229.
Brekke, O. H. and I. Sandlie (2003). Therapeutic antibodies for human diseases at the dawn of the
twenty-first century. Nat Rev Drug Discov 2(1): 52-62.
Breuer, O. and U. Sundararaj (2004). Big returns from small fibers: A review of polymer/carbon
nanotube composites. Polymer Composites 25(6): 630-645.
Brun, E. M., M. Garcés-García, et al. (2005). Evaluation of a novel malathion immunoassay for
groundwater and surface water analysis. Environ Sci Technol 39(8): 2786-2794.
Brzezicki, J. M., M. E. Andersen, et al. (2003). Quantitative identification of atrazine and its chlorinated
metabolites in plasma. J Anal Toxicol 27(8): 569-573.
140

Bujacz, A. (2012). Structures of bovine, equine and leporine serum albumin. Acta Crystallogr D Biol
Crystallogr 68(Pt 10): 1278-1289.
Buratti, F. M., A. D'aniello, et al. (2005). Malathion bioactivation in the human liver: the contribution of
different cytochrome p450 isoforms. Drug metabolism and disposition 33(3): 295-302.
Burke, D. H., D. C. Hoffman, et al. (1997). RNA aptamers to the peptidyl transferase inhibitor
chloramphenicol. Chem Biol 4(11): 833-843.
Cabello, G., M. Valenzuela, et al. (2001). A rat mammary tumor model induced by the
organophosphorous pesticides parathion and malathion, possibly through acetylcholinesterase
inhibition. Environmental Health Perspectives 109(5): 471.
Carlsson, S., A. J. Vickers, et al. (2012). Prostate cancer screening: facts, statistics, and interpretation in
response to the US Preventive Services Task Force review. Journal of Clinical Oncology 30(21):
2581-2584.
Catalona, W., J. Richie, et al. (1994). Comparison of digital rectal examination and serum prostate
specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of
6,630 men. The Journal of urology 151(5): 1283.
Catalona, W. J., D. S. Smith, et al. (1991). Measurement of prostate-specific antigen in serum as a
screening test for prostate cancer. New England Journal of Medicine 324(17): 1156-1161.
Cella, L. N., P. Sanchez, et al. (2010). Nano Aptasensor for Protective Antigen Toxin of Anthrax. Analytical
Chemistry 82(5): 2042-2047.
Cerchia, L., C. L. Esposito, et al. (2009). Differential SELEX in Human Glioma Cell Lines. PLoS One 4(11).
Cerchia, L., J. Hamm, et al. (2002). Nucleic acid aptamers in cancer medicine. FEBS Lett 528(1-3): 12-16.
Chang, D. K., C. T. Lin, et al. (2009). A novel peptide enhances therapeutic efficacy of liposomal anticancer drugs in mice models of human lung cancer. PLoS One 4(1): e4171.

141

Chao, G., W. L. Lau, et al. (2006). Isolating and engineering human antibodies using yeast surface display.
Nat Protoc 1(2): 755-768.
Chavez, J. L., W. Lyon, et al. (2010). Theophylline detection using an aptamer and DNA-gold nanoparticle
conjugates. Biosensors & Bioelectronics 26(1): 23-28.
Chen, H., C. Yu, et al. (2009). A novel near-infrared protein assay based on the dissolution and
aggregation of aptamer-wrapped single-walled carbon nanotubes. Chemical
Communications(33): 5006-5008.
Chen, Q., J. T. Watson, et al. (2006). Gene expression in the LNCaP human prostate cancer progression
model: progression associated expression in vitro corresponds to expression changes associated
with prostate cancer progression in vivo. Cancer letters 244(2): 274-288.
Chien, Y. M., F. Lefevre, et al. (2010). A solution processed top emission OLED with transparent carbon
nanotube electrodes. Nanotechnology 21(13).
Cho, E. J., J. W. Lee, et al. (2009). Applications of Aptamers as Sensors. Annual Review of Analytical
Chemistry. Palo Alto, Annual Reviews. 2: 241-264.
Cho, H., B. R. Baker, et al. (2008). Aptamer-Based SERRS Sensor for Thrombin Detection. Nano Lett 8(12):
4386-4390.
Chochois, V., L. Constans, et al. (2010). Relationships between PSII-independent hydrogen bioproduction
and starch metabolism as evidenced from isolation of starch catabolism in the green alga
Chlamydomonas reinhardtii. International Journal of Hydrogen Energy 35(19): 10731-10740.
Chou, R., J. M. Croswell, et al. (2011). Screening for prostate cancer: a review of the evidence for the US
Preventive Services Task Force. Annals of Internal Medicine 155(11): 762.
Chou, R., T. Dana, et al. (2011). Treatments for localized prostate cancer: systematic review to update
the 2002 US Preventive Services Task Force Recommendation. Evidence Synthesis(91).

142

Chung, C. H., J. H. Kim, et al. (2012). Nuclease-resistant DNA aptamer on gold nanoparticles for the
simultaneous detection of Pb(2+) and Hg(2+) in human serum. Biosens Bioelectron.
Codrea, V., M. Hayner, et al. (2010). In vitro selection of RNA aptamers to a small molecule target.
Current protocols in nucleic acid chemistry / edited by Serge L. Beaucage ... [et al.] Chapter 9:
Unit 9.5.1-23.
Colcher, D., G. Pavlinkova, et al. (1998). Pharmacokinetics and biodistribution of genetically-engineered
antibodies. The quarterly journal of nuclear medicine: official publication of the Italian
Association of Nuclear Medicine (AIMN)[and] the International Association of
Radiopharmacology (IAR) 42(4): 225.
Coleman, J. N., U. Khan, et al. (2006). Small but strong: A review of the mechanical properties of carbon
nanotube-polymer composites. Carbon 44(9): 1624-1652.
Conrad, F., X. Zhu, et al. (2009). Human antibodies targeting cell surface antigens overexpressed by the
hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates
prostate cancer cell invasion. Journal of molecular medicine 87(5): 507-514.
Conrad, F., X. Zhu, et al. (2009). Human antibodies targeting cell surface antigens overexpressed by the
hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates
prostate cancer cell invasion. J Mol Med (Berl) 87(5): 507-514.
Cooper, R. L., S. C. Laws, et al. (2007). Atrazine and reproductive function: mode and mechanism of
action studies. Birth Defects Res B Dev Reprod Toxicol 80(2): 98-112.
Coupe, R. H., M. A. Manning, et al. (2000). Occurrence of pesticides in rain and air in urban and
agricultural areas of Mississippi, April-September 1995. Science of the Total Environment 248(23): 227-240.
Cui, D. X., F. R. Tian, et al. (2004). Effects of single-walled carbon nanotubes on the polymerase chain
reaction. Nanotechnology 15(1): 154-157.
143

Cui, Y., H. Urich, et al. (2004). Selection of 2 '-fluoro-modified RNA aptamers for alleviation of cocaine
and MK-801 inhibition of the nicotinic acetylcholine receptor. Journal of Membrane Biology
202(3): 137-149.
Dane, K. Y., L. A. Chan, et al. (2006). Isolation of cell specific peptide ligands using fluorescent bacterial
display libraries. J Immunol Methods 309(1-2): 120-129.
Daniels, D. A., H. Chen, et al. (2003). A tenascin-C aptamer identified by tumor cell SELEX: systematic
evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A 100(26): 15416-15421.
Daugherty, P. S., G. Chen, et al. (1998). Antibody affinity maturation using bacterial surface display.
Protein Eng 11(9): 825-832.
de-los-Santos-Alvarez, N., M. J. Lobo-Castanon, et al. (2007). Modified-RNA aptamer-based sensor for
competitive impedimetric assay of neomycin B. Journal of the American Chemical Society
129(13): 3808-+.
Dieckmann, T., E. Suzuki, et al. (1996). Solution structure of an ATP-binding RNA aptamer reveals a novel
fold. Rna-a Publication of the Rna Society 2(7): 628-640.
Domingos, R. F., D. F. Simon, et al. (2011). Bioaccumulation and Effects of CdTe/CdS Quantum Dots on
Chlamydomonas reinhardtii - Nanoparticles or the Free Ions? Environ Sci Technol 45(18): 76647669.
Dong, L., K. L. Joseph, et al. (2008). Cytotoxicity of single-walled carbon nanotubes suspended in various
surfactants. Nanotechnology 19(25).
Du, C. S. and N. Pan (2006). Supercapacitors using carbon nanotubes films by electrophoretic deposition.
Journal of Power Sources 160(2): 1487-1494.
El-Mousawi, M., L. Tchistiakova, et al. (2003). A vascular endothelial growth factor high affinity receptor
1-specific peptide with antiangiogenic activity identified using a phage display peptide library. J
Biol Chem 278(47): 46681-46691.
144

Ellington, A. D. and J. W. Szostak (1990). In vitro selection of RNA molecules that bind specific ligands.
Nature 346(6287): 818-822.
Elsässer-Beile, U., G. Reischl, et al. (2009). PET imaging of prostate cancer xenografts with a highly
specific antibody against the prostate-specific membrane antigen. Journal of Nuclear Medicine
50(4): 606-611.
Evans, M. J., S. A. Rollins, et al. (1995). In vitro and in vivo inhibition of complement activity by a singlechain Fv fragment recognizing human C5. Mol Immunol 32(16): 1183-1195.
Extra, J. M., F. Rousseau, et al. (1993). Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC
628503) given as a short intravenous infusion. Cancer Res 53(5): 1037-1042.
Fan, W., T. Yanase, et al. (2007). Atrazine-Induced Aromatase Expression Is SF-1 Dependent: Implications
for Endocrine Disruption in Wildlife and Reproductive Cancers in Humans. Environ Health
Perspect 115(5): 720-727.
Feldhaus, M. J. and R. W. Siegel (2004). Yeast display of antibody fragments: a discovery and
characterization platform. J Immunol Methods 290(1-2): 69-80.
Feldhaus, M. J., R. W. Siegel, et al. (2003). Flow-cytometric isolation of human antibodies from a
nonimmune Saccharomyces cerevisiae surface display library. Nat Biotechnol 21(2): 163-170.
Feldman, B. J. and D. Feldman (2001). The development of androgen-independent prostate cancer.
Nature Reviews Cancer 1(1): 34-45.
Fenske, R. A. and J. T. Leffingwell (1989). Method for the determination of dialkyl phosphate metabolites
in urine for studies of human exposure to malathion. J Agric Food Chem 37(4): 995-998.
Ferrari, F., M. Trevisan, et al. (2003). Predicting and measuring environmental concentration of
pesticides in air after soil application. Journal of environmental quality 32(5): 1623-1633.
Ferrari, M. J. and M.-A. I. Assessment (1997). Pesticides in surface water of the Mid-Atlantic Region, US
Geological Survey.
145

Figini, M., L. Obici, et al. (1998). Panning phage antibody libraries on cells: isolation of human Fab
fragments against ovarian carcinoma using guided selection. Cancer Res 58(5): 991-996.
Fitch, J. C., S. Rollins, et al. (1999). Pharmacology and biological efficacy of a recombinant, humanized,
single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass
graft surgery with cardiopulmonary bypass. Circulation 100(25): 2499-2506.
Fordham, C. L., J. D. Tessari, et al. (2001). Effects of malathion on survival, growth, development, and
equilibrium posture of bullfrog tadpoles (Rana catesbeiana). Environmental Toxicology and
Chemistry 20(1): 179-184.
Fournier, E., M. Sonnier, et al. (1978). Detection and assay of organophosphate pesticides in human
blood by gas chromatography. Clinical Toxicology 12(4): 457-462.
Franklin, N. R., Y. M. Li, et al. (2001). Patterned growth of single-walled carbon nanotubes on full 4-inch
wafers. Applied Physics Letters 79(27): 4571-4573.
Gao, C., S. Mao, et al. (2003). De novo identification of tumor-specific internalizing human antibody–
receptor pairs by phage-display methods. Journal of immunological methods 274(1): 185-197.
Gary, N. E. and E. C. Mussen (1984). Impact of Mediterranean fruit fly malathion bait spray on honey
bees. Environmental entomology 13(3): 711-717.
Giebel, L. B., R. T. Cass, et al. (1995). Screening of cyclic peptide phage libraries identifies ligands that
bind streptavidin with high affinities. Biochemistry 34(47): 15430-15435.
Gietz, R. and R. Woods (2002). Transformation of yeast by lithium acetate/single-stranded carrier
DNA/polyethylene glycol method. Methods in enzymology 350: 87.
Giri, S., S. Prasad, et al. (2002). Genotoxic effects of malathion: an organophosphorus insecticide, using
three mammalian bioassays in vivo. Mutation Research/Genetic Toxicology and Environmental
Mutagenesis 514(1): 223-231.

146

Goda, T. and Y. Miyahara (2012). A hairpin DNA aptamer coupled with groove binders as a smart switch
for a field-effect transistor biosensor. Biosensors & Bioelectronics 32(1): 244-249.
Goertz, P., J. Colin Cox, et al. (2004). Automated selection of aminoglycoside aptamers. JALA 9(3): 150154.
Goldenberg, D. M., H. Goldenberg, et al. (1990). Clinical studies of cancer radioimmunodetection with
carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc. Cancer
Res 50(3 Suppl): 909s-921s.
Graymore M, S. F., Allinson G (2001). Impacts of Atrazine on Aquatic Ecosystems. Environment
International 26: 483-495.
Gugliotti, L. A., D. L. Feldheim, et al. (2004). RNA-mediated metal-metal bond formation in the synthesis
of hexagonal palladium nanoparticles. Science 304(5672): 850-852.
Gunneriusson, E., P. Samuelson, et al. (1996). Surface display of a functional single-chain Fv antibody on
staphylococci. J Bacteriol 178(5): 1341-1346.
Guo, K. T., G. Ziemer, et al. (2008). CELL-SELEX: Novel perspectives of aptamer-based therapeutics. Int J
Mol Sci 9(4): 668-678.
Guo, T., P. Nikolaev, et al. (1995). CATALYTIC GROWTH OF SINGLE-WALLED NANOTUBES BY LASER
VAPORIZATION. Chemical Physics Letters 243(1-2): 49-54.
Haddon, R. C., J. Sippel, et al. (2004). Purification and separation of carbon nanotubes. Mrs Bulletin
29(4): 252-259.
Hall, B., J. M. Micheletti, et al. (2009). Design, synthesis, and amplification of DNA pools for in vitro
selection. Current protocols in nucleic acid chemistry / edited by Serge L. Beaucage ... [et al.]
Chapter 9: Unit 9.2.
Hamula, C. L. A., J. W. Guthrie, et al. (2006). Selection and analytical applications of aptamers. Trends in
Analytical Chemistry 25(7): 681-691.
147

Harris, E. H. (2001). Chlamydomonas as a model organism. Annual Review of Plant Physiology and Plant
Molecular Biology 52: 363-406.
Hasegawa, H., K. Sode, et al. (2008). Selection of DNA aptamers against VEGF(165) using a protein
competitor and the aptamer blotting method. Biotechnology Letters 30(5): 829-834.
Hayes, T., K. Haston, et al. (2002). Feminization of Male Frogs in the Wild. Nature 419(895-895).
Hayward, S., R. Dahiya, et al. (1995). Establishment and characterization of an immortalized but nontransformed human prostate epithelial cell line: BPH-1. In Vitro Cellular & Developmental
Biology-Animal 31(1): 14-24.
He, J., Y. Wang, et al. (2010). Targeting prostate cancer cells in vivo using a rapidly internalizing novel
human single-chain antibody fragment. Journal of Nuclear Medicine 51(3): 427-432.
He, J. A., Y. A. Liu, et al. (2011). Isolation and Identification of the DNA Aptamer Target to Acetamiprid. J
Agric Food Chem 59(5): 1582-1586.
Heller, D. A., S. Baik, et al. (2005). Single-walled carbon nanotube spectroscopy in live cells: Towards
long-term labels and optical sensors. Advanced Materials 17(23): 2793-2799.
Herness, E. A. and R. K. Naz (2001). Prostate-specific genes: present status and future direction. Front.
Biosci 6: d1083-d1088.
Herranz, S., J. RamÃ³n-AzcÃ³n, et al. (2008). Preparation of antibodies and development of a sensitive
immunoassay with fluorescence detection for triazine herbicides. Anal Bioanal Chem 391(5):
1801-1812.
Herzberg, M., C. G. Dosoretz, et al. (2004). Simultaneous removal of atrazine and nitrate using a
biological granulated activated carbon (BGAC) reactor. Journal of Chemical Technology and
Biotechnology 79(6): 626-631.
Ho, M. and I. Pastan (2009). Display and selection of scFv antibodies on HEK-293T cells. Methods Mol
Biol 562: 99-113.
148

Holem, R. R., W. A. Hopkins, et al. (2008). Effects of repeated exposure to malathion on growth, food
consumption, and locomotor performance of the western fence lizard (Sceloporus occidentalis).
Environmental Pollution-Kidlington 152(1): 92-98.
Horoszewicz, J. S., E. Kawinski, et al. (1987). Monoclonal antibodies to a new antigenic marker in
epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 7(5B): 927.
Horoszewicz, J. S., S. S. Leong, et al. (1983). LNCaP model of human prostatic carcinoma. Cancer research
43(4): 1809-1818.
Huang, H. D., M. J. Zou, et al. (2011). Near-infrared fluorescence spectroscopy of single-walled carbon
nanotubes and its applications. Trac-Trends in Analytical Chemistry 30(7): 1109-1119.
Huang, H. P., Y. L. Tan, et al. (2010). DNA aptasensor for the detection of ATP based on quantum dots
electrochemiluminescence. Nanoscale 2(4): 606-612.
Huang, X. Y., R. S. McLean, et al. (2005). High-resolution length sorting and purification of DNA-wrapped
carbon nanotubes by size-exclusion chromatography. Analytical Chemistry 77(19): 6225-6228.
Huizenga, D. E. and J. W. Szostak (1995). A DNA aptamer that binds adenosine and ATP. Biochemistry
34(2): 656-665.
Huse, W. D., L. Sastry, et al. (1989). Generation of a large combinatorial library of the immunoglobulin
repertoire in phage lambda. Science 246(4935): 1275-1281.
Iijima, S. (1991). Helical Microtubules of Graphitic Carbon. Nature 354(6348): 56-58.
Iijima, S. and T. Ichihashi (1993). SINGLE-SHELL CARBON NANOTUBES OF 1-NM DIAMETER. Nature
363(6430): 603-605.
Ireson, C. R. and L. R. Kelland (2006). Discovery and development of anticancer aptamers. Mol Cancer
Ther 5(12): 2957-2962.
Ivanov, V., J. B. Nagy, et al. (1994). THE STUDY OF CARBON NANOTUBULES PRODUCED BY CATALYTIC
METHOD. Chemical Physics Letters 223(4): 329-335.
149

Jackson, G. W., U. Strych, et al. (2009). Portable FRET Sensing of Proteins, Hormones, and Toxins Using
DNA Aptamers and Quantum Dots. Boca Raton, Crc Press-Taylor & Francis Group.
Jackson, H., L. Bacon, et al. (1998). Antigen specificity and tumour targeting efficiency of a human
carcinoembryonic antigen-specific scFv and affinity-matured derivatives. British journal of
cancer 78(2): 181.
Jacobsen, R. L., T. M. Tritt, et al. (1995). MECHANICAL-PROPERTIES OF VAPOR-GROWN CARBON-FIBER.
Carbon 33(9): 1217-1221.
Jain, R. K., D. G. Duda, et al. (2006). Lessons from phase III clinical trials on anti-VEGF therapy for cancer.
Nature Clinical Practice Oncology 3(1): 24-40.
Jakobsen, C. G., N. Rasmussen, et al. (2007). Phage display derived human monoclonal antibodies
isolated by binding to the surface of live primary breast cancer cells recognize GRP78. Cancer
Res 67(19): 9507-9517.
Jayanna, P. K., D. Bedi, et al. (2010). Landscape phage ligands for PC3 prostate carcinoma cells. Protein
Eng Des Sel 23(6): 423-430.
Jeng, E. S., A. E. Moll, et al. (2006). Detection of DNA hybridization using the near-infrared band-gap
fluorescence of single-walled carbon nanotubes. Nano Lett 6(3): 371-375.
Jiang H, A. C., Graziano N, Roberson A, McGuire M, Khiari D (2006). Occurrence and Removal of Chloro-sTriazines in Water Treatment Plants. Environ Sci Technol 40(11): 3602-3616.
Jiang, M., D. W. Strand, et al. (2009). Functional remodeling of benign human prostatic tissues in vivo by
spontaneously immortalized progenitor and intermediate cells. Stem Cells 28(2): 344-356.
Johnston, W. W., C. A. Szpak, et al. (1986). Use of a monoclonal antibody (B72. 3) as a novel
immunohistochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy
specimens. Human pathology 17(5): 501-513.

150

Joseyacaman, M., M. Mikiyoshida, et al. (1993). CATALYTIC GROWTH OF CARBON MICROTUBULES WITH
FULLERENE STRUCTURE. Applied Physics Letters 62(2): 202-204.
Journet, C., W. K. Maser, et al. (1997). Large-scale production of single-walled carbon nanotubes by the
electric-arc technique. Nature 388(6644): 756-758.
Ju, S. Y., J. Doll, et al. (2008). Selection of carbon nanotubes with specific chiralities using helical
assemblies of flavin mononucleotide. Nat Nanotechnol 3(6): 356-362.
Kaighn, M., K. S. Narayan, et al. (1979). Establishment and characterization of a human prostatic
carcinoma cell line (PC-3). Investigative urology 17(1): 16.
Kang, J. W., F. T. Nguyen, et al. (2012). Measuring Uptake Dynamics of Multiple Identifiable Carbon
Nanotube Species via High-Speed Confocal Raman Imaging of Live Cells. Nano Lett.
Kang, S., M. S. Mauter, et al. (2009). Microbial Cytotoxicity of Carbon-Based Nanomaterials: Implications
for River Water and Wastewater Effluent. Environ Sci Technol 43(7): 2648-2653.
Kanwar, J. R., K. Roy, et al. (2011). Chimeric aptamers in cancer cell-targeted drug delivery. Critical
Reviews in Biochemistry and Molecular Biology 46(6): 459-477.
Karan, D., D. L. Kelly, et al. (2002). Expression profile of differentially-regulated genes during progression
of androgen-independent growth in human prostate cancer cells. Carcinogenesis 23(6): 967-976.
Kase, D., J. L. Kulp, 3rd, et al. (2004). Affinity selection of peptide phage libraries against single-wall
carbon nanohorns identifies a peptide aptamer with conformational variability. Langmuir
20(20): 8939-8941.
Kaur, H. and L.-Y. L. Yung (2012). Probing High Affinity Sequences of DNA Aptamer against VEGF165.
PLoS One 7(2): e31196.
Kay, B. K., J. Kasanov, et al. (2001). Screening phage-displayed combinatorial peptide libraries. Methods
24(3): 240-246.

151

Kelly, K., H. Alencar, et al. (2004). Detection of invasive colon cancer using a novel, targeted, libraryderived fluorescent peptide. Cancer Res 64(17): 6247-6251.
Kelly, K. A. and D. A. Jones (2003). Isolation of a colon tumor specific binding peptide using phage display
selection. Neoplasia 5(5): 437-444.
Key, P. B., M. H. Fulton, et al. (1998). Lethal and sublethal effects of malathion on three life stages of the
grass shrimp,Palaemonetes pugio. Aquatic Toxicology 40(4): 311-322.
Khandurina, J., T. E. McKnight, et al. (2000). Integrated system for rapid PCR-based DNA analysis in
microfluidic devices. Analytical Chemistry 72(13): 2995-3000.
Kim, M., H. J. Um, et al. (2009). Arsenic Removal from Vietnamese Groundwater Using the ArsenicBinding DNA Aptamer. Environ Sci Technol 43(24): 9335-9340.
Kim, M. J., D. W. Shin, et al. (2009). The production of a flexible electroluminescent device on
polyethylene terephthalate films using transparent conducting carbon nanotube electrode.
Carbon 47(15): 3461-3465.
Kim, S. N., Z. Kuang, et al. (2008). Enrichment of (6, 5) single wall carbon nanotubes using genomic DNA.
Nano Lett 8(12): 4415-4420.
Kim, Y., C. Liu, et al. (2009). Aptamers generated by Cell SELEX for biomarker discovery. Biomark Med
3(2): 193-202.
Kim, Y. J., Y. S. Kim, et al. (2010). Electrochemical aptasensor for tetracycline detection. Bioprocess and
Biosystems Engineering 33(1): 31-37.
Kim, Y. S., C. J. Hyun, et al. (2010). Isolation and characterization of enantioselective DNA aptamers for
ibuprofen. Bioorganic & Medicinal Chemistry 18(10): 3467-3473.
Kim, Y. S., H. S. Jung, et al. (2007). Electrochemical detection of 17 beta-estradiol using DNA aptamer
immobilized gold electrode chip. Biosensors & Bioelectronics 22(11): 2525-2531.

152

Köck, M., M. Farré, et al. (2010). Integrated ecotoxicological and chemical approach for the assessment
of pesticide pollution in the Ebro River delta (Spain). Journal of Hydrology 383(1): 73-82.
Köhler, A. R., C. Som, et al. (2008). Studying the potential release of carbon nanotubes throughout the
application life cycle. Journal of Cleaner Production 16(8): 927-937.
Komatsu, N. and F. Wang (2010). A Comprehensive Review on Separation Methods and Techniques for
Single-Walled Carbon Nanotubes. Materials 3(7): 3818-3844.
Kong, J., H. T. Soh, et al. (1998). Synthesis of individual single-walled carbon nanotubes on patterned
silicon wafers. Nature 395(6705): 878-881.
Krauland, E. M., B. R. Peelle, et al. (2007). Peptide tags for enhanced cellular and protein adhesion to
single-crystalline sapphire. Biotechnol Bioeng 97(5): 1009-1020.
Kronqvist, N., J. Lofblom, et al. (2008). A novel affinity protein selection system based on staphylococcal
cell surface display and flow cytometry. Protein Eng Des Sel 21(4): 247-255.
Kroto, H., J. Heath, et al. (1985). C60: Buckminsterfullerene. Nature 318: 162-163.
Krumpe, L. R., A. J. Atkinson, et al. (2006). T7 lytic phage-displayed peptide libraries exhibit less
sequence bias than M13 filamentous phage-displayed peptide libraries. Proteomics 6(15): 42104222.
Kucklick, J. R. and T. F. Bidleman (1994). ORGANIC CONTAMINANTS IN WINYAH BAY, SOUTH-CAROLINA
.1. PESTICIDES AND POLYCYCLIC AROMATIC-HYDROCARBONS IN SUBSURFACE AND MICROLAYER
WATERS. Marine Environmental Research 37(1): 63-78.
Kukovitsky, E. F., S. G. L'Vov, et al. (2002). Correlation between metal catalyst particle size and carbon
nanotube growth. Chemical Physics Letters 355(5-6): 497-503.
Kupsch, J. M., N. H. Tidman, et al. (1999). Isolation of human tumor-specific antibodies by selection of an
antibody phage library on melanoma cells. Clin Cancer Res 5(4): 925-931.

153

Kuriyama, M., M. C. Wang, et al. (1980). Quantitation of prostate-specific antigen in serum by a sensitive
enzyme immunoassay. Cancer Res 40(12): 4658-4662.
Ladjevardi, S., G. Sandblom, et al. (2010). Tumour grade, treatment, and relative survival in a populationbased cohort of men with potentially curable prostate cancer. Eur Urol 57(4): 631-640.
Ladner, R. C., A. K. Sato, et al. (2004). Phage display-derived peptides as therapeutic alternatives to
antibodies. Drug Discov Today 9(12): 525-529.
Lahiji, R. R., B. D. Dolash, et al. (2007). Oligodeoxyribonucleotide Association with Single‐Walled Carbon
Nanotubes Studied by SPM. Small 3(11): 1912-1920.
Landi, B. J., M. J. Ganter, et al. (2009). Carbon nanotubes for lithium ion batteries. Energy &
Environmental Science 2(6): 638-654.
Langan, T. J., V. T. Nyakubaya, et al. (2012). Assessment of aptamer‐steroid binding using
stacking‐enhanced capillary electrophoresis. Electrophoresis 33(5): 866-869.
Lee, J. F., G. M. Stovall, et al. (2006). Aptamer therapeutics advance. Curr Opin Chem Biol 10(3): 282-289.
LeNoir, J. S., L. L. McConnell, et al. (1999). Summertime transport of current‐use pesticides from
California's Central Valley to the Sierra Nevada Mountain Range, USA. Environmental Toxicology
and Chemistry 18(12): 2715-2722.
Li, J., S. Tan, et al. (2011). Peptide Aptamers with Biological and Therapeutic Applications. Current
Medicinal Chemistry 18(27): 4215-4222.
Li, L.-L., Q. Yin, et al. (2012). Polyvalent mesoporous silica nanoparticle-aptamer bioconjugates target
breast cancer cells. Advanced healthcare materials 1(5): 567-572.
Li, M., J. M. Zhang, et al. (2012). Detection of Adenosine Triphosphate with an Aptamer Biosensor Based
on Surface-Enhanced Raman Scattering. Analytical Chemistry 84(6): 2837-2842.
Li, W. Z., S. S. Xie, et al. (1996). Large-scale synthesis of aligned carbon nanotubes. Science 274(5293):
1701-1703.
154

Lin, C. H. and D. J. Patel (1997). Structural basis of DNA folding and recognition in an AMP-DNA aptamer
complex: distinct architectures but common recognition motifs for DNA and RNA aptamers
complexed to AMP. Chem Biol 4(11): 817-832.
Lin, G. M. (2011). Pexelizumab, an Anti-C5 Complement Antibody for Primary Coronary
Revascularization: A New Insight from Old Versions. Cardiovasc Hematol Disord Drug Targets.
Lin, K., J. M. Croswell, et al. (2011). Prostate-specific antigen-based screening for prostate cancer: an
evidence update for the US Preventive Services Task Force. Evidence Synthesis(90).
Lin, Q., T. Nguyen, et al. (2011). Microfluidic aptameric affinity sensing of vasopressin for clinical
diagnostic and therapeutic applications. Sensors and Actuators B-Chemical 154(1): 59-66.
Liu, B., F. Conrad, et al. (2004). Mapping tumor epitope space by direct selection of single-chain Fv
antibody libraries on prostate cancer cells. Cancer Res 64(2): 704-710.
Liu, J. and Y. Lu (2005). Fast colorimetric sensing of adenosine and cocaine based on a general sensor
design involving aptamers and nanoparticles. Angewandte Chemie (International ed. in English)
45(1): 90-94.
Liu, S. B., L. Wei, et al. (2009). Sharper and Faster "Nano Darts" Kill More Bacteria: A Study of
Antibacterial Activity of Individually Dispersed Pristine Single-Walled Carbon Nanotube. ACS
Nano 3(12): 3891-3902.
Liu, Y., N. Tuleouva, et al. (2010). Aptamer-Based Electrochemical Biosensor for Interferon Gamma
Detection. Analytical Chemistry 82(19): 8131-8136.
Liu, Z., M. Marquez, et al. (2009). Comparison of protein expression in two prostate cancer cell-lines,
LNCaP and DU145, after treatment with somatostatin. Oncology reports 22(6): 1451.
Lou, J. C., M. J. Jung, et al. (2011). Removal of dissolved organic matter (DOM) from raw water by singlewalled carbon nanotubes (SWCNTs). Journal of Environmental Science and Health, Part A 46(12):
1357-1365.
155

Lou, X. H., J. R. Qian, et al. (2009). Micromagnetic selection of aptamers in microfluidic channels. Proc
Natl Acad Sci U S A 106(9): 2989-2994.
Lu-Yao, G. L., P. C. Albertsen, et al. (2008). Survival following primary androgen deprivation therapy
among men with localized prostate cancer. JAMA: the journal of the American Medical
Association 300(2): 173-181.
Lu, Z., E. R. LaVallie, et al. (2003). Using bio-panning of FLITRX peptide libraries displayed on E. coli cell
surface to study protein-protein interactions. Methods Mol Biol 205: 267-280.
Lu, Z., K. S. Murray, et al. (1995). Expression of thioredoxin random peptide libraries on the Escherichia
coli cell surface as functional fusions to flagellin: a system designed for exploring protein-protein
interactions. Biotechnology (N Y) 13(4): 366-372.
Mallikaratchy, P., R. V. Stahelin, et al. (2006). Selection of DNA ligands for protein kinase C-delta.
Chemical Communications(30): 3229-3231.
Mandelbaum, R. T., D. L. Allan, et al. (1995). ISOLATION AND CHARACTERIZATION OF A PSEUDOMONAS
SP THAT MINERALIZES THE S-TRIAZINE HERBICIDE ATRAZINE. Appl Environ Microbiol 61(4): 14511457.
Maraj, B., M. Aldersley, et al. (1998). Prostate-specific membrane antigen expression in the duodenum:
implications in coeliac disease and immunotherapy for prostate cancer. The Lancet 351(9115):
1559-1560.
Marquis, R., C. Greco, et al. (2008). Supramolecular discrimination of carbon nanotubes according to
their helicity. Nano Lett 8(7): 1830-1835.
Matorin, D. N., A. V. Karateyeva, et al. (2010). Influence of Carbon Nanotubes on Chlorophyll
Fluorescence Parameters of Green Algae Chlamydomonas reinhardtii. Nanotechnologies in
Russia 5(5-6): 320-327.

156

McCarthy, I. D. and L. A. Fuiman (2008). Growth and protein metabolism in red drum (Sciaenops
ocellatus) larvae exposed to environmental levels of atrazine and malathion. Aquatic Toxicology
88(4): 220-229.
McGuire, M. J., S. Li, et al. (2009). Biopanning of phage displayed peptide libraries for the isolation of
cell-specific ligands. Methods Mol Biol 504: 291-321.
McGuire, M. J., K. N. Samli, et al. (2006). Novel ligands for cancer diagnosis: selection of peptide ligands
for identification and isolation of B-cell lymphomas. Exp Hematol 34(4): 443-452.
Mills, P. K. (1998). Correlation Analysis of Pesticide Use Data and Cancer Incidence Rates in California
Counties. Archives of Environmental Health 53(6): 410-416.
Miyata, Y., T. Kawai, et al. (2007). Chirality-dependent combustion of single-walled carbon nanotubes.
Journal of Physical Chemistry C 111(27): 9671-9677.
Mizota, K. and H. Ueda (2006). Endocrine Disrupting Chemical Atrazine Causes Degranulation through
Gq/11 Protein-Coupled Neurosteroid Receptor in Mast Cells Toxicol Sci 90(2): 362-368.
Moore, P. D., C. G. Yedjou, et al. (2010). Malathion-induced oxidative stress, cytotoxicity, and
genotoxicity in human liver carcinoma (HepG2) cells. Environ Toxicol 25(3): 221-226.
Moore, P. D., C. G. Yedjou, et al. (2010). Malathion‐induced oxidative stress, cytotoxicity, and
genotoxicity in human liver carcinoma (HepG2) cells. Environmental toxicology 25(3): 221-226.
Morris, K. N., K. B. Jensen, et al. (1998). High affinity ligands from in vitro selection: complex targets.
Proc Natl Acad Sci U S A 95(6): 2902-2907.
Moshfeghi, A. A. and C. A. Puliafito (2005). Pegaptanib sodium for the treatment of neovascular agerelated macular degeneration. Expert Opinion on Investigational Drugs 14(5): 671-682.
Mosing, R. K., S. D. Mendonsa, et al. (2005). Capillary electrophoresis-SELEX selection of aptamers with
affinity for HIV-1 reverse transcriptase. Analytical Chemistry 77(19): 6107-6112.

157

Moyer, V. A. (2012). Screening for prostate cancer: US Preventive Services Task Force recommendation
statement. Annals of Internal Medicine.
Muller, S. R., M. Berg, et al. (1997). Atrazine and its primary metabolites in Swiss lakes: Input
characteristics and long-term behavior in the water column. Environ Sci Technol 31(7): 21042113.
Nagrath, S., L. V. Sequist, et al. (2007). Isolation of rare circulating tumour cells in cancer patients by
microchip technology. Nature 450(7173): 1235-1239.
Nair, A. S. and T. Pradeep (2007). Extraction of chlorpyrifos and malathion from water by metal
nanoparticles. J Nanosci Nanotechnol 7(6): 1871-1877.
Navarro, E., F. Piccapietra, et al. (2008). Toxicity of Silver Nanoparticles to Chlamydomonas reinhardtii.
Environ Sci Technol 42(23): 8959-8964.
Nelson, A. L. (2010). Antibody fragments Hope and hype. Mabs 2(1): 77-83.
Nelson, A. L. (2010). Antibody fragments: hope and hype. MAbs, Landes Bioscience.
Newhart, K. (2006). Environmental Fate of Malathion. California Environmental Protection Agency
Environmental Monitoring Branch.
Ng, S. H., J. Wang, et al. (2005). Single wall carbon nanotube paper as anode for lithium-ion battery.
Electrochimica Acta 51(1): 23-28.
Nguyen, L. T. H. and C. R. Janssen (2001). Comparative sensitivity of embryo–larval toxicity assays with
African catfish (Clarias gariepinus) and zebra fish (Danio rerio). Environmental toxicology 16(6):
566-571.
Ni, X., Y. Zhang, et al. (2011). Prostate-targeted radiosensitization via aptamer-shRNA chimeras in
human tumor xenografts. The Journal of clinical investigation 121(6): 2383.
Nielsen, U. B., D. B. Kirpotin, et al. (2006). A novel assay for monitoring internalization of nanocarrier
coupled antibodies. BMC immunology 7(1): 24.
158

Nishi, K., Y. Imajuku, et al. (2003). Preparation and characterization of monoclonal and recombinant
antibodies specific to the insecticide malathion. Journal of Pesticide Science 28(3): 301-309.
Novak, J. P., E. S. Snow, et al. (2003). Nerve agent detection using networks of single-walled carbon
nanotubes. Applied Physics Letters 83(19): 4026-4028.
O'Connell, M. J., S. M. Bachilo, et al. (2002). Band gap fluorescence from individual single-walled carbon
nanotubes. Science 297(5581): 593-596.
Ocana, C., M. Pacios, et al. (2012). A Reusable Impedimetric Aptasensor for Detection of Thrombin
Employing a Graphite-Epoxy Composite Electrode. Sensors 12(3): 3037-3048.
Okamura, K., H. Koike, et al. (2008). Gene Expression Profiles of Prostate Cancer Cell Lines, LNCaP, PC-3
and DU-145, Assessed by cDNA Microarray. Kitakanto Medical Journal 58(4): 363-369.
Ouyang, M., J. L. Huang, et al. (2002). Fundamental electronic properties and applications of singlewalled carbon nanotubes. Acc Chem Res 35(12): 1018-1025.
Oyston, P. C., M. A. Fox, et al. (2009). Novel peptide therapeutics for treatment of infections. J Med
Microbiol 58(Pt 8): 977-987.
Ozalp, V. C. (2011). Acoustic quantification of ATP using a quartz crystal microbalance with dissipation.
Analyst 136(23): 5046-5050.
Paborsky, L. R., S. N. McCurdy, et al. (1993). The single-stranded DNA aptamer-binding site of human
thrombin. J Biol Chem 268(28): 20808-20811.
Pansri, P., N. Jaruseranee, et al. (2009). A compact phage display human scFv library for selection of
antibodies to a wide variety of antigens. BMC Biotechnol 9: 6.
Pantarotto, D., R. Singh, et al. (2004). Functionalized carbon nanotubes for plasmid DNA gene delivery.
Angewandte Chemie-International Edition 43(39): 5242-5246.

159

Panuwet, P., J. V. Nguyen, et al. (2008). Quantification of atrazine and its metabolites in urine by on-line
solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry.
Anal Bioanal Chem 391(5): 1931-1939.
Park, T. J., S. Banerjee, et al. (2006). Purification strategies and purity visualization techniques for singlewalled carbon nanotubes. Journal of Materials Chemistry 16(2): 141-154.
Pasquarell, G. and D. Boyer (1996). Herbicides in karst groundwater in southeast West Virginia. Journal
of environmental quality 25(4): 755-765.
Pengfei, Q. F., O. Vermesh, et al. (2003). Toward large arrays of multiplex functionalized carbon
nanotube sensors for highly sensitive and selective molecular detection. Nano Lett 3(3): 347351.
Petersen, E. J., L. Zhang, et al. (2011). Potential release pathways, environmental fate, and ecological
risks of carbon nanotubes. Environ Sci Technol 45(23): 9837-9856.
Peyret, N. (2000). Prediction of nucleic acid hybridization: parameters and algorithms Detroit. MI Wayne
State University PhD Dissertation.
Pienta, K. J. (2001). Preclinical mechanisms of action of docetaxel and docetaxel combinations in
prostate cancer. Seminars in oncology, Elsevier.
Pienta, K. J. and D. C. Smith (2005). Advances in Prostate Cancer Chemotherapy: A New Era Begins1. CA:
a cancer journal for clinicians 55(5): 300-318.
Pluth, J. M., J. A. Nicklas, et al. (1996). Increased frequency of specific genomic deletions resulting from
in vitro malathion exposure. Cancer Res 56(10): 2393-2399.
Pollack, C. E., G. Noronha, et al. (2012). Primary Care Providers' Response to the US Preventive Services
Task Force Draft Recommendations on Screening for Prostate Cancer. Archives of internal
medicine 172(8): 668.

160

Popov, V. N. (2004). Carbon nanotubes: properties and application. Materials Science & Engineering RReports 43(3): 61-102.
Popov, V. N., V. E. Van Doren, et al. (2000). Elastic properties of crystals of single-walled carbon
nanotubes. Solid State Communications 114(7): 395-399.
Portney, N. G. and M. Ozkan (2006). Nano-oncology: drug delivery, imaging, and sensing. Anal Bioanal
Chem 384(3): 620-630.
Potty, A. S. R., K. Kourentzi, et al. (2011). Biophysical characterization of DNA and RNA aptamer
interactions with hen egg lysozyme. International Journal of Biological Macromolecules 48(3):
392-397.
Pucca, M. B., T. B. Bertolini, et al. (2011). Therapeutic monoclonal antibodies: scFv patents as a marker
of a new class of potential biopharmaceuticals. Brazilian Journal of Pharmaceutical Sciences
47(1): 31-38.
Purcell, M., J. F. Neault, et al. (2001). Interactions of atrazine and 2,4-D with human serum albumin
studied by gel and capillary electrophoresis, and FTIR spectroscopy. Biochimica Et Biophysica
Acta-Protein Structure and Molecular Enzymology 1548(1): 129-138.
Rasmussen, U. B., V. Schreiber, et al. (2002). Tumor cell-targeting by phage-displayed peptides. Cancer
Gene Ther 9(7): 606-612.
Regino, C., K. Wong, et al. (2009). Preclinical evaluation of a monoclonal antibody (3C6) specific for
prostate-specific membrane antigen. Current radiopharmaceuticals 2(1): 9.
Renneberg, H., A. Friedetzky, et al. (1999). Prostate specific membrane antigen (PSM) is expressed in
various human tissues: implication for the use of PSM reverse transcription polymerase chain
reaction to detect hematogenous prostate cancer spread. Urological research 27(1): 23-27.
Rérole, A. L., J. Gobbo, et al. (2011). Peptides and aptamers targeting HSP70: a novel approach for
anticancer chemotherapy. Cancer Res 71(2): 484-495.
161

Reus, G. Z., S. S. Valvassori, et al. (2008). DNA damage after acute and chronic treatment with malathion
in rats. J Agric Food Chem 56(16): 7560-7565.
Rice, J. J., A. Schohn, et al. (2006). Bacterial display using circularly permuted outer membrane protein
OmpX yields high affinity peptide ligands. Protein Sci 15(4): 825-836.
Ries, L., C. Kosary, et al., Eds. (1997). SEER Cancer Statistics Review, 1973–1994: Tables and Graphs. NIH
Pub 97-2789. Bethesda, MD, National Cancer Institute.
Robert, R., M. J. Jacobin-Valat, et al. (2006). Identification of Human scFvs Targeting Atherosclerotic
Lesions. Journal of Biological Chemistry 281(52): 40135-40143.
Robertson, D. H., D. W. Brenner, et al. (1992). ENERGETICS OF NANOSCALE GRAPHITIC TUBULES.
Physical Review B 45(21): 12592-12595.
Robertson, M. P., S. M. Knudsen, et al. (2004). In vitro selection of ribozymes dependent on peptides for
activity. Rna-a Publication of the Rna Society 10(1): 114-127.
Rodriguez, L. V. and M. K. Terris (1998). Risks and complications of transrectal ultrasound guided
prostate needle biopsy: a prospective study and review of the literature. The Journal of urology
160(6): 2115-2120.
Rohr, J. and B. Palmer (2009). Aquatic herbicide exposure increases salamander desiccation risk eight
months later in a terrestrial environment. Environ Tox & Chem 24(5): 1253-1258.
Romanov, V. I., D. B. Durand, et al. (2001). Phage display selection of peptides that affect prostate
carcinoma cells attachment and invasion. Prostate 47(4): 239-251.
Sabeti, P. C., P. J. Unrau, et al. (1997). Accessing rare activities from random RNA sequences: The
importance of the length of molecules in the starting pool. Chem Biol 4(10): 767-774.
Saifuddin, N., A. Z. Raziah, et al. (2013). Carbon Nanotubes: A Review on Structure and Their Interaction
with Proteins. Journal of Chemistry.

162

Saito, R., M. Fujita, et al. (1992). ELECTRONIC-STRUCTURE OF CHIRAL GRAPHENE TUBULES. Applied
Physics Letters 60(18): 2204-2206.
Saltmiras, D. A. and A. T. Lemley (2002). Atrazine degradation by anodic Fenton treatment. Water
Research 36(20): 5113-5119.
Salvetat, J. P., G. A. D. Briggs, et al. (1999). Elastic and shear moduli of single-walled carbon nanotube
ropes. Physical Review Letters 82(5): 944-947.
SantaLucia, J. (1998). A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor
thermodynamics. Proceedings of the National Academy of Sciences 95(4): 1460-1465.
Sass, J. B. and A. Colangelo (2006). European Union bans atrazine, while the United States negotiates
continued use. Int J Occup Environ Health 12(3): 260-267.
Sayer, N., J. Ibrahim, et al. (2002). Structural characterization of a 2'F-RNA aptamer that binds a HIV-1 SU
glycoprotein, gp120. Biochem Biophys Res Commun 293(3): 924-931.
Schaffitzel, C., I. Berger, et al. (2001). In vitro generated antibodies specific for telomeric guaninequadruplex DNA react with Stylonychia lemnae macronuclei. Proc Natl Acad Sci U S A 98(15):
8572-8577.
Schier, R., J. Bye, et al. (1996). Isolation of High-affinity Monomeric Human Anti-c-< i> erb</i> B-2 Single
chain Fv Using Affinity-driven Selection. Journal of molecular biology 255(1): 28-43.
Schierz, A., A. N. Parks, et al. (2012). Characterization and quantitative analysis of single-walled carbon
nanotubes in the aquatic environment using near infrared fluorescence spectroscopy.
Environmental Science & Technology.
Schnorr, J. M. and T. M. Swager (2011). Emerging Applications of Carbon Nanotubes. Chemistry of
Materials 23(3): 646-657.
Schrama, D., R. A. Reisfeld, et al. (2006). Antibody targeted drugs as cancer therapeutics. Nature Reviews
Drug Discovery 5(2): 147-159.
163

Schwab, F., T. D. Bucheli, et al. (2011). Are Carbon Nanotube Effects on Green Algae Caused by Shading
and Agglomeration? Environ Sci Technol 45(14): 6136-6144.
Sefah, K., Z. W. Tang, et al. (2009). Molecular recognition of acute myeloid leukemia using aptamers.
Leukemia 23(2): 235-244.
Segawa, R., J. Sitts, et al. (1991). Environmental monitoring of malathion aerial applications used to
eradicate Mediterranean fruit flies in southern California, 1990. EH91-03.
Senter, P. D. (2009). Potent antibody drug conjugates for cancer therapy. Current opinion in chemical
biology 13(3): 235-244.
Shangguan, D., L. Meng, et al. (2008). Identification of liver cancer-specific aptamers using whole live
cells. Analytical Chemistry 80(3): 721-728.
Shi, H., Z. W. Tang, et al. (2010). In vivo Fluorescence Imaging of Tumors using Molecular Aptamers
Generated by Cell-SELEX. Chemistry-an Asian Journal 5(10): 2209-2213.
Shukla, G. S. and D. N. Krag (2010). Cancer cell-specific internalizing ligands from phage displayed betalactamase-peptide fusion libraries. Protein Eng Des Sel 23(6): 431-440.
Siegel, R., D. Naishadham, et al. (2012). Cancer statistics, 2012. CA: a cancer journal for clinicians.
Sievers, E. L. and M. Linenberger (2001). Mylotarg: antibody-targeted chemotherapy comes of age.
Current opinion in oncology 13(6): 522.
Signoretti, S., D. Waltregny, et al. (2000). p63 is a prostate basal cell marker and is required for prostate
development. The American journal of pathology 157(6): 1769.
Silver, D. A., I. Pellicer, et al. (1997). Prostate-specific membrane antigen expression in normal and
malignant human tissues. Clinical cancer research 3(1): 81-85.
Singhal, R., B. Gangadhar, et al. (2012). Remediation of Malathion Contaminated Soil Using Zero Valent
Iron Nano-Particles. American Journal of Analytical Chemistry 3(1): 76-82.

164

Smith, P. K., S. K. Shernan, et al. (2011). Effects of C5 complement inhibitor pexelizumab on outcome in
high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials.
J Thorac Cardiovasc Surg 142(1): 89-98.
Snow, E. S., F. K. Perkins, et al. (2005). Chemical detection with a single-walled carbon nanotube
capacitor. Science 307(5717): 1942-1945.
So, H. M., D. W. Park, et al. (2008). Detection and titer estimation of Escherichia coli using aptamerfunctionalized single-walled carbon-nanotube field-effect transistors. Small 4(2): 197-201.
So, H. M., K. Won, et al. (2005). Single-walled carbon nanotube biosensors using aptamers as molecular
recognition elements. Journal of the American Chemical Society 127(34): 11906-11907.
So, H. M., K. Won, et al. (2005). Single-walled carbon nanotube biosensors using aptamers as molecular
recognition elements. Journal of the American Chemical Society 127(34): 11906-11907.
Soh, H. T., J. S. Swensen, et al. (2009). Continuous, Real-Time Monitoring of Cocaine in Undiluted Blood
Serum via a Microfluidic, Electrochemical Aptamer-Based Sensor. Journal of the American
Chemical Society 131(12): 4262-4266.
Song, S. P., L. H. Wang, et al. (2008). Aptamer-based biosensors. Trac-Trends in Analytical Chemistry
27(2): 108-117.
Sooter, L. and A. Ellington (2004). Automated Selection of Transcription Factor Binding Sites. JALA 9:
277-284.
Stattin, P., E. Holmberg, et al. (2010). Outcomes in localized prostate cancer: National Prostate Cancer
Register of Sweden follow-up study. Journal of the National Cancer Institute 102(13): 950-958.
Stebbing, J., E. Copson, et al. (2000). Herceptin (trastuzamab) in advanced breast cancer. Cancer
treatment reviews 26(4): 287-290.
Stoger, E., C. Vaquero, et al. (2000). Cereal crops as viable production and storage systems for
pharmaceutical scFv antibodies. Plant Mol Biol 42(4): 583-590.
165

Stoltenburg, R., C. Reinemann, et al. (2005). FluMag-SELEX as an advantageous method for DNA aptamer
selection. Anal Bioanal Chem 383(1): 83-91.
Stoltenburg, R., C. Reinemann, et al. (2007). SELEX--a (r)evolutionary method to generate high-affinity
nucleic acid ligands. Biomol Eng 24(4): 381-403.
Stone, K., D. Mickey, et al. (1978). Isolation of a human prostate carcinoma cell line (DU 145).
International journal of cancer. Journal international du cancer 21(3): 274.
Strehlitz, B., C. Reinemann, et al. (2012). Aptamers for pharmaceuticals and their application in
environmental analytics. Bioanal Rev 4(1): 1-30.
Sueoka, N. (1960). Mitotic Replication of Deoxyribonucleic Acid in Chlamydomonas Reinhardi. Proc Natl
Acad Sci U S A 46(1): 83-91.
Sundaram, P., J. Wower, et al. (2012). A nanoscale drug delivery carrier using nucleic acid aptamers for
extended release of therapeutic. Nanomedicine-Nanotechnology Biology and Medicine 8(7):
1143-1151.
Suri, C. R., R. Boro, et al. (2009). Immunoanalytical techniques for analyzing pesticides in the
environment. Trac-Trends in Analytical Chemistry 28(1): 29-39.
Suzawa, M. and H. Ingraham (2008). The Herbicide Atrazine Activates Endocrine Gene Networks via
Non-Steroidal NR5A Nuclear Receptors in Fish and Mammalian Cells. PLoS One 3(5): e2117.
Takahashi, S., H. Mok, et al. (2003). Selection of chronic lymphocytic leukemia binding peptides. Cancer
Res 63(17): 5213-5217.
Tans, S. J., A. R. M. Verschueren, et al. (1998). Room-temperature transistor based on a single carbon
nanotube. Nature 393(6680): 49-52.
Tavitian, B., F. Duconge, et al. (2009). In Vivo Imaging of Oligonucleotidic Aptamers. Methods in
Molecular Biology. G. Mayer, Humana Press Inc, 999 Riverview Dr, Ste 208, Totowa, Nj 075121165 USA. 535: 241-259.
166

Tchounwou, T. B., B. A. Wilson, et al. (2001). Atrazine potentiation of arsenic trioxide-induced
cytotoxicity and gene expression in human liver carcinoma cells (HepG2). Molecular and Cellular
Biochemistry 222: 49-59.
Tewari, A., G. Divine, et al. (2007). Long-term survival in men with high grade prostate cancer: a
comparison between conservative treatment, radiation therapy and radical prostatectomy--a
propensity scoring approach. Journal of Urology 177(3): 911-915.
Thess, A., R. Lee, et al. (1996). Crystalline ropes of metallic carbon nanotubes. Science 273(5274): 483487.
Thompson, I. M., C. Chi, et al. (2006). Effect of finasteride on the sensitivity of PSA for detecting prostate
cancer. J Natl Cancer Inst 98(16): 1128-1133.
Thompson, I. M., C. Chi, et al. (2006). Effect of finasteride on the sensitivity of PSA for detecting prostate
cancer. Journal of the National Cancer Institute 98(16): 1128-1133.
Thostenson, E. T., Z. F. Ren, et al. (2001). Advances in the science and technology of carbon nanotubes
and their composites: a review. Composites Science and Technology 61(13): 1899-1912.
Tran, C., C. Lin, et al. (2002). Prostate stem cell antigen is a marker of late intermediate prostate
epithelial cells. Molecular cancer research: MCR 1(2): 113.
Tu, X. M., S. Manohar, et al. (2009). DNA sequence motifs for structure-specific recognition and
separation of carbon nanotubes. Nature 460(7252): 250-253.
Tu, X. M., A. R. H. Walker, et al. (2011). Evolution of DNA Sequences Toward Recognition of Metallic
Armchair Carbon Nanotubes. Journal of the American Chemical Society 133(33): 12998-13001.
Tuerk, C. and L. Gold (1990). Systematic Evolution of Ligands by Exponential Enrichment-RNA ligands to
Bacteriophage T4 DNA-Polymerase. Science 249(4968): 505-510.
Tuerk, C. and L. Gold (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to
bacteriophage T4 DNA polymerase. Science 249(4968): 505-510.
167

Turner, B., J. Waithman, et al. (1991). Environmental monitoring results of the Mexican fruit fly
eradication program, San Diego County, spring 1990. California Department of Food and
Agriculture Environmental Hazards Assessment Program.
Ulrich, H., J. E. Ippolito, et al. (1998). In vitro selection of RNA molecules that displace cocaine from the
membrane-bound nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A 95(24): 1405114056.
Urata, H., K. Nomura, et al. (2007). Fluorescent-labeled single-strand ATP aptamer DNA: Chemo- and
enantio-selectivity in sensing adenosine. Biochemical and Biophysical Research Communications
360(2): 459-463.
USDA (2009). Pesticide Data Program, Annual Summary, Calendar Year 2008. U.S. Department of
Agriculture.
USEPA (2006). Reregistration Eligibility Decision (RED) for Malathion. U.S. Environmental Protection
Agency.
USEPA (2011). Atrazine in Drinking Water. http://water.epa.gov.
USEPA (2012). 2012 Edition of the Drinking Water Standards and Health Advisories. U.S. Environmental
Protection Agency EPA 822-S-12-001.
USGA (2000). Organophosphorous pesticide occurrence and distribution in surface and groundwater of
the United States, 1992-1997. U.S. Geological Survey, NAWQA Program Report 00-187.
USGS (2002). Pesticide Use Maps. http://water.usgs.gov.
Vaccaro, P., E. Pavoni, et al. (2006). Efficient display of scFv antibodies on bacteriophage lambda. J
Immunol Methods 310(1-2): 149-158.
Vally, M., S. Seenu, et al. (2006). Emerging peptide therapeutics for inflammatory diseases. Curr Pharm
Biotechnol 7(4): 241-246.

168

van den Beucken, T., H. Pieters, et al. (2003). Affinity maturation of Fab antibody fragments by
fluorescent-activated cell sorting of yeast-displayed libraries. FEBS Lett 546(2-3): 288-294.
Vardharajula, S., S. Z. Ali, et al. (2012). Functionalized carbon nanotubes: biomedical applications.
International Journal of Nanomedicine 7: 5361-5374.
Veiseh, O., J. W. Gunn, et al. (2010). Design and fabrication of magnetic nanoparticles for targeted drug
delivery and imaging. Advanced drug delivery reviews 62(3): 284-304.
Vera-Avila, L. E., J. C. Vázquez-Lira, et al. (2005). Sol-gel immunosorbents doped with polyclonal
antibodies for the selective extraction of malathion and triazines from aqueous samples. Environ
Sci Technol 39(14): 5421-5426.
von Minckwitz, G., S. Harder, et al. (2005). Phase I clinical study of the recombinant antibody toxin
scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid
malignomas. Breast Cancer Res 7(5): R617-626.
Wang, C. L., G. Yang, et al. (2009). In vitro selection of high-affinity DNA aptamers for streptavidin. Acta
Biochimica Et Biophysica Sinica 41(4): 335-340.
Wang, J. (2005). Carbon-nanotube based electrochemical biosensors: A review. Electroanalysis 17(1): 714.
Wang, J., Y. Liu, et al. (2011). Selection of phage-displayed peptides on live adherent cells in microfluidic
channels. Proc Natl Acad Sci U S A 108(17): 6909-6914.
Wang, J. X., X. Z. Zhang, et al. (2008). Toxicity assessment of manufactured nanomaterials using the
unicellular green alga Chlamydomonas reinhardtii. Chemosphere 73(7): 1121-1128.
Wang, L., V. Castranova, et al. (2010). Dispersion of single-walled carbon nanotubes by a natural lung
surfactant for pulmonary in vitro and in vivo toxicity studies. Part Fibre Toxicol 7: 31.
Wang, L., X. J. Liu, et al. (2012). Selection of DNA aptamers that bind to four organophosphorus
pesticides. Biotechnology Letters 34(5): 869-874.
169

Wang, M., A. Liu, et al. (1999). Growth of HPV-18 immortalized human prostatic intraepithelial neoplasia
cell lines. Influence of IL-10, follistatin, activin-A, and DHT. Int J Oncol 14(6): 1185-1195.
Wang, M., L. Valenzuela, et al. (1979). Purification of a human prostate specific antigen. Investigative
urology 17(2): 159.
Wang, X. X. and E. V. Shusta (2005). The use of scFv-displaying yeast in mammalian cell surface
selections. J Immunol Methods 304(1-2): 30-42.
Wang, Y. Y., Y. S. Wang, et al. (2008). Fluorescent detection of ATP based on signaling DNA aptamer
attached silica nanoparticles. Nanotechnology 19(41).
Watters, J. M., P. Telleman, et al. (1997). An optimized method for cell-based phage display panning.
Immunotechnology 3(1): 21-29.
Weisman, R. B. (2010). Fluorimetric characterization of single-walled carbon nanotubes. Analytical and
Bioanalytical Chemistry 396(3): 1015-1023.
Wels, W., I. M. Harwerth, et al. (1992). Selective inhibition of tumor cell growth by a recombinant singlechain antibody-toxin specific for the erbB-2 receptor. Cancer Res 52(22): 6310-6317.
Welsher, K., S. P. Sherlock, et al. (2011). Deep-tissue anatomical imaging of mice using carbon nanotube
fluorophores in the second near-infrared window. Proc Natl Acad Sci U S A 108(22): 8943-8948.
Wenseleers, W., I. I. Vlasov, et al. (2004). Efficient isolation and solubilization of pristine single-walled
nanotubes in bile salt micelles. Advanced Functional Materials 14(11): 1105-1112.
Willemsen, R., P. Chames, et al. (2008). Selection of human antibody fragments directed against tumor
T-cell epitopes for adoptive T-cell therapy. Cytometry A 73(11): 1093-1099.
Williams, K. P., X. H. Liu, et al. (1997). Bioactive and nuclease-resistant L-DNA ligand of vasopressin. Proc
Natl Acad Sci U S A 94(21): 11285-11290.
Williams, R. and R. Naz (2010). Novel biomarkers and therapeutic targets for prostate cancer. Frontiers
in bioscience (Scholar edition) 2: 677.
170

Wilson, D. S. and J. W. Szostak (1999). In vitro selection of functional nucleic acids. Annual Review of
Biochemistry 68: 611-647.
Wilson, J., F. Llados, et al. (2003). Toxocological Profile for Malathion. Agency for Toxic Substances and
Disease Registry (ATSDR).
Wong, Y. N., N. Mitra, et al. (2006). Survival associated with treatment vs observation of localized
prostate cancer in elderly men. JAMA: the journal of the American Medical Association 296(22):
2683-2693.
Woolf, S. H. (1995). Screening for prostate cancer with prostate-specific antigen—an examination of the
evidence. New England Journal of Medicine 333(21): 1401-1405.
Wortberg, M., M. H. Goodrow, et al. (1996). Immunoassay for Simazine and Atrazine with Low CrossReactivity for Propazine. J Agric Food Chem 44(8): 2210-2219.
Wright, G. L., C. Haley, et al. (1995). Expression of prostate-specific membrane antigen in normal,
benign, and malignant prostate tissues. Urologic Oncology: Seminars and Original Investigations,
Elsevier.
Wu, Y. R., K. Sefah, et al. (2010). DNA aptamer-micelle as an efficient detection/delivery vehicle toward
cancer cells. Proceedings of the National Academy of Sciences of the United States of America
107(1): 5-10.
Xie, S., J. Liu, et al. (2009). Biodegradation of malathion by Acinetobacter johnsonii MA 19 and
optimization of cometabolism substrates. Journal of Environmental Sciences(China) 21(1): 76-82.
Yagoda, A. and D. Petrylak (2006). Cytotoxic chemotherapy for advanced hormone‐resistant prostate
cancer. Cancer 71(S3): 1098-1109.
Yan, L., L. Yang, et al. (2009). Production and characterization of monoclonal antibody for class-specific
determination of O, O-dimethyl organophosphorus pesticides and effect of heterologous
coating antigens on immunoassay sensitivity. Microchemical Journal 93(1): 36-42.
171

Yang, M., M. Loda, et al. (1998). Identification of genes expressed differentially by LNCaP or PC-3
prostate cancer cell lines. Cancer Res 58(16): 3732-3735.
Yang, P. Y., H. X. Wang, et al. (2010). Microfluidic chip-based aptasensor for amplified electrochemical
detection of human thrombin. Electrochemistry Communications 12(2): 258-261.
Yao, S. L. and G. Lu-Yao (1999). Population-based study of relationships between hospital volume of
prostatectomies, patient outcomes, and length of hospital stay. Journal of the National Cancer
Institute 91(22): 1950-1956.
Yi, C. Q., C. C. Fong, et al. (2007). Interactions between carbon nanotubes and DNA polymerase and
restriction endonucleases. Nanotechnology 18(2): 025102.
Yildirim, N., F. Long, et al. (2012). Aptamer-based optical biosensor for rapid and sensitive detection of
17beta-estradiol in water samples. Environ Sci Technol 46(6): 3288-3294.
Yoshida, W., E. Mochizuki, et al. (2009). Selection of DNA aptamers against insulin and construction of
an aptameric enzyme subunit for insulin sensing. Biosensors & Bioelectronics 24(5): 1116-1120.
Youn, S., R. Wang, et al. (2011). Mitigation of the impact of single-walled carbon nanotubes on a
freshwater green algae: Pseudokirchneriella subcapitata. Nanotoxicology.
Yu, B., M. Ni, et al. (2005). Human scFv antibody fragments specific for hepatocellular carcinoma
selected from a phage display library. World J Gastroenterol 11(26): 3985-3989.
Yu, C. C., Y. Hu, et al. (2011). Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of
Anticancer Drug to MUC1-Positive Cancer Cells In Vitro. PLoS One 6(9).
Yu, M. K., D. Kim, et al. (2011). Image-Guided Prostate Cancer Therapy Using Aptamer-Functionalized
Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles. Small 7(15): 2241-2249.
Zhang, G. Y., P. F. Qi, et al. (2006). Selective etching of metallic carbon nanotubes by gas-phase reaction.
Science 314(5801): 974-977.

172

Zhang, L. B., H. Wei, et al. (2010). A carbon nanotubes based ATP apta-sensing platform and its
application in cellular assay. Biosensors & Bioelectronics 25(8): 1897-1901.
Zhang, X. Q., Q. Guo, et al. (2009). Recent Advances in Nanotechnology Applied to Biosensors. Sensors
9(2): 1033-1053.
Zhang, Y. and L. Zheng (2010). Towards chirality-pure carbon nanotubes. Nanoscale 2(10): 1919-1929.
Zhang, Z. Z., C. C. Shen, et al. (2008). Aqueous suspension of carbon nanotubes enhances the specificity
of long PCR. Biotechniques 44(4): 537-544.
Zhang, Z. Z., M. C. Wang, et al. (2007). An aqueous suspension of carbon nanopowder enhances the
efficiency of a polymerase chain reaction. Nanotechnology 18(35): 355706.
Zhao, Z., L. Xu, et al. (2009). Recognition of subtype non-small cell lung cancer by DNA aptamers selected
from living cells. Analyst 134(9): 1808-1814.
Zheng, M., A. Jagota, et al. (2003). DNA-assisted dispersion and separation of carbon nanotubes. Nature
Materials 2(5): 338-342.
Zhou, E. H., R. J. Ellis, et al. (2009). Radiotherapy and survival in prostate cancer patients: a populationbased study. International Journal of Radiation Oncology* Biology* Physics 73(1): 15-23.
Zhou, J. W., A. V. Ellis, et al. (2012). Aptamer sensor for cocaine using minor groove binder based energy
transfer. Analytica Chimica Acta 719: 76-81.
Zhu, L., C. Li, et al. (2012). In Vitro Selection of Highly Efficient G-Quadruplex-Based DNAzymes.
Analytical Chemistry 84(19): 8383-8390.
Zhu, X. S., L. Zhu, et al. (2009). Acute toxicities of six manufactured nanomaterial suspensions to Daphnia
magna. Journal of Nanoparticle Research 11(1): 67-75.
Zitzmann, S., S. Kramer, et al. (2007). Identification and evaluation of a new tumor cell-binding peptide,
FROP-1. J Nucl Med 48(6): 965-972.

173

Zitzmann, S., W. Mier, et al. (2005). A new prostate carcinoma binding peptide (DUP-1) for tumor
imaging and therapy. Clin Cancer Res 11(1): 139-146.
Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids
Res 31(13): 3406-3415.
Zuo, X. L., Y. Xiao, et al. (2009). High Specificity, Electrochemical Sandwich Assays Based on Single
Aptamer Sequences and Suitable for the Direct Detection of Small-Molecule Targets in Blood
and Other Complex Matrices. Journal of the American Chemical Society 131(20): 6944-+.
Zweig, G. and J. M. Devine (1969). Determination of organophosphorus pesticides in water. Residue
reviews 26: 17.

174

rwilliams@hsc.wvu.edu

(304) 293-9566
Ryan M. Williams
1 Medical Center Drive
PO Box 9530
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Education
•

•
•

Graduate
o West Virginia University
August 2008-Present
 Ph.D. Student, Pharmaceutical and Pharmacological Sciences
 August 2010-Present
 Ph.D. Candidate, August 2011
 Ph.D. Student, Department of Biology
 August 2008-July 2010
Undergraduate
o University of Virginia
August 2004-May 2008
 B.A., Biology
High School
o Graham High School, Bluefield, Va.
August 2000-May 2004
 Advanced Degree, Summa Cum Laude

Research Experience
•

•

Graduate Research Assistant
o Dr. Letha Sooter
January 2010-Present
 Investigations in Molecular Recognition Element Selection and SingleWall Carbon Nanotube Properties
o Dr. Rajesh Naz
August 2008-December 2009
 Novel Biomarkers and Immunotherapies for Prostate Cancer
Undergraduate Research Assistant
o Dr. Edmund Brodie III
September 2006-May 2008
 Evolutionary Genetics of Caribbean Anolis spp.

Fellowships and Assistantships
•

American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship in
the Pharmaceutical Sciences
September 1, 2011-August 31, 2013
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WVNano/NanoSAFE Graduate Fellowship Program (NSF Cooperative Agreement)
August 15, 2011-August 15, 2013

•

Cancer Nanotechnology Graduate STEM Fellowship
Selected for period of August-December 2011

• Graduate Research Assistant, West Virginia University
o Dept. of Basic Pharmaceutical Sciences
August 2010-Present
o Dept. of Biology
May 2010-August 2010
o Dept. of Microbiology and Immunology
May 2009-August 2009
• Graduate Teaching Assistant, West Virginia University Dept. of Biology
o Biol 321: The Total Science Experience
Spring 2009, 2010
o Biol 441: Vertebrate Microanatomy
Fall 2009
o Biol 115: Intro Biology Lab
Fall 2008
Publications and Patents
Williams RM, Hajiran CJ, Nayeem S, and Sooter LJ. Identification of an antibody fragment
molecular recognition element specific for prostate cancer cells. In Preparation for
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Williams RM, Eamonn Maher, and Sooter LJ. In vitro selection of ssDNA molecular recognition
elements for the pesticide malathion. Submitted to Applied Biochemistry and
Biotechnology, March 2013.
Williams RM and Sooter LJ. In vitro selection of molecular recognition elements specific for the
herbicide atrazine. Submitted to PLoS One, March 2013.
Williams RM, Taylor H, Thomas J, Hines B, and Sooter LJ. The effect of DNA- and sodium
cholate-dispersed single wall carbon nanotubes on the green algae Chlamydomonas
reinhardtii. Submitted to Environmental Toxicology, March 2013.
Williams RM, Nayeem S, Hines B, and Sooter LJ. The effect of DNA-dispersed single-wall
carbon nanotubes on the polymerase chain reaction. Under Review for Nanotechnology.
Submitted December 2012.
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Williams RM and Sooter LJ. In vitro selection of cancer cell-specific molecular recognition
elements from amino acid libraries. In Preparation for Molecular Cancer Research.
Williams RM and Naz RK. (2010) Novel biomarkers and therapeutic targets for prostate cancer.
Frontiers in Bioscience S2:677-684.
Letha J. Sooter and Ryan M. Williams. Single-stranded DNA sequences that bind atrazine and
simazine. Disclosure of Intellectual Property, West Virginia University Docket No.
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Letha J. Sooter, Kailey Imlay, and Ryan M. Williams. Single-stranded DNA sequences that bind
to Pseudomonas aeruginosa Exotoxin A. Disclosure of Intellectual Property, West
Virginia University Docket No. 00585. Submitted December 2011.
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•
•
•
•
•
•
•
•
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Engineering (AIChE SBE) 2012 International Conference on Bioengineering and
Nanotechnology. Berkeley, CA.
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Rho Chi National Pharmacy Honor Society, Alpha Mu Chapter
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Ethel N. Bowen Foundation Scholarship, First Century Bank, Bluefield, WV
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2004
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•
•
•
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15 Undergraduate Students
10 Graduate Rotation Students
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1 Pharm. D. Student
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Williams RM, Hajiran CJ, Nayeem S, and Sooter LJ. In Vitro Selection of Molecular
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Engineering (AIChE SBE) 2012 International Conference on Bioengineering and
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Williams RM, Nayeem S, and Sooter LJ. Antibody fragments for the targeted treatment and
diagnosis of prostate cancer. Appalachian Health Summit, University of Kentucky Center
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Molecular Recognition Elements. American Association of Pharmaceutical Scientists
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Williams RM, Nayeem S, and Sooter LJ. Identification of Antibody Fragments Specific for
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Industry, and Commercialization (LIINC) Biomedical Sciences Graduate Student Event,
Invited Oral and Poster Presentation. March 2013.
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Williams RM, Nayeem S, and Sooter LJ In vitro selection of antibody fragments that specifically
bind to prostate cancer cells. West Virginia University Health Sciences Center Van Liere
Research Day. March 2012.
Williams RM, Nayeem S, and Sooter LJ. Molecular Recognition Elements for Prostate Cancer
and Pesticides. West Virginia University Linking Innovation, Industry, and
Commercialization (LIINC) Biomedical Sciences Graduate Student Event, Invited Oral
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Williams RM, Nayeem S, and Sooter LJ. In Vitro Selection of Prostate Cancer Cell and Pesticide
Molecular Recognition Elements. West Virginia University School of Pharmacy
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Williams RM and Sooter LJ. Systematic Evolution of Ligands for Prostate Cancer Cells and
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Jackson AM, Williams RM, and Sooter LJ. In vitro selection of molecular recognition elements
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Kulick AR, Williams RM, and Sooter LJ. In Vitro Selection of PETN Molecular Recognition
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Day. October 2011.
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March 2011.
Imlay K, Williams RM, and Sooter LJ. In Vitro Selection of Molecular Recognition Elements
Against Exotoxin A. West Virginia University Health Sciences Center Van Liere
Research Day. March 2011
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of O,O-Diethyl Dithiophosphate. West Virginia University Health Sciences Center Van
Liere Research Day. March 2011.
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Activities
•
•

Rho Chi National Pharmacy Honor Society, Alpha Mu Chapter
Member American Association of Cancer Researchers (AACR)

2012-Present
2011-Present

• Member American Association of Pharmaceutical Scientists (AAPS)
o West Virginia University Student Chapter
2011-Present
•

Member American Chemical Society (ACS)
2011-2012

•

WVU Cell Biology Training Program
2010-2012

•
•
•
•
•
o
•
o
•
o
•
o

WVNano NanoDays Volunteer Community Outreach
March 17, 2012
National Science Foundation Workshop, Science: Becoming the Messenger, West
Virginia University, Morgantown, WV
October 11, 2011
WVU Biology Graduate Student Association Treasurer
2009-2010
Cavalier Daily Newspaper Associate Sports Editor and Staff Writer
2007-2008
University of Virginia Children’s Hospital Pediatric Unit
Over 60 volunteer hours
2007-2008
Energy Express (Americorps) Mentor, Mercer County, WV
Over 300 volunteer hours per summer (>900 hours total)
Summers 2005, 2006, 2007
Martha Jefferson Hospital Emergency Department, Charlottesville, Va.
Over 60 volunteer hours
2006-2007
University of Virginia Madison House Boosters Program
Over 30 elementary classroom volunteer hours
2005-2006
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